var title_f8_46_8928="Pneumothorax PA";
var content_f8_46_8928=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Pneumothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 245px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD1AhIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5W3ey/lSgk9FH5U8Q88nip44uoAwKAIUUg8hfpip0j3fwIB9Kmjix0BNWUh5weTQBCkKsM+VGB/u1MtvGB/qUP/AatxwgAbhk+lTrGxPTFAFJLSMkZgiH/AavwWFuT81vF0/uVZggIxkZq7FFjGR9BQBDb6XaOctaW+P9yr8GkWBA3WNsQP8ApnU8ERGQDknrV+0ty+eSFz1xQBVi0XTX66da89P3dXYvD2mhgW0yzK/9cxWhDEcAAcdCcVcCMOimgDN/sHR8/wDIJsv+/QqWHQdFbIOk2P1MQq9yoII6+tWoIwT0474oApDw9oZXK6LYH/tkKfF4e0FyRJpOmxEcDMQ5rRUKp+8VHpTpHtdpMhDfUUAYl34c0GNxt0yxxjoIxVZfD+kE5GkWRH/XIVq3CoDuEewnoKRZVdF5wF/M0AU7Xw9orH5tHsfxiqxL4a0PB26PYHjr5VWoJuSf0qyHXHDfhQBz0vhzSEY50qxX2MVRDQdHH/MKsvxirauTuO4nmqzkRj5zt+tAGO+g6Wp/5BdkfpFUbaFpTHjTbQfSIVbvr9VwsOWJ71lT37DJLAe2aAJ38P6dsJXTbPHUfIKrPodgp502059IxSLqjK330z2Gau2mpRzAK7KGPvQBh3WhWo5isoOD08usyXT7XOBaQKR6pXclSDlDuHtVS6tIpt25AD7UAcLLZQKf+PeID/d6VTktkAbbBF9dtdbd6ewBKDcn61mNZ9eMfhQBgxWqbhuiTn/ZqdreBE/1MJPbKVovbOORzVeaJipBHI6GgCgWgQ/8e8BP+4Kmh+zyAlrWAfSOl+yrnnHvU0aCNcD8aAIiLePBFrbtj+9HR5sLYxY2n4R1HPKWPCk+lQoJGbOSKAL5igI5tLfPoI6+j/gX4L8M6x8F9U1LVvD2mXN/HJdhZ5bdWcBV+XBPp2r5vJZAMjP07V9Xfs5Nn4Bayx/563x/8doA+KaSvd/hr+z5qPjPwG2uSX32C6nbNnFIuVkT1buM84rzrx58PfEPge9Nv4g094oyfkuY/mik+jf0oA44cjgU5ULHHT61PFEVJA5NTLCf4j+VAFdY+SOo+nNWIbcE8qDx0qxDGDnAwKsww5+7x6mgCtHaxkjci89sVp2GnQM3zwRtz6U2CAlyT2P6VtWUYVckYoAntNHsGGWs4D9VrQh0XSypJ0+2P/AKdbDjI+7jFadkvyEnrQBVj0HStozptqSf9ir0HhrSD97S7T/v3VuFULDnDehrQj+TGCTj1oAqW/hrRIWy2jWEgP8AeiBrVg0LwxIAraBpqP7wimEs6/KMH1oZJDGcuB6nHSgC0fC3hlzldE0zH/XIUf8ACJ+G/wDoB6d/36FZG6dZOJRx2rUNzIsPJ5xQBBceGfDUZLHRdPC/9chWXeaR4dQfutDsSf8ArkKuzXDHOTkmqjlhyozQBztxo+lSOcaXZx89FjqhLo2nAHFjbjH+xXSPGGPIwao3kLKGIGQRQBy91pNkoOLSEfRawL6zhWQ7IlUdsCuwucY75xXP3secjJoA514FzlVH0qu8QAPBzWtJEDns1V5I/wC8PxoAyyCOtJVyWHoW5FV3jKgntQBHRS44pKACiiigDaSEY5+X2pyRAMc8jtWyuiXY5aPP4086TKgJMLfhQBkxxEgYHHrV2CDHPP5davR2LAKfLbjrxVy3siCcjn3HWgClFBnquPYVchtAR6H3q/HZgdvzqybZlALHj2oAoiDAGD9fap4Lcu+I1JatG2sNwDPkKe/c1rW8Cxx7gu0d80AULTTCoDTHB/uitCOFEGFX8ajlvI0Y87gO/asPU9fkUeVCdnbIoA6NpRCQGYLnnrUMmqpHwoDH2NcJNeyu+WlZj35qI3GGxlj6c0AdwuqEvyp29+a0re7jlXKNtavN0u3TG0sPxrQt9TMYG89+CDQB34nAYZYEjirEQR1yACwOelcxpupCf5WBPpW3ayASArxmgBdRhldmw1ZnkzB8qcj2rYvWD7ctgjjNVkA8ssR0OKAEsofm5bB71ddAiMeT6VUgHzGrQl+XGMn3oAruxTkkYzxXP61qCiQl2GPar+rXZSNwh56CuMullmZi2CfQ0AQX+oyOxKMVU8cVjtdOSepz71duI9rYdS3HSq0luOTgD6GgCDzm54Ht7UiTupyDThHGpwWPHbNSpFCVHXmgDV0y/lC5Eh/Ot6z1TzNqzAE9MmsC1jhiXgVejIT7qrQBvmJZCWQ4P91qrS2PnLkLtk7+9R29yyKMqGHoa17C6WUBTgY6ZHNAHOyWpBKkHPoRVWWzJz8tdvNAHwdoDj9aqeQpODGMnsaAOGltB6HNVJIGUnGTivQ30uFskqCcVm3GixknYSp9PSgDh9i91H5U0+Wh5AB+ldNdaHKCSpDZrOm0qdODEfqKAMaZwwAU/WvsD9k2FLn4PTQzLvilv7lGU9wcAivk2WwfP+rJ7fSvrP8AZikOmfBi8uWQt5F3dS7fXaAcfpQBS+OvxG1XwNcaX4b8IRQ2m23DtK0e4Ig+VVUfhV34b+Ih8XPAOs6N4vtIZru3XZJIqYDZB2sB/CwxW5o954I+LkGj6vuhk1GzKyiEsBJGw5KMO65qh8TPGnhb4c6Zq6aPFa/2/fjDW9vjJcgjcw7AUAfFt9YCy1G7td24QTPFn1Ckj+lNVAMYXmrLhpriSWZgXdi7Y7k8mpUQk/KBQBAkJ/i4HpViNCwqaKIk84J7Crdvbu7gKuT7UARW8XT0HWtW3gaQhYlJqa0sQGG8bn9B/Wty3jSFQMqCPSgCO0tCuBt5q8sJUghKhM8MXLuAPrSJqdoCAHyenJoAuRR7VyR8xq7bgMAA351UguYZVGWHHPFW0YL84wQPSgC50HNRSv8AKVJGevBpxAkUNk49qrXUCMM7yOOKAITIGfJwST1zWhgPGB29qy4YIzJjJPpWjMDFHhF56GgCm/ynaAQvf3phUsnAI96e8ojLM/XHSsTUdaiiJXlmHZaANExDPL81BLGrHgn61z7eISTxFiiPxD8w3x5BoAs6jZtw0eG7kDtXN3ceSc5HNdUl9bTjcjFc+tVL+1WZCzKDn+IUAchPF+fY1Vkj2gbsEGty6tmhOCNynvVOWDIIxj2NAGO0R528j0qu8QPTgitXyuoKge4qKWDrkZHqKAMVowFPBqFlwcd61njI6jIqs8PUrgfzoAoUVb8tv7p/KigD12KLeRyBWhb26jlgCKYssZ++lWbeWJcsQWB6jHNADxDGeRGv5VILdSQfKAPc1Ol1aOoUK8YHqtSBoXGRJ+dAFYWkQOQo/KrEdnEOXUfSrUECnDMwOelOuAYkbaVZ+nHagChLFDFy33v4V9Ky7oNOxCyHGePSr0yEgeZz3rLupAmQPWgCvcWrhCC9YE9oATlwxznmtS5nDDDSEe1ZE8wTOATj1oAhaBAfmIGfSgRxKehYVBJcOxxgc9Ce1IJWIyGyKAJ1jViQFFIsJD4BIPpTopTgHAzTnlRZQ2TzQBbtmaEqVycV0un3W8KQea5u1ljYEK+T6Vt6YvbrzkH0oA3J3ym7HT9agS4xkMPlNWkTdFzn61HHbIwBPf0oASNwHGD+VTzuSAuOg6jtRHAkbAckA1JcDPyqMcUAYGsBmwFGAeprG+zgFmkzjPatzUInZslgFrn7++jhcoDkjrQBnXagyNx06YrOmCKfmO0/zqS7vHJfAwKy3YliSSR70AS74ixypPvip4GjJBIbA9qzmlAPHNBndRgAjPrQBvpLCW44x3qzDLB0LnPrXKec+RycU7z/AGb86AO3guo1Xgg+2a0rS4gI6gY75rzhJ8EEFga07S/2kCXPXqKAPVrSaOSMcgkDg1MVjb5j97p+Fcr4fv0aVArAmupZNxDLyfT1oAWNI5BwRkU2S1VhwBu6HNV5Qyz/ACg7SPyqwjB/vNtb19aAKTW7RdAD6cVDLEM8ryea0ZVkAxgN6Gqr/N8r/K4oAoPBgbdvy19CfBZcfBzVAo533fAHX5a8GaJW+9Iv419BfBX9x8Kb5omBZZblhjscUAeAeEobb4e32g+LHeWa3lRo3tXXy50Yj723uvvXCeJb1tY17UtSYnddzGT5uuD0FdTevcalK1xfu09w2MtIc4HoPQe1Vjo8Mg5XYfYUAchHb/L0JqzHbk8449q6E6G4bMThgPUUsWlzI4Dx9emKAMeG1ZjhVwe/0rTijjgQYbapHLdzWoLQIm3H1+tU3gHnlpRnHIXsKAEjYquFXGfzxSXFwYo8lsHtTbi6ji4J79B2rEvLrzZW4Jx0zQBPJKZGZnlJJ/SmbA/8ZNVDMx9OKely+fug/SgDTspZYW+Vj6DFdPpl4swGcLIPvehrlLG7iG4uCBWzYujurI2fYUAdZFIPL5444rOnulLso4I6VLbkGI9SMcfWqRtQ7udxAzQBPazbphkj/wCvV2eVihywFUbGFFbOSfTipL5mAAxgHvQBja3ekL5UeQzdTXKXAJZixx/jW3qUyoSXbDZ61zl9dqCfLGfXNAEUmFx8gJPU1Crc528ehqB53dic4HoKiNwQcbqANizuAjbc4z2rctJ2U7VIK46VyMM5LqcAjpmtW1uwMYyh9+9AG48UboVHAHVfT3rOntijFWGR2PrWhBP5xViuG6bhVyS2aZMFTjsfQ0ActLADwMnnpVSSJgeOg9q6OS0kUkNHznpiqk9k4JO0j3oA5+WPPKgknrVaSME4PDVtTWpHbn6VUkgOOgxnJoAy/Kb0oq6YTnjpRQB61NZBOGGDjr60lvZkDOe/511tzYRuqbiowOao3Jt41CxgscUAUEtSTtC5z3qeOwViA5C1G0jt3x24qzawuVJydzdM9qAJVRVBKDpxnsKx7+4Me7a+BnrWlqEogtjzhcc81wuqag8r7UJCelAFu91d0JCEMT69qwp9UkJ/eDcCahkZyxC5OKqsuR+8OD6UAWn1CIrhlPXpmopCs4+U8jiq5KAkKAD64pgkI+UHp2oAWSJz9zH1FKkLADcRnvUciuFDI3HpRFdEt85/KgC01u7AMGB4702aN9ikjn1FP85TGAG4qYLuVQMFRzmgBLWAqocg57GtrTpHik+ZgfSoIUJULnoKs28e6RQygemKAOntXZ4Ru6mrEAAOCckdKq24PkbVwcDgipELpg7c/TrQBbY4lUnGD+lV55CJBnkVISZSMDBxzUE0b78DkCgDE1WQr5gHfmuGvEdp3IYkE13erxjb1+Y8Vyc6hWOTk0AYE4fzCHbA7Z71Xcbz8xJ/GtO6iBYkj5evNZkjqrHB4zxigAVVXoKU474/GoHuAuOMGomus9UBFADyx3E8GlLAjlR+FQNPls7cD0pRKuOcigCdEV++D6VOikLjriqiOu9TuHWr9vlpAEPWgDS0eZ43LISpGOteh+H9TW5RY5W2yD7v+1XBwKpXGOelaVr5luyOmcg5BFAHf3UJbEgGCOoqrVrTbtbu2Rwfnxhs96ZcQFCpTlW6UAMimZOnKnsasm3gvV+Q7JQPuk1TIIPIqeJdoB/ioArSWvlttdGDele/fB+LyvhTfjGCXuTg/wC7XkWnzx3DJDcqCR91u9e3fDq38n4dX8fYtcHP1WgD5bjnIjXdH0Har1o9vJjLsH9COKiFjICioMgjrUy2vkkecyg9x3oAtC32nMYJBqxb27nnHOcVTjnCELFvyTwc/wBK0RdGOP5zwBzigCK7CKhUhSo6k1gXrJKGCgIn6mrN5eLdOVUkAevSqcioijDAnHegDKmsGLFoyoUjkms2exfzOSoJ9OlbMpyRuY49Kz55B1C5A9aAKa2gzyetTix2pgHP9ajaRgecVPFIwQHt6UAMisXEjNwRjpVq3R0kUDI6dKk89DHlgQ3TI71YtUD4KnPvigDoLWVmhOSMdOKeroysAfmH61WgQsmDkYH61OlsWUsGPsKAJrXbnC9Ko6vOVAxgDGDV6OAon3setZGpgybguTnpQBzGolpWJzwPesiW1zguxyewravwE4+76msu5mXaAuSc4zQBRe3UdDzVd7dMk/MfXFTSTs2QOQO9RGRiMFuKAJ4IIyF6g9s1dhh4JB/OqCXSK/zAfnViO+jDfKMmgDYtrl4McKcdRXT6dOtyqr/D2A7GuJS93Lhhx2xVyz1Ga3lDpyo6igDtWhKsTt/Go3gDrnbx9KfaXf2mGN1Iww5z2NN+0SxMVOMDtQBRmsowSWjDZ6E1Rm0e2cZVSrexrofOEqgKoJPUGqkxVWO5SB0DUAc+dBhyfnf8qK2ty/36KAO9vpjI58oHYR61QZQwwavzp8xwOCO1VxEMnJOKAIFHQD6VpRoI0wOOMlqjt4ADv546ZqPWJmhtcL99+BQBy/ie8Nw22M4jXgAd65iSPBLS8DsBXRXMaqMvyxH5Vg3zLGW8zoOgoAqTSEIQowp6cVlzyKOox7+tO1C82qNmeOB71jvI7/eYkGgC3JdAZ24yKhkuWLZT5RVeigCw9wWjKZOO1V6KciFyQO1AFhCdi9/WrttcMjfKxH9agiiRYdxORT44Q5+9he2aANu2vn2gYDD1rYsZFlZcAbs/jXN2kZQAZ4Fbmmp+9Qo3Q/nQB1duMDjGBx71ahJ3YHSs+3fAJPIJ5rQt1O4BeAaALYjUKcg5HPFVLnJwoODWkVIUH1rPuhg5zz60Ac9qrAI5bt/OuHvr1Q7lcHHSus1hDLLKgPWuF1GzeCc5IwfWgCrLK8hJY8enaqEhCbvQVZZGPyufrUMyKABigCo5LNlqbU5jXHAGaQoCAUCmgCGipjGP7opRGvdMfjQBEiFj7etadjuyixMVJIAJ5qtFFkHHAqzADEQw+8D1oA7jS7C2lX96wjbO3d6tTri3NrN5ed6E4zWn8NvDGreOU1A+H3tjd2IUy20z7WYN0YHp2NO8ReD/ABpok2+58M6i0EfLyRL5it+IoAtaETGVKDC5GV9q6Ux+YhXHXla5DQrhZ0EkRII+8p6g12loDLAjDnGM0AZvltnO32pUjLdeBWhNEDI23ge9RpGT97IFAFdFMbqytyPWvffhpL53w5uWJyMzj9K8OWNV7ZPvXtfwvBHw1vQRj57j+VAHgFxPtGyEBcdx2rMIZnI5JzjmrjKcKQD0oSIkEgdaAGWMJ3mRhwvT3NGqP+5KjAB9O9akUIROw29T71h61MsUW6TtwB3NAGPM4TJJCqPSsq5vGZiF6enpTp5WkcljkdqpSqVclj+FAD/tEv8AfqVJPM5kTjviq20npz7DtUkWAclh9KAJNiuCN30zVhLYbVG/mqx2bgT1PpUrXIVwMnA6igC0tm3lt0PvVjTYXjlVgSQe1SWUizxHPc1q2sI5bjb2AoAmgLFTkk5q5aoWz9cVHb24bOBg/XrVq3tmUnPI9qAG7TjOOKxdRDCT5RnPtXRiIqp7DvnrWddQKSWHXuRQB51rkc3mEujD0GOtYsrt5R3dT2zXoGqwB4TuH1J7VwWqKkU23PHY0AUJWKgYqHccYJJHvTpXBIwTUW9f7woAdSqxVsimgg9DmnLgsM8CgCxBMQ3XOexrUsZQxwD9V9KyQgx8nXsfWp7clZFOcGgD0DQ3KYQcoeqk1p3keCGBz61zegTh3weH9PWuvRRLHntjBFAGWCR04NWUdZUCTDII+96UjwBWwQQR2pQoXoKAG/2YDys8e08jJop+z/Z/SigDt2AYEHpVizsmmB8vhfU0Iihz3xWlYuBEVXAPf3oAqy2yxKACDjkgiue1g5c9d46V1d0VWN2z8wHeuI1y4MIMhOWP3RQBh6nKkagHG41y16zXGd556D2rSvJDIzEkknt6VmMhdeeE9aAMC/Uq5U8nOKriFs88VsXagDamPqetZxyoyc49aAKh60lLMUQ/ezULy4I2j86AJamiKKQWbHHaqBYk5JNTQklDnsaANUyRCNQhyetLBJEWyG+ntWZj2pckdKAOnhO4En73fHStrSVAfPbH864mxuJElVQ3HvXZ6HKHQlv1oA6izUSjj5SOBWlDAQAV59D6Vm6QF8oEtjk1uWyllGOe9AEhV8YIPAzVC5iYpyR9a0TlgxPylfSq8qb1POKAOZv4lHzKDnvmuU1u1R0Y7ckcg12V/ja+7oDiuS1mXZE6gYAHU0AcfcjD8nmqsrpjnnHpRO248HNQkAjBoAQyR8Y4pnmJt6c5zQyMXBGMfypZuFG0cd6AHB1J4PNKCD05qBFwpcnGOlO3KXAXgZzQBeQjaAuDXuHw0+Hvw8u/CFn4i8ZeJjE0+d9n54j8sg8jAyx/KvBhnJ7VJEA0oLIrH1IzQB9ifDLxp8LdI8TQ6L4IshFPehkkvtm1WC8jc7cnrXJfHP413d/Jc6B4JkZbEZiutQjPzSeqx+g9TXz9ZzIxCgtGe3OP5VpxRFSAv3e2OgoA0PD0zwKmxSoBxtr0/RZPNiG3OCORXnWmQBsOCA3p2zXY+H7hoplVsgNwc0AdFcw5dSp+U1CsRD84xWiYsrtHHcVCImJ7UARKqr0GK9j+Gox8Or3P96f+VeTIgUY6/WvXPhzz8P73/en/AJUAfPiwnaMEdKmt4CZV7n0FSRxHAz0xWtp9qHBkfAXGBQBn3KiKDkY4zXHamrXMj5z7cdK7LX0IKKrDb/FiuXu0Csyg4I5zQBzjwiIALjf3JrNnlUH52BzzitTUZAQwQYXHzN61hvHubOaAEMrksUAUelEa7mDdPcnNIIi54wn171LboFbDfNmgBUbB4Iz71On72MkDk8E4qWOAY+UAk9B3NWrKEu2NhBJ5FAEmlozRKADnNdFYo0aEuvXpmnafZpHGCRx2rU8gHAXv2NABaIQmCOavBVTB6YpsMbKADiiVsbe560ANK5d92eBms+7YKHJwO1ahyUyANxFY9+mEOTnFAHM6vKxLc4GelcDrLZuSB0rt9ekWOM9NxOK4LUXLzFmxnOKAKUv3DxmoNpxnBq4EJGRz9KkWIYGSc0AUVQtnt9alQMDhuR61b+z5GfmxSGDK5XNACRPnCnr2rYsLYzbUAB77vSsURsHAYEA+laul3TWkquVLRnjAoA6SPS57NVmjbcvUnvXXaHIJ0zwVZeR6VzttqkLwZVi4bA29/wAa19FxDexsM+UwwaANS5h2se464qusQByFNblzHujGOCKqiLnk8UAUMH0P5UVo+UvqaKAOlqS3GZQKURfMQc47GrVsgHzdOMCgCve7VgfPCqMk56155rkrTzE9Qegrutefy7cRp1euKuIRGzs33x0HpQBzksG0lm5z2qjOQQe2D0rXuxgtIx+Xt71z+ovI5IUgIe2aAM3ULlI5MKCx657CsqSV5D8x49KtXTFSSR16elVMFidoNADGQN1piIFf72cdqlZMMA386CASSB070AQmH0P50+KNgCM89amhBJPTpjmp1QrHxjPr60AQxwkSBw2VNST2p3ZAyOv0p6JgLyMj3rRhjVwM4yffpQBRsrNpJwoUs1dtYW32eFEP3u/tVDR7b96Ohx3rp7aJflyARnuKAL2nQ7YxjoOtbtqNpI9qo2Vrlco3BPStONAvOeSOaAIhHmQrk49cVHOmMjOMc/WpjueQgcY96W4TcpLEBRQByt+hbeeetcZ4g2hDGvpkmu81Aj51A7da8/8AEDFLkgngcUAcu1v0+UGozGpx8uK0ZnQjBcAj0FUZGUc5OPegBnlL6GoXjJJ+XipxIoUtzjpTSysCM4oArFVIAxwOlIyZxtO3HoKkx82AR9aeIiQDkUARpGcZAz71NEhXk8H0p6qFGBU8KBlJYZ9KAGQnEgrasJHjkGMspPQ1ShtQeV4Y9jV+GMxgZ4agDqtMCOo8nsc4rorVQzqB98HIrjNNlKYYcH2711+lyiUKw4cfeU0AdpakvBE5B44PFPlXa3Tg9KbpTNJAB361alTcq7sjtQBWRSxwK9b+Hi48BXg9Wn/lXlijA6AGvVvh8P8AihLvnq038qAPDoItoBJ7VpW37qIKQcA5qCKEkqOoxVooRGfrQBz+szFpmXgf0rlbyUyMVB+Udx3roNdZlkZerNySP5Vz0kBfJAwp6mgDHuYBJyg5rO8kRPycmujkjZVYKvasafC5DDNAFZ8NzhajO1ThF3GmSqpXIzgmltztkBxmgCQNKCMDbzzV/ThK0xIcjb+tRRP5kmGAxW1Z2zqdwX5c8GgDQtrhkUAjIrZtWEirjIz2qklsfKQlPmrU0+2JdMA4+tAGxBEBHggH6VDPbpuDEVpW8BA6cHpTLiAkYAxQBht90/SsnUf9SfTFdDNasdx6eorGvLbdlT360Aeb+JpGkU7MjaTnFcS+ckt1z3r1DX9MkI3IO9clNpWWyU4oAxLe0uJLeW6jhla3hIEsgXKpnpuPbNW44yq5zla9V+BmsaZ4e16/sPEtv5+l63EtmyFcxhiwwX9B79q47xJok2keI9SsJ7b7Mbe4dFiHIVM5XB7jBBoA53JLcKceo6U4RB+VY/TOKttGVdlA6VGY/mDEEUAQPbjZk8moVjZW/dnr61eVnVj0ZfQ9qeIlkHy4z6UAGmStHIpwQc8j1rvNGw7K6HK/yriraImUBhg54rstBBtXVW6E880AdzGivAm4Zyo5PWq5jCsQwHB9K0LFDJbgHtyMUs0OZMleevSgDN8pfQ0Vo+U3oKKANby8swB6VY2eWFHtmhRlhgVNMpLZ7AUAc/rAzKST0HFctqeApkb6fWuo1Qh3cnIUDmuQ1NjI2egH3R2oA5a/kaWRs4x/d7Csa4JHJ6dq3rqIu+EHzd6oNB5eQQGcevSgDnrm2dz8zFVA/OodqrwBtrXvkJOSee9Yl0wVtqng0ARSlS+QM/jUTMFBJNRNKc/LwKYGw27g/WgCzFOei/yqRXdhsBJzVNSN+W4HtViMgMCDkA84oAdlk7kZrRtXO0uDyOajmkgGzClgR+VWrMKWz/CB260Aa2iXMgc9yfzrrrGZZVAHBHTNcrplsY1DkdTkeuK6TS4/mGOooA7PTYgEGce4NaYjynCgg/pVTTkJjUkAE8cVrwRhjjBIAoAzmiXBAXBPNVpQNrA9K1Z4juxkcVnTQ5U4PBoA5bUWRd+896828Th3ud0Odo616Zqtvh2JHPbNcZqFmHLkL8w5oA4ZgVOGGDTHQMPQ1uXliS+SACfWqh08gfezQBmsiBeePeo5Iyh9q0ZLRlxgYNRTBmZtyH0NAGeRnuR9KcrMq7QeKdMpHPboKZ25oAmWXO0Y571ftZFLAMMY/Ks+NOhIwRzU8ZIYbepoA3oYucqc/Sr8WM5IyB2xWLbM6HcD9K1oLpeI5Rj/AGvWgDQjgATKHk/w1r6M7JOpB59DWfbQkFJOqnpitqyhQ4I4kx09aAO+0Jw8QYdxWrMgEanseTisDw8xjVY2GCe1dP5WYSp6nmgCgi7jx09a9X8BD/ih7of7U38q8wCEAYBGf1r1HwKu3wVcj/am/lQB5Dax8qcc+lSXu1I+cAVNYKS2e2OvpVfVAcpGO/WgDldRjaR2Y8DPJrLnjwhKcDH5V0d8g7cjOOa5nU3+Zo1ysfrQBiX8rY2xj8a5+Y5YZBY1u3a8HHJ7YNZYhYEb8A+hoArGN34ROpycVNb2jnO8YFTCbYCETCjqR61YglBI80lQTQBp6bZW6lWK54zg10djGrj5BjHrWJZumPkI57mt6BJI4FywJbptoA0oIsqC3OK17C3XIbbg9xWTYxuCCSSAea6PTyCEHGc0AXFt8Lk5x7VBJFzhgT7itiGMeX1zx0pvkbuStAGMbQFCQhwe9ZN1aAEnbXXlcAgjArMvoRkrjg0AcTf2ispDjg1yepacI93AKZ4NehXtrliHA47isbUNLDwfLz3oA4EwAuQdp7dav67d3mr3P2vUpTPOI1j3sOdqjCg0t5bi3mKsMOOSPWoGY7Dgj5v0oAybiAMflGDjtVKS3AHU49T0FaLyPE+Sufeq4O4Z9aAKHkEck8diO9OKDHHB9RWjGm4EgKfY1EbffnYACDQBDpziS5USHnsTXbaYgc7WwORgmuI2bZ8HgDtXV6Jcb9qbxuUd6APQvD7F42Qg7l6/StO6jw4IBxjp6VleHH+YE9+DXQyKrAAjB6/SgDMCrjliD9KKu+R7j8qKANCNNvGc88e1OuFKIQOTinxDLj060l7gIWPTFAHG65IUygJH94VzciF3YY4NdFqqGaRsjC9z7Viz4RgEUkDjigDKnhRUGAO/1rEvl2gueFHaty9mjh+V+ZOwFcvqUzszHOKAMPVJ3+bHHfNYztgbmya1tScFSDzWS4LLgECgCB33dgD60xiQOBk+lS+WerECmgAZBHGeTQBH8xIx+INTwdGB4PpSvtUgkZ9qtWgDOAUyDz9KALVpAJV4U8cjNaunW5MhBG0Cls5YIVwcZNXGljjQEdDQBs2tsRAvAIPSt3S7Qh1xySefWsfTLiOS2QOSD/Kuo0lCwBUg80AdHYrhOmMdOK1rZNrDnrzVSwyYzuAzWpBENwOcH3oArXceWyo5qjJCRGfl7dhWzNAWmz29qa8IKk7OtAHEalbZcs3I9KwLizQsxxn3rsdTi2yOCM4HFcxM21zkcE9aAOQv7JfNb5SQDgVk3UQjJx1FdRqkwjueuVI6Y5rA1Ntylhgd8UAYkgcox59M1V2krtweaseYwBZznmq8tyUIwBz60AU3Uq5VhwP1phjU9sfSpZp1mk4GG70ygAjTnC5/GpkiYkEYIHpTY84wGAyauxlFx1BoARXZVHHA9e9WIG8xgW7mmkBwBwRU8MW0jH4CgDe0mdoUwx3AnpXS6bglTGcqT+INcpYj5RgHg85rpdCYxyZb7p5oA7axAKKV4cda6mE5ijPTIFctYA5VgcA8/SuqtAWtlb0wKAEKZfOeByBXpfgjnwZcj/am/lXnkygYIr0PwP8A8ibcf70v8qAPL7SIiJBnk+lUtV4JYfeBxWrbqCqAccZrP1QcEgdB+tAHL6jKwXapweprnrtWkBDA5PYVs3QZ2YDlj1qpJB8pORmgDDktzGCQMsentVCSEbMnGR1zW3fhIYxuJ39s1z10Xc8j5R2FAFZ28okhdwzyTU1rb+a5lUZUHuKnigUwgMmV64zV60jA+6CM8YoAWxtvMl3HKqD07V1VlGTs4yPWqumWIXaACcnmumitOVCj5cdKAH2duQ2MDafStizgXeuOMHrils7f5OAM9a0beA8E/T6UAWoIz04yam8o46ipYIj+PepxH8rAjntQK5nmPPJHSqF7ENwO3NbghPccVVuIMdQRigEczcWxfjGR6+tZ8lsBlB0/SuplgVefU1RubcMpyAD2xQM8+8Q6L9p/eR8Sj9a5GaxmjbEkZUqa9YniDAqRkj9axruwR87gMGgDzaSM7xgcZ5yKpzwEM2PXpXZXumFWLKmQD0xWXLaKYypBHPpQBkaJYzajqUFnC0Uck7bVed9qA+57V6Zo3wi1PUIr3OsaNE8CBl8ucSBv97HQe9cBLaBSBwV6cikiQ2qSfZ3eMSDEgjYqHHocdRQBW8TaU+jay9jcS288icb4H3ofoadpiNDKCw56gjvVC4dft8SNhVHQAcV0VjCHCofXrQB2fhjmNW7ntXYGPLg44K9a43w+vkny2PGO1dtBl4lPfFAFYoQSOKKkZTuPB60UAaUaKqMwHIqpqeTAAOCx4HrV2ED7PyTzVfUAFiQN6frQBympIFjKjOfSuW1acWyEAgydAD2967DUiEDuTz6V5/rBLuzNhiTyKAMC8nZmZnYnuayrh9wOTznitK7TLFR1PFZ7W20ksMH0oAzLmPzMnovrWe8SkYjH0JrXuDuYqUP4Vn3LKnVcGgCjIhRtp603j+IZXvRPKNxPX0qGRiUUnIz2oAnMiMpEajjuaW1dwwznHtVMZJwOprYsYikILKVPp60AWoFG4Bup71alnH3T1HeooZhHlnXdxwMUttF58vHAzmgDb0jcVTbxnrgV3OlebEQM5BH5Vz+i6cI1RiOPrXU6cm6UnpigDrNNdvLU8dK2bbJG7HBFZWnRZjHOAa3LSPKAEcCgAqKUkDHUGrxXJXGMDtUIjY8gY9KAOV1mIl3xkk/pXK3FqBIcZJHf1rvdVQHOBzmufkt8lmGMmgDhdcs2ctK3G0dMVzExRX/e7ig6ivSNQtWYOSMr0PvXDavZlSyEcdjQByk8kUlwRHkpmqF4AJSOd1aD23kyMw459aqTQNJJI7P34yKAM5/kBAXr3pQg2cggjvU7RMBnGaTaACGyDQBHE2QCCcjuanikIb5ycVRPHAPOanj+7jB/GgDXhki2giTaOgzW74d0XUtVv7VbTS76+iaVQ4iiYApuG75iMDjNN+FXiDSvDHi+HUdf05dSsFidTAUDYf8AhIB4r2O+/aGu2i8nw5oFrp0BGAZTkj0OFwP0oA7yX4D6E6+bp97e2gZQRFIRIF46V5f4t8MR+FdXFlHqMF8cZbyh/q/Zu2a6u7+Ml9f+E7Kxtsrq0qFby7VcBeTjYPUjHNcIuJW+c53HJYnJJ9Se9AGzpEhZAjYOOR7V2ek4aIr0bNcHZboZlXv613mikMiNxnoRQBbkXI4+8D36V3/ggY8HXIPXdN/KuGnAGCByTXd+DBjwhdf70v8AKgDze14Tp/CKztSzyMZzWpB/x7rn+7WXP85ds9DxQBz93bCI7gDk1nXOIgS+N7dFFbt4pRSwyfSsCaOSclj170AZN5EXxk7s9zWfJabpMHgH0rcmgXGckDr9aiiiEjHC4WgDNNqgjAjUk/rU0KiIInBJP3qtXcscBVVGXIxgVTRJJLyMvwgPQdBQB0Wny5I2j05x1rat9+8EsQSelZdiU2bVXBHcd637GFvlZ1yccUAaVk2CNzEcVq25BPHesqK3ZmBP3a1rOPpz04oA17cYUk1YVAR3zTbdcqMjoKsgelAiFkAHeqtypGCRWjtPpUFygZf0oAxZI+u4cdqqzwjb1rUdDkgg4qtNDjIPT9aBmBdW4JHy4+lZNxDtOAWH0rqZoCTnPAFZ1zBkEbefagDmZrcMDnketYt/Z/KTtz+FddPBj0BFZ15DmPkY7UAcbLBjkDH8qqPbb9wAwR+tdBPb7ZCCKj+yhsEcN1waAOE120KyRuAVKmug8Pt9oCmT74/X3q/f6d9oVkdcg+naoNPs2s5F7qpxn1oA66wX9yrqPmHt1rsNPAe3jfHJHFctp23Yh6A85rqrBdtso5wKABlwSM0VOYwTnJooAlh5hQcgE1W1Ehm2EdBxVyAYjA7CqGr/ACozelAHL625J2jgDrXH6nCHPyD5+4xXVXZ80/LyW65rKvIxGCFHPrQBycsKQ/LwW9fSsqaI7iXAbnrXRXkAbLt8qjqTXM6lOxU7DtXOOlAGJqFwqPIqEkjjNY0sjO3zZwOgNXrt0Dse+etUZCCxbBwehoAiCANnHNDYLAdSO1OKO2Nn8qWOF92QpLHvigB9rbGa5G44A7YrZlVEVNucjjJpbOMvhnxuHpSXwGA0hCKTQA5V655HvV/TAk1xGi8DIyayzOiRxnaxzxmtHQpXafKqFGeDigDv9PgbOwcAeldLY26ZUjjHeuZ0mWR5AA2eK7PT8SL+8BzxigDd02DpnmtiNCBgc45qnp6Dyww7frWtEowox1oAYVzFhR+Bpixkgk8envV8wrjHP1o8pcAY/EUAc5qdurctkY9KyZY1CcDHrXTaggbr2rAvhwwxigDAvoRtYE9feuL1CSPbLDIq7uxIrtdQTMe3PPtXI6pp2/J6n+E96AOFvYgshAIrInVmLHjAPaui1K0khRxKnzA8VzpVS3yk8H1oAgdSE9G96gIdh8yf8C9KuTFghxt3ds1XSYgnK89x2oAqvEqtyMHqCO9PWPcoIbn0NXI1WQHKj1zUYg/eZxz60ANhUr1TBHfHWtazxkHvnmo7ZTxnke/etCG1U4Ktg56UAbOlSmFgVxt7rXU27q6K6gbe49K5K0yhwwxjvW3pkxVxgZX07UAdZZRiUDdzxwa6/QhgADgmuV0vBKgZ2+tdXYDZKjADb0oA15uY+nOa7jwaD/wiNzn+9L/KuIf7rDviu38EqV8IXAJyd0v8qAPPYx+7UH0ArMnX52XGFrWhXMZyOg4+tZ+ooQpbufQ0AY1025sL0HT0qnNEoQkDG7r71tWlk0y9MKPXvV0aQjElhn60AcO1r5iglTj1qrdgxLtiU9K9Bk0+McIgCjqKjbTImByi/pQB5i1uzFWJwOvIpzRkTRiPJBPJ7V6Z/Y0MgC+WMD2pp8OWxB2pt+lAGBpVp8q7skdcV1VrAoTABwP1otNJW3AKsQMdDVyGKRM9gO/rQA+GHJBwKvW8J3f19KghQ5z1Gc5NadovIz35oEW7aI4OeKnVTuHAIFLCuFz61KFJHAoAYRUE8eV6Yq2EORkYFRzr8uB9aBaGY8W3k1WmAL5J5A4rQkUEVUlTd060hlGVByc9e1UZoA3IFajIejKarmNuvAHrTGYk8IPDAZ/nWZcWwZT1HtXRSmKMYI3NVKV1ILBAaAOO1K1ZcOFNUhE/UcHrjvXVXhYgjaCOvNU44kILsAWH60AZMCF+JFIPrS3NqqKWA4HpWv5MTk5G0+lMktnjTkExnuKAK+lDawXOQeRzXZWgBhf6CuW02ALOOMgH8BXXWsZCsvqM0AMzRU6j5R8tFABD/q/xrM10nySOxPNasQ+QAd+azNUAaTnle4oA5d12L15PUVnXajqScDkmte8ixJkkACua1i6Bl2I3yL1PvQBg6xI0rHaCIx0H+Nc1fxkgnHFdJdMAHOeKw7mNp/uHAxyaAOWnhDOMLu/CqzrlcYGQenpXQzxbcomPc1UntQoUAAg9TQBkKOSNzAj24qZBIMfNhMdTU0yJAhLHdTLa2lv5ygO2P17UATQ3oT5UA9CTT2iWZcuxznOT2NWrrQfIRSHIYcDB71UG6IGM4yDz3oAuyPbpaxwjljwTWzpSxD7gGcYGK5WOCR72PA3IefpXZ6VZMCpBHPSgDo9IQBk4H09K7DTQTtY57GsDSrXJUnBro9PVw3t6UAdXpqlYlGMnrWvAuWz6Vm6bgxL61twxkrzgY64oAVI93fApTGwPAz71YjjOML0FSeT/ALQoAw9QiyvyjB9K568iJJz1rsL1fkz3x1rnLmA5Y8cUAc7PaF84BPrxWXe2X94c5rsFi+Q5A3VnXkBPpye9AHnOsWPmREYPHBwOtef63pj28hkiXgdRXtN/a5jbpknkYrmtW02N0YMpGeM4oA8mYBwFK8+tV2U/dIxnjjvXT6lpAhlDRnGD0NZ0tm3KEA55BoAxVgaMknOPSrtmwXiReRVpIhDGEYZJ/ipkkbHJVRj1oAtRiJyDnDeg6VdjjCjPU1jwfKxw3T9Ku287oVAA2DrQBtQNtADfMp6itiFAEV4+R1xWRZbJVBTIPoa2bIFQOcEcUAdR4cnV8JjJA79q7Szyyque/auJ0qAJtkQc9xmu10xgyJjoKANjHOe/Su38FDHhS4/35T+lcU67SPcZrufB4P8Awi9x7vL/ACoA4KBCI+Oe5qM2ouJCCAFX9auwJ+5Awc45q1bwhVGRzQBTW3CDAGF9hUnkh8BetXmXnBGfanpFzjGKBGf9m5xtP50otPWtWOLrjn61IsRPYUAZK23sKc9so6KM+4rVEOOmKDCT6GgEZKW4UknGPap1tgccGr3kHP3RUscBPvQBn/ZQM8cGpooyMVpLDnrS+T6Hj6UAJCgI55FTAYp8cRK8YxTvJb1FAERHGD0qKVf3Zq35Rxyaa8WVIoAxzGSDn6U0wBQMir7xEYxzVe6yuAetAGbcvtJ2r+NZ855AzWpInPXrVS4iB5xxQBjXCZJHfqKpyISD1HataaME47jvVO4RlPByMdBQMyp4+MHnvVKJcEqPXiteYZQ8cis4RszHtQAGDJG4A1ahhaMjPzp79qkgUqDuAya0LeHJHcdxQBT+xKGDJ+IFbNqmUB9BjmnRw8dgPSrdtEArHk0AUihyaK0DDzxjFFAGagC7BnNZ+opmV+Op/WtKL74+tU7vAaQntmgDltcJjgIX75HNcJfg4OP/ANddzqWZJGJOR3rm7qx2bnYgj+EUAc3HHmT/AEgExj9ahm8l8pGCuOmK1bpOpJwOuMVjXMghLZ6npQBQuIVXqMkcVk3SfvCCCR/Kr8xd2DMduPeqgZmfKnCr1JoAzLmE7gGy2B0qxpUgid1fClsEGnTkO5Man5u4pkVsQ4LcMf5UAbRy255Cqg/MTnrVBbNRcPPKNwPIzSSEIMkk+gJ4FI0jSIN7BU6ZoAniGZkIAAHpXW6HGzkEklegFcZbXKxyhY13fXpXX6Q8gCtu+X0FAHa2Me0YfAz2Fb+n2+45z1rldNPmShgSAK6/TNyuMNkGgDqNPhHlqEPFbMSYHPXufSs6xACAgDI71sQKNrflQBJFGd2FPHWpChDAH86khGE6VYMfKhTnPNAGVcwKVJUnjnmsOeAZPy4rqp0GxsjkVh3MRODu4zQBiuiKcgZ7YFUrwKWLFOO9a9zD5fPGOlVJowynge9AHNXe0ryuayb2OPyirLyenFdLdwbW3AZX+VY15Ec89KAOD1axjk3BD+VcvcQESlAMhTXeatakFmUHB9K5DVo5LV1c4IbtQBTdQEAdQQOBx0qmY9r4b7prRt5FdysnGfyptxAscp28kD9KAMp4HYllHFKkbAZIHue9acaq0eOnPNPMIcg456ZFAENqCpAUnjvXT6PIZTibHHRie/pWLDaS527SVz1xW5aRBQFPbmgDqbAbTsPUV1ej5KfL35xXGaRcjBjkI68E12OiMRMN3G6gDoCpaNTyWxXceEQR4ZnB67pP5VxypjIHGBnFdj4Q/wCRZm/35KAOTtlIQkj0FXIVwDmoLMExrVxFyQKBAqjPA5NSrF3apY04A61OsYxyOaAIAuTwKcqk9KsKoXoKcBnoKAIVj67sU4RKKsJEerVMEUdAKAKYjX+7T1j4yoAq1S4J6CgCr5Z9PxqSJODuGfaptp9KMH0oAFXPAxQQQealiT+KnlQTQBWoPSrDICMAUwxEKfWgLlBkIJ44qjcxszZJ+la7rng1C8J7AH2oAxJYuPeq0sbBeuM9625Is9Bg1Wkh68YNAGC8POGHXvUEsBwRW3JATzgDFQtEemARQBz8lquDxzVFrJkJJGR6V1T22RytRtZDAGOKBnPJC2Rjr3FaNsuCox0rQNiByooWDGd2PyoAIk4GQCrc1OkeDjGAaW3j2gZ6VYxQIgKtnqKKn49qKAMSFcLk9TWdrLBEIGASa1YxlB644rH1dPMudrdAOaBnPPFklm6EcVmXkZc44/GtuYjO0DkdKyr2QqfLAHmHk8dKAOS1NvLcqo3PXNTgq7M4+aux1LYgZQo3+o9a5a9hdT+8HzH070AYV6TI5WMYA4xUQjZI8MOvpWmloI03tktnp3qtKhBJC5Y8fSgCo2yNQFBA9qao3uWPAqxNENqrnn1qpdSrDBhclv5UAGoOiRJk5zz+NUyWuIwWzgdhURLSquT/AFqzp6HBQcZNAEunRs1zGWAKA16DZIFRRt69q4myj2SHB4Vs4PWu80bMxUkdRxnrQB0WmQjys8YrpNN34+Xk1nWFmVKevpXQ2FsRg7eDQB0ulA7AXHbrW1AgIAH1NZ2nKBGox9a24kGFAxz3NAEsKAt0+UVZUfKQBwP0oiUBlXHGatKuF4HAoAz54zknGOOaxLqMb2UdjXUSruU8cisa6gzKxwMduaAMOeEsuCOlVHtufu8e1bpi4AX8SaikiIycD60AcvcR4LEjg9ax722DISvvXX3NtvBBGP61mz2m0HgDFAHC3VurRHeM964fxJabMkrwOQD2r1DVLNl5UY57VyWvWvykMCTjuKAPNZSW+YHaB6VMnzorjG7HU1NLbETSRnqT0pbeB9pBGAvP4UANToN3P0rQity0eVPTtUSWvmDcPlUfrVy3DRbQVP0oAu2sWUAwR6j1q6lqJBujGGHbNRWzIxG47SKviNjhozlf4qAIbYESEEYI7envXcaBIGiIP3lrm4IFkKt/F1zW/pSmEqP4gcmgDuY/3kKk4DEdcV1nhMY8OT/78lcnZN5lmjr+IrsPDIxoE/8AvSfyoA5a1GEAxV+Bc4OOtUbb7q1qW69PYUCJkQLTwCTwKFBY8VYRcD2oD0GpEOc81Mq54UU+NMnkVMFA6CgCJI/WnmMegp9Lg+hoCxGIx6Yp2BTtp9KUIxHSgBtJgelS+UcdRSGMjvzQGgxR2FO2EHnipEjwck0913CgPQgCHn2FNqcR46U1o/lwBzQFyq0eTwMUxkI+lWSCDg9aSgCnIm4c8VXkh46bhWmwzUTR8ZFAGY0ORkDGKia3HoCa0yDg1GYsnJOKAMw2+f4cUpgx0Wr5iOTjpTWRh1HFAGe0QHbH4U0xAnI/Kr5APWmMU6ZFAFPywM8ZpAoxyBmrO0Z4PaomHSkxMrleTxRTxyKKLhcxUGF/3R1rLv1JRiPvEnmtYD9zIfas6VQYzuzgDmmUc3fHykOcbiOD6ViuzFHkfhs4HvW3qSbpMZ68nNYt9EzoFj6k/wAqAMS7h8yRiOTnH0qrPZ4XDjJB6muijtXXKhSzNzkDNMfRr6cnZCcHueMUAcZqNsMjyhgZ5rJaMI7Ejp37V6K3hK+kGdyIT171Un8BXToR9qQevFAHmd7OSSEXC+tUp4tyBh+fvXo9x8OrzecXKsen3agk+Hl+ke1JEbBz0oA86S3AjPGO/FWbaJjNH5Y+WuzHgDUfM4dD29BV+HwbNAQpIzjBIoA42O3JfOSq967/AMG2qSKhwx28ZNMtvDGw7XG5R1J7V1Gh2yWe5EUE5yDQBuWNsVC9l9TXQ2EK4YZOMVkQCQoCzfhWtpqlZQe/cetAG/p9uSBntW5HCg/hJ46VR0tC/BHXpWxEhXJPWgBI4xhTg7quKAUAPOPWmwrg55zVlY+AVOD7igCu6f3QB61n3UKmQ4698VsNEQCc5qlOnz56CgDImjAOMfKarSAKMYOe30rVmRc7SCfrVOSEuxAUgdjQBlSgEjKYrMuo02uckfWuga0dsZB4qBrSJTlhuY+vSgDjri3aZSqZJb2rE1DQ55ugAB6k130yrHlY1UZ74rHvt7H58+oAoA84m8GCS5Z5plV+wUUkfg21hPzyyOT6V11xATKGzx+tDIy4UHDDv1oA5l/Cts0YCl+Dzk1BJ4UPOyQge9dl5WUG44zwQaYsUkbDBJH50AcBPoN7AcoocDuKdaGaCTZKpAJ5DCvRYVEhAdcfhTrjR4pxlkHoaAOWtYgT5iAEdxWxDEXHy8OOfrT30Z7UlrflT1GasWsbDbuzkdqAN/RzutzG3bmu28OjGhTj/af+VcTYDAD54zzXcaCMaHN7lz+lAHKW33a1LbJ57YrJtMFc+1atu3T0oEX4F+XNTopYjHSoLcfKfrV6MYUUAKBgU5QTyBmgKSCe1SRrx160A3YRBnIK1MFAFAGKWgEhMCgUtFAxDnHFMZScnnNSUUCsNUYFOpVxuGakAJ7celAbEWCaKmwcHFRlWJ5FAJkEy8Z71Hsb0qw68YNC9KAK2D6UlWsUwoC3NAXKjJk+3tTGjI6dKtOuG4zimUAVSpHWkOO9WGQGq8o+8KA9SlK2ASBVapbg5YCoqBkoA7YqJwMnFOj60j/eNJE9SsRyaKUufSigNTIxi3c+tZ0gDRnPpRRTKMbUUAY7eCwqzpujwTAGTkn2oooA3IdMt4v9Wij8Kn+ypjGBn1xRRQAfZUzkfyoFmh79MnpRRQBG1jEcnv16UyGzjdCSORRRQBG9pEGIKggVEbGE9sUUUAZ99YxvIU6D2qOCyijYYGfwoooA17SJc7QBir1ko8zA4FFFAHT6Tyg+tbMIBLA8jFFFAFmIAuParFFFABUNxGrLk5oooArGFCfmGR29qjaFVZQAOfaiigCleDbnHfis+5XB69DiiigDPnXYpPU9aybtAPx/SiigDNeIGQ84xzSCMeZtJ6DNFFAD/KX3/Oplt12g/wBKKKAJfKX3q9axjbj1GaKKAJXgTBJGcDjNUprVNpZflx6UUUAOsOgU9M13GiHGgze2+iigDj7FswjjqM1p23VaKKBGrbdB9avUUUATRDCkjrUmBRRQAtSMoIHaiikxMjox8ufeiimUFFFFAEkYGAcc1NRRSQkMJwaAc0UUX1IY11zUVFFCKiFFFFMoQgYqJ1GM96KKOhL3IqrzD5sUUUFGc6hgc9ajCZAGeM0UUiWPKhcAVXmONxFFFHUCrRRRTKP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: A left-sided, simple pneumothorax is seen on this PA chest radiograph (large white arrows). Right panel: On the expiratory film, the pneumothorax is larger and more easily seen (small white arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert A Novelline, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8928=[""].join("\n");
var outline_f8_46_8928=null;
var title_f8_46_8929="Calculator: Mayo score for assessing ulcerative colitis activity";
var content_f8_46_8929=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"MayoScore_form\" name=\"MayoScore_form\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Mayo score for assessing ulcerative colitis activity",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <div id=\"calc_input\">",
"      <center>",
"       <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Stool pattern",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Patient reports a normal number of daily stools (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           One to two more stools than normal (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Three to four more stools than normal (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Five or more stools than usual (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Most severe rectal bleeding of the day",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc2\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           None (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc2\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Blood streaks seen in the stool less than half the time (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc2\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Blood in most stools (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc2\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Pure blood passed (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Endoscopic findings",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc3\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Normal or inactive colitis seen (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc3\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Mild colitis: mild friability, erythema, decrease in vascuality (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc3\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Moderate colitis: friability, marked erythema, vascular pattern absent, erosions seen (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc3\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Severe colitis: ulcerations and spontaneous bleeding (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Global assessment by physician",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Normal (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Mild colitis (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Moderate colitis (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MayoScore_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Severe colitis (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"       </table>",
"      </center>",
"     </div>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <div id=\"calc_result\">",
"      <span class=\"medCalcFontCCTabBold\">",
"       Total Criteria Point Count:",
"      </span>",
"      <input name=\"cctotal\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <center>",
"       <input name=\"reset\" type=\"reset\" value=\"Reset Form\"/>",
"      </center>",
"     </div>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       Scores range from 0 to 12, with higher scores correlating with more severe disease.",
"      </li>",
"      <li>",
"       Please see appropriate UpToDate topic reviews for further information.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately  active ulcerative colitis. A randomized study.",
"        <i>",
"         N Engl J Med",
"        </i>",
"        . 1987 Dec 24; 317:1625-9.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"   <script language=\"JavaScript1.1\" type=\"text/javascript\">",
"    &lt;!--",
"",
";",
"MayoScore_fx();",
"//--&gt;",
"   </script>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8929=[" ",
"",
"var calctxt = '';",
"var xmltxt = '';",
"var htmtxt = '';",
"",
"",
"function MayoScore_fx() {",
"with(document.MayoScore_form){",
"",
"Score = 0.0;",
"doCalc = true;",
"",
"if (cc1[0].checked){",
"Score = Score + 0;",
"}",
"if (cc1[1].checked){",
"Score = Score + 1;",
"}",
"if (cc1[2].checked){",
"Score = Score + 2;",
"}",
"if (cc1[3].checked){",
"Score = Score + 3;",
"}",
"if (cc2[0].checked){",
"Score = Score + 0;",
"}",
"if (cc2[1].checked){",
"Score = Score + 1;",
"}",
"if (cc2[2].checked){",
"Score = Score + 2;",
"}",
"if (cc2[3].checked){",
"Score = Score + 3;",
"}",
"if (cc3[0].checked){",
"Score = Score + 0;",
"}",
"if (cc3[1].checked){",
"Score = Score + 1;",
"}",
"if (cc3[2].checked){",
"Score = Score + 2;",
"}",
"if (cc3[3].checked){",
"Score = Score + 3;",
"}",
"if (cc4[0].checked){",
"Score = Score + 0;",
"}",
"if (cc4[1].checked){",
"Score = Score + 1;",
"}",
"if (cc4[2].checked){",
"Score = Score + 2;",
"}",
"if (cc4[3].checked){",
"Score = Score + 3;",
"}",
"cctotal.value = Score;",
"}",
"}",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f8_46_8929=null;
var title_f8_46_8930="Thigh sleeve";
var content_f8_46_8930=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thigh sleeve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDtwMdDzTjuzjPPt2pByf8ACnZIYY71xlCg5xzj2NP69xmoix3HaBTgcZP5igW5IACCD0p3+7jiogx6YBp2TjgjmmBJ7ADNKASfTHFRg45zzTgWA9RQApFKpGeRmmAtg84FKAVPT6UgJNwU4yAfQ0MNzAg4/lSDG7oC3rS4I7kU7iJBkHpQMBzkDNM/gG7k+1IW6jNAEzdOwqMOCSB+INND8dPy7UA7uV6DrzRcTHF+ec8elPQ5HNMzn/CjcQc4/KmmBIWAVgAPxpoHy8/rTSc9eMUrc9ScUAh2AF5IHakI5AzmgkAcZx6mkz2zn60wHfQUoOOP50wMe2B7mo5zJgCMKSTyW6ChATEBhn+6eKbjPPp60m4AAFucU4EFRkgetMCK7iFzaTQMobcuAD69q4PYYLiAAKrElXAHU16ACuMAqcVxuvW3lXkwj4G8OPbPWsqi6nVhHq4mH4ksTpejXWq2iTidmLvmMmORAOcsOAR2rlLPXIbpBNFJ8pGSD1x717JctHc/DvUFCLNE1m5wOp65r54m1a317SIL+20xLO+t5vIc2mFiEZ/2SfvZHHb616GHrulE463vzbZ29vqMUiqjuSf4e+Pp3/ImtCKVXXcjFnHpkn8xhvzBrgIjIbxrZZRMOWRlxz9e2au22rNHtDscjpk/4/0xXoU8dCWjMZUux2e88uuQwOSV7/Ur/UVSmKOcgIW6kjaT+hB/SsL+2WbJOfQbuT+vP61FLqokC56dBls/+hA11+3i1oZKDOhMjj5VEg46DzBj9TSYL4B83P8A20/xFc2upRgknZ9SE/wFO/tZVA2CPd6lIyf60nVXcai+h1MdvAg3Sg+vP/12qeIQycxoioP4isYP8zXKwarEDumdFA5xtVf5JS3fiwopjslZsfxeYw/kBVKrFasOVnXyXVtZw73lVQBzg4/ktcvrPijzMpasGB7h5B/hWC02papLlpJivu7EVftNCJwZpAM9zjj8zUyqSnpHQagluZm2e5lLFWJPqSf51s6ZoUkzruHBPcj/AOvWxaWljbRjdIhI6/MD/IGi98RWVnHtifc3YBX/APrUKMYe9NhJ30ibFjYW+nx7nJGOvb/CsrXfFVpZo4jLZHBKlP8AE1xera7Jdly4TywM7VTk++TmuZu2urnLwW5CIcEBeM+9c1bMIrSBUaF9WbGpeIbi6DLG8ojbJCuRgfpzWTb2aXUvnOrMScb24BPpUsdnfcGRI0yQGBGTzyCPrWnDZXLjcCAp6tjr26V50sUm7y1OlU30Gxwqp2dAOMY+77Ef1rK1jWVsg8Vqoe4I2F+ojHp7n3qa5WQKYiz71yrHPv2qgNMJRtwPzjAFTLFNqyHGnqYGWlkMkhLE9SanA9KSWJoZTGRyKkhiZsg9KwbOmKFjTdyc1o2cOMYHHvUUERFadnAVIJ/I1lJmsI9waJjwFyKv6V4Ym12ZYYYsgfekPAUe5ro/DvhO61EpLOrQ2pI+dhjPsK9MsbC2sIFt7OMJGvpyT9aha6k1ZRWiOrHb3pcgZHfvUe4AcmnRkEkZz71RyjtwDY6GnDrk4pjZbqAaeOFOcfWmCFPr+lOQA5AqLOcCnhvlx3H6UhMfgc8mlBGBn8aZlhjOPr605WDDOcZ4p3AcCOh6UuR17imA4HzUKc89qBDwVbr1p+G6k9PSoj0BA4/WngnGDmkA9SoTnOT60Mdozjimj/a4p424wopgRlgOTxTgdvXGD6U1jzwOfQ04A446+xoAjOQ+ckj37VJuPBpFzlulEfr3FADjz1x9KduyADycUxckncc+/rTs5AwcH0pgxNxU8856Uu3J4HT16igjj5qQlgCARyKBCgnODQepBBz7U1WYkgD/AAp/BYE0wE6emB2NKVU4LD86bnJAXjJ7U1mbcVJHNAFyyi82YrjCgbicVWSwZvFiylQbeOMSfVugFa1iyi0XyxjHB+tR39x9nC7RiVhjNXZNaiU3HYw5keDT/EFmEDyLHN5aIMbt67lAFeIL4Efwfo2k3V/dEyamoe4s2XBQ9So9wDXvEYUzNdAv5hwkmRg/L0/nWD8RNOi1W10e5Ybkiu1DnPQONpNX0sQcLb6Boep2aSaO6lmfaAxwVOcc+wAJrLm8LEtuiL/NkhCO2cA/j1rp9a8B3Ojw3F7YiXaOUK8k+5A6Vi6frN9BDCrKjrEiq3mfeOD2PesnG25SZwOv297Y3zoFO1Sy5A4wOtUVmZly6EHjkcV2dxq94Zp1NrFKJTLD8w6cgg/0rLmv9Lu7TbPatbyhtzKo/Dj8aFOS0TLWpzZvSMj5wQccE0C7YuMGQk8jmtOaDTfPcrJIN0xGfQFeMUyK2sTLp6+cflDA+/XANP20+4+VFGG/DnG2VverkGoCPlbZCexdv8Kk0u0sDZ7zKQRIQT9RViWLS49NDZcyxzbSM54I4P51axM11FyRK0nia6R1jS3iBJwv7vP8zSPr+ptkxFw+DwigdPoKvXq2sV1K6wttieJ2YjpnFaMy7bueOOMAKzbTjg4GcZ9ap4yr3D2cdzmmm1q82EyygOcZZzxVU2EzQvJd3DttUPyffB/I1sTTyiMxhW3eTC/ryG54+lQTRs80nyt5TLLHnOBtblTWMq05bsfKlsaFnDZxXZjKKcsyljztGzJ/pUnmk/2hbqFQ+SnlsBxuOefp2qDTbeaZiAHZ8BsqMZYJg8+uOoroo/DV08ymERBJI98ZByFzjCt3FRqPY5qSRUvIFMWU2Q7ueGK//r/StaxzJbBEXcqMyLtGWI7Z7Vdm0WOWC4VbeYXtuASJD1HcAe1as9syWX2i3gCBlG8DjkDriqSC6OUfRis0czKPm5Knsc1NcaWGQjAz2I71vWGbmN0kAZfvAjse9WngUJ1zSsCZ5V4i0UxzJOvA6Px+tVLfTmDe3t3r1caOt/IEkUNHnLA9xW3a6FpNpJvis0D9gxzik2zeE0tzzbQPB1zqS+ZjyIf+ekg6/Qd69B0fwtpenouIvtE6/wDLST19hW6duBjAxxjGMU1R1O0rtOOtKwSqOWg8HtuGRxj0pynB6frTSMkHvSnJbA6UzI3iFPHUHtQMJwoFIpOBikYDJOeKRJIpLE4PSnbivAODUamnZXGDzQA8EhcHGaUENg5x7UzIwMU4HnOAfp1oAeOWwfzp4wV461EDhsgfgafwDx+AoEKQG+Vh+NL2IPIpq8cDqaCeRk/lQA9SFx+mafkhCRgmowSHGcFfpTyN3HegQ7OeTimqAXyM0igqMNzSgY6cY6igB6tjI4/LpSH5vrULpIWO11Cnpkc1KOgDUAOAA+tITyAOc+lIQMemKbu5x09qYCnOcbcU75sZpquSo67c+lO6/WmA4neCOefSkACjvjpzSqRjp+dIW9DQITdtXigFgenBHXPf0oA3HpmhmAB3DNAC9F+983tSMN6e56EGlLqAD2rB8Xa/FoOkSzKVN3N8kC5/i/vfQVtRozr1FSpq7ZM5qCcnsa/h7WFn8RanpilW+yQJKxH94kgj8OK0blv3wIdW6MVYZx7ivEvhjrLW/jVvOlbdfRPGzE/eb7w/rXsU0TxW/mEqdvpzwa7cfhPqdZ0ell+X+dzOnP2kFLuTysZGZiSS3eqsaC4gu7JwMEeYg+npTIZg6PCx++CQe9VDcNamC4wXaFsPjqy9/wBK4WUdBJbyT6clqtw8SAcnqSrdq4PxPpGnRlIYYrqHcAWmRFZAc8kg9OnUV2g8R6NLbRpZ3kc82NoA+X8OelIZ9NjRZ75GznCAjPH1FD1DY830PwguPNkvLc/aXbyVliYFvfjoKqal4Au3Z5JEtTGMgFc5J9OOleuzWNpdeXcQFQ+PkdelV7Oe7hLR3yIGViFI6FexFLlK5mfPl94PuoplItZVVsn73cdTVKXwxdgRusM/XI+X05/rXvsmoabqGsS2LJJHOi5EvVW9RiqSaTJHqkIExe3jbeFI6ntS5R8zR4lo/h26hadZYHKq4YgqMhufU/yrT1Hw7KbYSG1njt3bGdg52nJ/LNdvqV/YaZpZk1BIpJp5jL+8Tdg5/SsDV/EVnqNrKtu7xlZQ6MucMAOVx2B6VNkNNnNXWizzzTEpOWmiWbZx8yDgHjtgV0GnaLNc20Zngc+YmdxYt1GAeO4xXUWgi1axiktJBaShBuiCjP0z6VFpiXmjXpMVwxhLZaE/dP0HanyoLnNyeGGi1q1tJJ1jaRfNwi8BM9M9jmi60W3t9bhtbUGWdXUu8g9Dkn6c4ArrtSgWXVortDgOgIGc4Oeahv4QNWd8fOUUj3oshFex0uHTdQuIJbcNbSPvjWQZwPY1s3llG0EZjRFVPuADpRG8k8CLKj/LypK8CorPUknu5rOTCqP9W/v707aAUEKQa/Mk2GjmjTOe3FXbuxYxeWihhnI9xWXfBW1/AOXRBWoZXaNlXJwPWgZjx2CWc7b5Qm/jHoDVhtPVTgMG9aoXFrNMxM7mNc7QAfatzSl+02ETN/rUJjf3xSKGwW4hhLY56ZpApGc96tXa7VVAcnrVYevTFQ9zRDhyKcpAwOgphI9eD6ChT8pLdOgxSBEpJJ4AApMZJOD6ZxTFHHTP405mKrzxQM2gTtODQmUQAksfU00bQ2M4FPCnHXgetIhDs4HAOaJN235ThjSBsr/KlJIAOc57elMCTt25pV6YBqND1z0NOLdBg0CJFOOR1pScjjkUxTwQRweKVflwO1AMceoIJx705AOc+lMPP4Ub8cAc0mxEoOBxzz+VKvAPXHfFRbhnI4zTtrZBP55o3ESHOOCacDjv1qPd820Gh3CjLcdqYD+Sec7fWjuCT+tR+YGXgdfWnLkr81AEuRnFB24zj8aixjlO3bNPyMYNMBQRj3pCN3I6030HQUjNt9OPfmgA2urcOSndT/SnDj60ij0PWj2yPxoExxbg8UhYErkAdqQjI9/Sms21SyozdtoGTQAy7uoLa1luLhwkESlmYnoK8L8Xa7Lrepy3T5WIfLEhP3E7D6+tdF8SvEyX0q6dYnFtEcysP439PoP515xPJk5Jr7fI8u+rU/b1F78vwX+b/rqeXi63PLlWyJoLx7S7guYTiaGRZFOe4Oa+hdO12C60dZ2OYp4g6Ee/b8DXzVI+ec16P8LtYM1lPpDsPOtyZ7cHup+8v9aw4gw/PCNeP2dH6P8Ayf5nRgXo6b9UejpckbZEJcg547DvVm4Kl8p/q5kz171k28qKgKMSkmSw/pU0F0pRraR8bDuVj2FfKnU1qcH4njbTdR89FzGTh1zjP412ejzLe6Qse5vlXcuWyPwNY+vxR31oRwzA4rF8Jam+mX4s5iRASdh9PUVOzGtUek+G9ejtbo2N8wQN9xjwK3/Ed9ZWWnie4uUDj/VorAlj7V51rSrhZMqSDkY9KwDp63ZaRbghh/DnkU72BRNG7vZF1L7XD8r8HrXcaf4q0u5s43uZ/Lux8vk45zXmMVnKtyJJpiQDwuOtWXt3iuDLbEvsGSF5BNJMGjs7200O6WSCVS96QZQc5QDPHfj6VnHwhAwka0GyUfMEdP144rnWk26hNNE7r5tsrEx43Ait/wANahJHI4jaW4wq5P7w7fXrQGxQH2jS5wWj3MDhu1dAbmC/tAyoQ/cVo6nZJqFqJEH7w9R61yX7zT5zyQCcYNMRruw8uLIwyttGTUOrqUuIZc43RY/I1nw3jXmpxRiP+MYxW9f24uYQB96POKAMaO5nVdiyttJ5GaztMHnz3MiSEskpCc8H6VcdHhYluFUE1m+FQX0kSd3dn/Wlcq5agnEmrTvzmONVOexrWt3yjsx9uelYmnpm6uZe8kmfyrbjj/csNu4HqKY0Z95LFuZgWlkyMP8Awjjv6VqeF2L20hIHzOenTNc74tSaz0K5uvKddrqrbeEGeBx61teAxv0mPPDA81I9i/qq+XdDrgqCKrZzjkir+tgC5Qf7PWs8jA5OeeMVD3LT0F4A9qYoYE4xt9+1PPruGfSkB2rSYyQqFXO4A0npkmm7ty84pwQjpk/jQNG3xv4xRuOcAcGk4znHPrTugPp1oRGw4YwAfzpuHHB5A70Agpnb+dKrZGO9ADl5OR1xThnqaRRkChqNhD+ec0KTnpSIc8Z5HFO6dTn1pCF4xz19qU8HjrUfVuKkPIHPPtQAhcgfIu4+9Pjyyjd37elMyVHtTh+I4oAV92SAMCmoGU9STQ745J4FKGDgFT8vrTAl64yctQ3IIzge1RHnlSMj9acW6YpLUQYwe/vSom1mwcg+ppOeuc57dKMZzhiCOtMB/f5enekY847imoACxXr3A70pPPI59h1oAUkKcnjPQU0tuJAyPrQeFxjIpF6AKeD0NAClhnG7Fct498SDRtLNtbSH+0LgYXH/ACzTu319K29Y1G20mxlv7xVxGNqju7HoorwXXtVn1K/mu7p90shyfQDsB7CvfyTLvrFT29Re7H8X/kupyYqtyR5Y7soXExYtk5PXJqjJIT9KWVySTnmqzv6V9lKRwQhfcV34Ip+m6hNpmoW97asVmhcMMd/UfiKqu2aiZsDJPSuHEzjKDjLZnXCPLqj6EtNStrq2tdQgI+yXQDH/AKZufX8affBoZlcc44f6eteKeEPFv9mSPp11l9OnPPfyie49q9f0XUYrqza3d1aaNcKwOfMQ9CK+EqQ9lUcOnRnoytKPOvmU7mXyLxlXG1xke9Y+q24cM0fDZGCOxrV1OImEx5xPGco3tWJPNuYL8quf4SSMn2rNvoQjrfD97HqOleXMi/aVG0k1mttsr5kmBMDnDFe1Zun3TafeIwOM/K4rd1eNLmJJU5VxyB2oWoiS50kyAPbSb4D0z1qh5r2ySh8KwHGBjFXfDWrmzmNrdKHiJwrHtXQanpttq1uTEirgcEetNBc89huJRfTNHuy0IAwT/St7TtYmiy1xLeSfIuEMflr/AD5FUv7HuLW/K3EYVGUhX7EVY0vSZHkUSxxqpXgtGRxnqDnmkkxs6/w/qpmi3MNuTwPap9bsYruAvGNpPes1YvL2xQjG0Y4rUtBJ5BSXBYetWIz9CsEsg8hwXAJyRzVuylhE5Ex2o5PPoacykQyHOB0471iTyIYX2gtjg5NJ6CRX8WifT9N1GWbAiWJthHJJPArO8MoY9JtFPB8ofyrK8f6pPPpcFo7MfMfGCf4RXS6NZSS2kPlr+7CAZ/CkVYqwRMqADg7sn6VtwKxhIU4bsarywrGCo5I61YyBAVIJyOgPNAI5jx1Obbw1fqw3l5EQlnzjJ6gVt+B22aSuwlhgHJ71zfxDnWPwvcQKURpbhNqYJbj/AGq6XwQNmkqHABwKS3KNbW3Bni6AlKzWJbGB+FW9Ubfc4HRVAzVTIDYrKW5a2GBdxPAp5XGO49accCmseOtLcodGQM+1SFvpio1OB0oOCD3FO4WNnkjk0uWPHpTM4p2QMAfr3oRA8b9vHP408ZIz/F2wagZA+OqsPQ1IuSpGSh9cUASqSev86UnkYpkYZc7m3ehxinAj86Yh4YAjjFODYPHQ1Fkg9eKViQOBn60gHMG4xj3BpwH4D2pmScc8UoO44zzQIl9j+VB67fyNMIORg04sepyKYClQykMBRgDC4AHpTQSPp6U4YyT0/GgQ4+pFKMA9zxUZfBAwTQHPOTlT0AHIoAcevOSaOCOc/SjJFAYngigAPysDtJ/GjkHOOtJu4IK80RkE9waQDuSOmPamk45JGOpJ7e9HA9/oa4r4o6lcWOkQJbSMqXLtG7A8kAZ2104TDPFVo0U7X/4cmcuSDl2OQ+IviQatqXk20mbG2JWPH8Td2/wrgppck81Lcy5JrPkfIIr9Fp04YemqUNkeQr1ZOUhXbNQO2RihmPQVFK4jUkniuWtXUVqdUICu4RSWPAqk8j3D7IwQO5oAe5OWO2MfrU5KqNqjArx6lSVd9l+Zvbl9RixJEMLye5rU0TxDc6PNEyszxxHKjPKjuB7e1ZLP71C7Z6Vz1qUKkeVouEmndHutlqtvrdnFf2rAoRtZe4PcGobiCJ5I3OMk15J4W8QzeH9QMi5e1l4mi/8AZh716xpdxb6qyXNmwlhZNxwfzFeLUpuDszQbeQ7oznhutaei3P2i2aCbIYDj61BcRhVb+JP1WqUEhtJ0cdCec9xWL0Yy/cRGJifQ/lWjoermOXy2fGeDUlxbrdWvnQnqMkVglRC+T+HtQxHT3c/2jUIlIzGoPPYmqmnG5tW+SPYhXp5uVPPoen4VBbTvNLGxIKR8sq/eNV7CS3eXdE7sdpO15lYDn+Edf60xGmmpTi43O6naf4a37C/F0VywRge/Q1yBgR0IWRlJOTSwtJEVUPkDpVXHY7bVnRLdn34THT1Nc7bnzJJemDyPaqkkktzgSSOQvQZ4qzbAxo/OcCluFjhPEjtda6sfO2M4Aru9Eu3hhWIt8uB3rh9ol1ORs87+tdZZqQqgZY7f4RSiDNq7Kbi+ck+lND/us5PTqOtVUy5KtnIHrzVlFEMDFmI47UDR518SLp5bjTrBtwXd5xy3cnA+lejeFk8vS4lPOSATXmHjQC58cQwnaqrDGCcEA8V6joK+ToiFm3Kueh6+lSNkdzKJLqQnkbuKj5LHgD3Bpo+oJ9aUyBOHOPSs2zRbDwc9enrQQAO5PalOOwoUdz1PrRYYq5xk0ikkkYwPSngrgUYDd+aANcN7UNyMc49qYSOhPFO3D15oJHYwKfnjGc1FkntinrnHqBTESIMggcUcgjnimbj26GnBuORzRcGSE4waUHJxg1GCONxxTmx60hDl77uDTgQPrUbKSysG5HY96kHoaYbACe1OBIHX5qbnB4OT0oRjnaQPzouA4EluaXg855pMjpTFOOMBh/KgVkTDjk4JpFccMeMUwc0bue1AD94PfBpVJDZzmotozvA5PX3pwOMZxmgLEvXmkG3jPHqBUZcjHBI7igNkngjHbFAEd1KI1O0Hcfu/WsPxtpX9s+EriKLm5t/9Ij9WIHI/EZrQvpQ12kYxhOc/WphLsZWTOAeo70qeJlQqxqw3izpp0VOm1LqfM1y+Sefwqm7Zr0L4qeGf7OvpNV0+P/iX3D5dUHELn+hrzqRtgJPSv0COOp4iiq0Ho/w8jyPYulLlY15AgJY8VSG65cknEY/Whi1w+Bwg6mpiQihVGAO1eTObrO7+E2S5V5is2AFAwo6ConfBpGeoWOaUpjUbiu2ajZqHYYqMkntXLOpc0SsIxzxXdfCLUXt9YubPd+6ljMm0+o64/CuKtrae7uY4LaGSaeQ7UjjUszH0Ar3LwH8MW0SA6nrUgbVDGwS2jbKwgjnce7Y7dBXHWkrajNyaMq2VAIYYIrFuoQNwC/n2rSt7kFpIBkPEcBT3X1pt/Hx79cVxMNhmg3pRmt5ORjgGpNVtwrb1Q7T2NYlwGjl8xTgr6d66GxuUu7XbK3OOQe1JdmBlLOiPghxj8DVQQWc0ymOKBZCGJeOUlyc/xAdDWlc2485YZeUz8rUW2lo0ud6qMMc/Zxz/AMCByaXkBRa3mjYCC6ZiP4W5qWBb12ydr7f7tW20+CJdzyNyeqjGanhRYVzC7+xamkO5ZtzuiHykdjUtywis3IODiobA5Z+fvHk+9JrjbLUqD9abA5bTk33rHr82a6dwFVQiueOdprn9IUrMzdfettJG8wMq/wCFEdgNbTGT518vBxwcVcuIHeIJCu92HftVCCRlkV84yMEds1fu5HjUGN3C99nWhgcl4n0VxrlvqMrNcRSxLEzbceUV6D3zXb6faE6QIF4Ijyv86yXRL9LdZY2DK/duSD6j8q6W04JI+4BtpDOaQgjp+lPCjHGfxpXILtjpk8UwsRnH41kaocAc4B570qqQcHJFRh9wyvX1HenqWYgsePekxokYgDpSqBkHuaTjkNTQdnehAavPXilXBYEnJ7UxST979acGAbng9Kq5A8dOO1AyOc8elJnBODwaUHPPWkIezEYGASaUHmmA88dKFJJ9BSsBL25GacCy44+WogxHenq/GMdO1MB/VuvHqKXOM5Gc+9Rh+p4H9acCmeRRuIcWUHrz607dn61HvU9utOVvlIPPpQA9TQxANRgnBxkZoUEAc5HegB+RuJ70H5emKbj585wTSscCgQ8Zz+lKmMc4/GohJhc/ypyNu6n8KAsSgkdKiu7hLeFpZM4UevWl285J4HOOlYOo3LXl0I0P7qI5z6mlKXKi4Rc3YSF3kDyOeWOTn3qxDcKEK7smm3QK2+OhA/OshHePJc4rmb7noxVlY0bi5gkWS3vEjlglUo6OMgg9jXhvjzwrLpN8ZbItLo0jYjmzkx/7Le/oe9eq3k2+Qg8gL+dUPJF7A9vOu63lGJEPTFdOFxcqDt9l7oxr0lU9TxIgRrtXgCoXfrXR+L/Dk2h3JdMyWMh/dyf3f9lveuYc819NGrGpFShseW4OLtIQmmFqCcUh61jOTLSEPJzVrS9PutTv4bKwgee6mbakajk/4D1NaHhbw3qfifURZ6Rb+YwGZZW4jhX+8x7fTqa+i/A3g7TvCNiUsz5+oSrie8YYZ/8AZUfwr7d+9ctWqqfqMq/DzwLZeEbMTuUudZkGJrkDiMf3I/Qep6mutc8/UYpeevT1AprjcOetefJuTux2PPNYgNvqMsiZDI+cD0q222e2R15B7+lXdYtwL6UsMrJ821v5isW1kNpdmMt+6fgZ9aYitdQFg2B0NU7edre42nof0rckXcDg4PoRWTeRZbJAyDxSfcDW+SaMMp3HisCG8WzvpUW3VnGR1OSc+h/pVmOZosL/AAnnHrTVBmu32xTHcW+7Jn07Gi9x7Gl9tubhgJI5IzjAXZkfnV82oKBXJBxk4qvp1w6kR5UsOAJDjFWdVmDxCFG2Z+9jvTEN00oXaMNu2k4YDg1X19iUZewqbSQsZx2zVXWcNcMOozSuCKOlxfL1960t+0gBTz6VW09cRsR0zipyccY7+tNDNANJsjZAD3NRzavLBH+9iKc4DrzipkjHloCxAI7VHdFEg2rHvLcDIzSGV/CGoPcX1ymd21WbHHc8GuyLCK1UA/dUk81zng/T0tLOaUKFaVzuPBJrY1CUfZyCcFvlFJaLUFuZRJOc45pwOD0+pqMEA4A57Ggk9xWTVzUfx2HenYBXjimLuFKORyfypDQ9Rnkk8H1pxIxgVXUyMwBUADjn0qduRn0p3Avht+CpDAd1OadnAGc14faa3fWxHl3Ui/jjmtyz8Z6pFgSES/73OaExOLPVt3PY+lP3ADmuAs/H0WcXdqAfVTit+y8W6VdgASmPP96mS0dCvIJ9KASSc1Ut760m4t7iJiegDVbGcZH5ikxDuF7cUqkdqYWJI9BRnng4NMCTAyecinAkDnkdKYen9KUZA55FFxD1xSZUZ54+lNLHjAyPX0o3AYzzmkA5SemCcd6egznp9aZtK5weD+tDZAyR1NMB3NICQMHtRwRgGmj8aBDwAFySMU4EAZUCmMfloyEUkdBzSGjM1y92f6PG+JGx07CqltGqNtViVUck9Sax7+7X7VLM7DLHgE1NbagipGobIK5Yn1rnnK71O+jT5UbN05aPC8H7tZV7A7Kq9cHOfWifUYztw465471Rn1eNdwGOeMioubXsLNHJnIAYZ6n+VSBlVMjAI5rHm1dAMgnPuaqzaoZSCCfT2pproZvUv6tcxywyQ3MUckbDBRhnIryvXtAMEjSafl4ic+Xnlf8AGuxuLlmbk5qjKwOTzn0roo4idF3izOdNT3POZFKttcFT6Hiur+Hng248Xai6+YbbToMG4uNuceiL6sf0rp9A8NHxDdHfGq2qfflZc/gPevZdH0+10rTYbKwhSG3iHCoMZPcn1Nd/11yjorM46lPkdrjtF0qy0PTY7HS7ZLW2jHReS5/vMepJq8M5PTmmg5fke2KXdnA5yPaua99WQLkj8KY4xycmgEE9/r61HITg80wMPxMqbIZSxVkfAPrntXOX8IZeFYseeBnBrrdZgM1i4A3SKQ6exFYYQuhldAp6MueR71SEzO0+fz18qXHmpxg9x60txDvJ29B2NRajCIZBPCcEfeA7VYtp1uVAbAlx/wB9UkBlywgxMvO5eao26Zu2ZsKSxHynn610EsG1z79azkgX7XKEL7dxO3OR+RpNDv0L5+YotwMSr92QjhvrUsvRDjPt2qSx+UhSdy/3T2p12uGXaeD2qhEtguHU4xj2rMuiZpJSeik1q2gZEbcRjHFZoABm460hiWh222T0JqbYGIIH0NRQL8iLnqa0I0AfaOT39qdwJCPlU5+UfpSxQtMZJOmFIAofPCqO/StCBAsfIALYH60WAuWsQg0+MLwSOaz72UtIsfZRj6mtjYNyg/dTJOawJdrSuwGcsTiom9CoCjAPNIRnoBxTdxP1oy/ZQc/hWaNB46e/ahPryeKMFuo2/jShAv3R1obGhQATuzTuh57UDA44zSMMnuR7U7dxHhrKJQBk7QeoPSnMSANuTXQyadayAl4CpxwwbA/Kqkmjq5IhnIPTa3ODRuO5kmUkkhct3yeKcjYyWGCB1B71ZfR7pQvltG4OeSSOlRy2s8ZYSxup9hu/lTYXHxXMsYPlzMrDpk5rStfEmqWjAw3Mm0H7hJrCY4wNxUjuRyaYuWyQScccdqmwHdWfxA1CMgSIswPXKj+lbll8QrRxm5tyh7lT/Q15eMk5Ckk09XI++MA57ZoV2Kx7ZaeKNIucFboRMezitaG6t5lzBcxSD0VxXz8WXZlfvflSx3s8TAq7rzzg9qNQ5Ox9CjIHAyDSDpmvErTxNqVs+EunwOME8Yrds/H99E4WdEkXtlRmmS42PVExxjkn1pqnOQeOe9cTbfEKxZR9rt3jfPVGyMVsWvizSLoApdFGPAEi1N0Jpm8BzkjmhJUJ2gjPTGaht7y3uMGG4hf/AHWFWNvOcDHt3qhC45PU1BfzCGymkAzhcVYU9eee1Z2vBjp8mxctjj3pPYFueb6ru+zNIM/e79arW2oZAO7jHT3qvd3Ejl4wSUyRzWfJazBBLByR94VzJdz1UtDSmvG5YMTVZrhmPcnH51RZ51+V0IJ55FS28U8rABSF+lLlBolD7uT1NO8zYvGKT7OyHJ69MVFLlQQfWhK5NhkknzHJxV7QtFm1m6wCyWqH55QP0HvT/DmiS65qHlKdlupBlk/uj0+pr1nSdMisYVhgQJFGMACtYQ6mFapy6LcXRdOgsbJYoFCIOAo7e9aK5/4B6CmgcZ60KcsR27c1urHHe5IODkE/4U4AAnGATyeetR7go4GBSAbQSHJ/DmmIeW9c4qNnAwRkj2oDk8Y4pkjEkjOD7UwI5SWBBHHauY1JW3nbkMpIYA/erpHySQpx6Vh6qDuIkjLAcrIpxhvf2pxBlFZYrmLYow3dT1rKKPbXBjIJBOU/wq8HSSYLMnkzDoSNuaW/tnmXJznsfemSPt51kj+Yk8Yz3z71SvYQNRYKcZUc9QTjP4U22Zi25TiZOHX1FS25S81CVo2aJlzjuOmMZ6/nRuBasfuADdkf3utPuGOAPemwBomKOCGB/A066YbCO+QabAtJ/qO2TVJRtmk7girynMC8HOKpgZlb1xQhhboWkXjJ7VdgHyuRwc1FbAjLYK4GPrVqBflKtnmgB0SfMD1JqaXcbqBRztbOPenxqEj3AE4PFWLWMtdxAnBGXPegEW5jizndhwRXPqNv3cYrb1a5CW/lJ0Y1hSF1+4Fz7ms5PU0iP4JyM5p6k55NQxM5X5wAf9k5qQcsM9ahIsdwOCfrTh9w4prFcE4pdy4+UUbABH5d6UKB0ppwOTmlOSvGPWjViOCki4O4jLAdaaV3jAGGJPyg8fhU6ja5wcgnketIUDFc7Sy85zmkhEexvL+UHkYIx0+gpDHs3FODkAmpcAxkElWUDPYilGAWVFyNwAX+vvRcCm9tFP8ALNEjJyeAM+3NVW0m2P3VZBjqOhz7VqKoKKSwGc8DpSMo9D93jPbnrTuGpgy6PKrgxzBhnaoI5NVp4JY2AZGAPYDP+RXVMAHbI4zxgZJ/wqMAEk7eMEEjn86TBtnEzPgDg7e+ByKPlZwASQemOK6+WNWVgYs/KN2VAOBVeXTrZ25t1Vdw+71pp30Kvc545QcPn+9kdKQnJLZ6Ht1xW3Jo9u27ZIyksQMc/his+bQ7tc+RKjADIzwfpQguUlIaRiODjoBxU0TFTz1xjHODQ1ncxAM8EwAXLEcj86iZnUoQpUj+9wT780WC5ZWWWAjbcvG3bnArVs/FGqWjqIrmVlxnBbP6VheZuGGwQOfUf/XprqSDINxbHLdyPU/SgNzvLT4g3qHNwkcgxnLDn9K2oPH9jcwmK8t3jLDGVP8AjXlMeSMZ5HbNTrjhnGQBgD196HoJpGiLhBeSqzZiLEq3qK2bSeNVDKAQemK50IhAC4I74qWJ5IFID5X0Nc0kr6HbB6HULNCxBaJWIHGRTGuIFz+7Cn0Fc+L6RRwOfrULXcjHOaXKzQ1ry6T+HFZiJLe38Npb4aaVgqg/zqnPcMRhAWc9/SrvhZxba/Zz3B4Eg3E9hTUbMzk7J2PY/D+jw6Pp8dvB8zA7pHI+83rWqDx0xVWGSC4A+y3auB2VwasncByvBrqiec229RzH6GlKqcH0pgPHbFKC2frVCHseOTxTHAwfpSO4A+7mmsx6Ece1ACYXA2Z+uaRiefWhjxwaickLnFIBJCQOPzrP1GIOocNhkU844Iq8W+TnrVdmAyGUsp4I9aEPcwZwyr5MttLJGeVIIYf8BqrBdx28uyZ38o9HPVPqK1b3TG+aSB/Mt1G7b3GemR2+tY19Ns2R3A8zjg4yy/U96u+hBbvrMkpc2+G7hkPDCqMcPn6pNLGTHMBnK9D7GptJuZLdwIP3tu3WM9/pU8yxyas82mSKy4wUPB6dD6GmgLgBnhG4bZV/WqF6cAD0/StBH3p5q8How9DVK/Xc4cdTTEi1Yyl7baW6YppRVkLdKgsJI0yJJFQkdzTpZ4JGx5qgDvnrQtCiwpLIdvPNXYxuKnOO3NZiXtrEpEkg+tWLPV7QTAHOOxPAzRoBsiMNgY4HSrVpbsZ3cHC4wfeoNPlhuZCEkVmHOAai1C+FnaySMuCpwMH7xNJ6asaV9CHVZVa4Cg/cXFUywx049arW08lzEs0pG9+TVjJxgAYrG93c2WisHzDGBn1pc8dKMnHHWj8OaYDsbscj3FPx6ACmYx6fhSKcscnFJgPJ5+b8KQ4waGx6803GWwaaYHHOzkqVRCAcsMkZFMKZy2HHBIOKmb5hgZHGSR1ppwY2AIwF6dKmxIxEOwqx64z05pAyEldwLbs5AqURkINxJ56A9qFY72J2/ePyjqR6D1pDGFc7d+AuDhW/pTWC7MnqRjGc8U88nOGAx3GT7c9BTrjLKzFQCFA4GKYkRhDH1VjkgZ9aRtxJ4GCccHg1JGGG9hgBiMBiePpUZViXLhirSYHv7e1IGRlGYKeOhBPQfSlaMGMqD8zgHleh9KlXAx8hKngnJwvpinFfl6gqBzzj8DQGxFGgDE9Pm5QY5P1600KR8qjgEjI4FTrjktnAGeOcUsS7VZcrgtxxjqKaCxWTCjcWcBkzjHX3pJY47gN5yBsEEggHAPHerLIIlXO7PQk9SPrSqEdR/FkclTwMUBa5myaRZvsJhAwxUmPjcMelVX0VFLeVNsPcHkE+1bBj5Z0fYOCDjAH19TSkTb1+ff0wp5Jz3HpmlcNVsc9Jo1wixss0OCueQQcVSuLK4hcF4nHHReQPc49a7FVAwQVGCQVAyc0kMaF3DAF3BBYdQRzjNArvY5azyQchlIGPm7fWppeVGBz3q9qPMvUk47iqSLhuawludtN3RSkOOeRTFDyZCc+tX5YF7dKadsSEKKdzSxWEQjGQRxUSyAyAA96WZsITwM1WGN2S2BnGfSqSFLRGlBcz258xZ5B/EDjI+gHWtWz8U6nagLHdu2D8wz29cVzvmAvldwb+HPqO59jSiUbscHPp39a1scLszvrT4g3cWRdQxyqDgtjBP5Vs2Hj/AE2cBZoZI29QcivLRIDw+Nvb6UgRAWCjDcDPTPoead+wmux7dBr+mXm3yrkKfR+M1fSWORP3UqyDr8jZrwNbh42CqSrHjOSMH2q1Bqd1Eu5ZGVxwG9eec0XE42PcG4y3Iz60wuT1x7V5Jb+LdVt2+Wfdj1Oc1o2/xBuB8tzCjEd8c/pTDlZ6G8gBIbhvSonfJ44rl4PHNnJgXEDLx6/41fh8SaVPgLcGPPTeKLgkbsMxjG5HMb/wyDn6hh3FUbq1gu2cy2g3n70kDY/8dqGK6tpz+6nikB9GqQjg4zQJpFaG0XT4ZJLFmmCkfuZAMn3FZekXVvNdTzZEV6c71bjdzzW0x54FZ+oaXbXrCRl2Sj+NOCafNYXKNe8WOTzACB/GPWm/aopshJFIIyOazNQ0m+VSLaUzRjoGOCKyfs2pQKCbZif72KfPYFE2Ll0zuyMe9RZGMhgB61iS3U6nbJGN46rnB/Kke8uQyxpACfxqee7K5dDXXLknOR71o2kPmhBt49SKwrM3jSpG0IAYZ5OB+dXJdcjtokD3kaSgY8uMb8c9KafcFF7I7TR4Ft5fNQ7FUZY+tc7ruqvd3MhBxGWOwDpishPEjGzlt1MjvM4+YnG1fQVVMvnTJ2P0rKrO6sjopUmtWdfpTZtYx0IHY1oKMYA7Vk6ICtvyRgdK1FPHNNPQzejJM96RTnmm/MQcHFPHvwT6U0Id16cGlyAvPJpoxnmhuDQAu4d6GZew5703A64pynA4pjscbKwUMCQ4HGWP9acG4z8wJwOOef6UqqC8nygNkAeuP5UrqWUbV6t39vSpuL1Da3mEEDl+QvHAH60IgCDkswJORUkW8sCxbuefT61GuQYyuflB46ZouISPDxYU4yp6Hio5dyY+ZchQcYzn2zUrKOrgk7cnLAg/lUaJlWYM7lhxg8Af0oFYWReGZgwUgHJ4ApWUOFDZYh880kp2qQ2MccE5x+NNJPG8YOQBkZP6UAKMrIMAEZOflzj/AApIVLqqZ8zGTnv9RTx8nBOVLAEqcfh6/jSxqdiEEYBbt976/wBKd1sAzOIzgE/Ly7HJHpmkl5V9pIOFYE8gc1IHG5MhQTnp1pqAMT0B24JOOg96QNCeYwHz4I3btoX9felLYADAgcqAB+nsKV12gk5VSuc9T+FO3gL8pbK4YBun1osAgE3yYcbiu3Dc5pqAoSCuQy9SeSR6n0qRnyQ+S3zALg9PcCmSTLChdyMI20nOMe+KYhwbdkqCoAzkH/Oac+zHG0spDEsuN1Nw0ijaqEgELuHC9+KRBE6h2IwwKNk5XPr/APqo6hYoanG4OSwfkgE9hVIJzk1e1JztiO4HPBGOhHFU4suQGrCW51UXoMkUIhIrPuXIYZyT3q/dHyyQpySKzZXDA560ROiJVm+8F6itPw5ZrdPKZY/Mi+7tx1NZpjaWVUjG52OAK7HSrT7Fp5jAKuw56jcfWtVuYV56WK8+gafLwFaIv8vyN0YVnSeHZMMbeVSByUkGDkdea6UK4+fkE8nJxz+H86adknykujLhxt7nv161dzkuchLo97GAY41kjGD8jZyKqy29zbyq08EkajqWXPHpXbn5VKpvfb8xYrxj0ApoRgFZ92wcEH5jz3PpR0DmODedyCu0fVuxz1oeb+J+d3PAI5967a7ht5YgtxbRS7jsPy5YH6isu78O2coBheSIkZKq+4A/jRoNSOeSdCvHzA9AP5fSnSMCp2qNo+7x+lXX0GUMrQXEeCMhXXBHr7VWn0e+iD7IxKo5Uxnr9BTGmUlbaqh3ZsHr/s+gpSwILb2yTgeuPwps0Vzbg+dFKuDzlahEirnGC3bd3FMLk4mnhC4mYLnBzwauwa5qNsAUuZML784rLknDrhwcdMg8mo95HGSQeMf40/UJHVW3jXUoBhwsinjla1YPHqhc3FspAOCVJrg9wAYMcHpzzmoy2QSCOu0ilyifkepQeMNLk/1nmRt1ya07bW9NnX5LqMZ7PxmvGDgjnIPSljcp/GfSly3GdV8S7dft9teW7qySrtLKehFclHczQNmOaRT6hjU08jyxmN3LL6HtVEoUODVJWVmbQ2saS3E1w2ZJpWyOcuTV62jQYBGQR1FZNqRjBOD2NblgpcDaOemKykzpikSqArjk4+lW45jlWBphj+UIwIb2p8aIq7SOe1YtlNHYeGWMttuJzgkH1FbqnoP0rlvDJZNwzxu7V1CjucYx1rZao4ZrWxKD8vWkHuMU1W9KfuH8QqloQG7g9sU4Nnrj61GCNuBTgxIpoY49MHGfakBK5wOT2ppOaYoZZSdxKnsaAObQI/J6h+/9aCkilcvuPNKoHHzYYDPI60q42HJHIwFA5qBCDLCMhjkAkcfzpjfLIrbQcr0zx9frTwjLGBtZQq5APOP/AK1IhAwWCgleozn8KEriG5G35lA4/hGOP6UjEZ43O20ZPQH8ae2D8ykcLxkYH40siDaduVyvc55p2GCZYvuzuwDjsPwpHIZ3b5QDjgc01TtZlJYEgcf3fx96kLJtkHX5QGwODSYMaEboTwGBwOuaYUZypxyG7Hafy7VKQQHY5OMAAYzSNuwxIGABntjPt/WgRDs4Q5bdu2kjtUiDaqqW3sCVznkiljCBCiFgA2Tg05AoZC+CS+AORwfftRfURXQhPKCptDBlAPU49Kl3ASIAD0xzzj3ozsOQHVg2Cc5FRoCCAQDhj25IoGPUdT8xYrwuQCfWhkJUhuhAO1sEA/h3qNVZgiiRkZSfow9D6VNGMlQAmNpX5TQBGrKEYMflb5jhuR7+30pcFdx2DbkOSAO/ce9EbFcK5I6jDLkfX2pSyeaNj4TbjODn/wDXQhEF7GJLV1jAXDdR/EPessfL3rZZC8ZCgYYYwflPFZE8bxja6kMP1qJo3pPoVrxt/UCsiVgGIX61fvjtUkdelZrHjmlGOh1J6F/QYvtOo9/kXfkdQe1deWabdsPmEAMSG5z6elYHheAGGWcK3mbwAO2PetN5FQlio3A5JZcEg8cCtEcdV3kTzKEcOobfgMACGHuKeCqSM2Sqqc9c9u1VVkUMwQIkaHbgDgL/AI0qSlVI3kEMV2lcceoxQZ2JfNXzN74VQeW6ZzSsd2QxB5xy+PxNVVkyGDrkjhmGMEdhmmPMh4YDLHYVx1NAi1IMd2CnjKnBBHQ1GQz7t5LSZySvGKiLYQeWMBz8zK3AIpVmVlKhVBc87uMN70x2Fc7cFcHHzKA2M+o+lMVtxYEyDBJBI28elBl8tx824sQRyG+uBSM6MCFYZXkAcgj0P0pAOlkTgZ3LjB9h2OfWqVzZ20+DJEki5xkgZJ+vvVibcuSoOxRuGe4Pt/WoiACPNY7ugJ7ihMLGdPpFs27CiNjx8h4B9MGs+bRiOUnO0jgslbrgspf5W54wOc+tRsNvKgEs3zcdGp8zQHNyaXcgAhfMGOSpqs1rKoIeNsDg8dPeurOWAK4A7Ln8x7/SmsjLHuUHrwAOq96qMu47XOLuG2MuSTuO3Hf61IApGccnt6V008NvICZQrMDneRjFVJtNtnC4j8vvlT+tPnQJWMXcvADZPfnvTWAJPQVpz6OowySMM+o4zVK7tpLVl3kMrdxVKzLjdMZHGxPUGt/SW2LhgCw6VzyMwHBI9M1etZHVxz9azmrnVCaN57hC6kffzirAQAq2Mk9KwMhLgMWJJ5ya11mwiMzVhKNixt1qc+n3jfZ2K9PpV638bXUZCzJG6/SuR1G4WW7kBbgnjioQBuJ6f0reMbI46mstD0y18aWzkCeEoP8AZNa9v4i0y4wFm2sezV4+4+UnPWmK+CPmIHSqsTc91guLaYZjnjb0w1SnOQR0NeHR3MyFSsrLV631/U7UnZO5A6AmizQJHsYOAeajXkkV5nb+OL9MeYEfnBBWtm18docC5txkdSvFTqDRqR7lBkZQSFwPYdOlISrHOAqqvXvn29KRyqtJ8zscAE91/wABTmKur+U5yVC5HA/yaViRm1lVjG2VAzyc8f40EEsRIvzbOcdlpJVZVbykXdgY9qk43Fd4HyjI3Z5/lQIZcyYiOS6hVwAoyMevNRrhg3AYiPjB6g1PIrICZepG0nPJFA/ePIS2E2bSp6A+poGRggb48gHYOWOBmllVSZCjYZVGCFwadIEWMqnKBRnGDSFiGZfkdSvY4IoER7cl93IwCBzx65p7AhuAc8MAR3pQv3hk/c7nIFGTtbIz8mN3dvcUAI6RuJQpIlOGKrnn8f6UhXLSF2whAKk8lfb3oJIXa6jCpleecf1pxzsVlLpwBlRz+VTYBrqGEnGHBDKAMEio5cIZFBJwc7Rzu+nvUpck8kfMByep96bjczGLdgx4ORgN/XNO4XEl+42xVV3YMRuzml5BYAxFVOfp+VJIgycBiWTPze3XNCDG5VDEOMnbxjHTND1EMxskkAG45EmDycetOdC6DYGZd+Tn1PamlgIyCwAK9c9foaGHIIARioODyaAFYsibSMKrYKdWrodX8NTXVhbXtsFaUwLmLoTx1H+Fc6IWurhY1QmSQBQ4Y59MCvYLmyWGyhtgA3lRqn5CtIxUtx87i7o+f9XtZIZAs0bxv/ddStZkdpPcyLHbxtI/YKM17VqkLldjgsg6B1zj86w/LEecKq/7oxUunY3WI02OZFuunW0NuoZ5QuHC/wATf4Cq5mU7VbG5RtZgeR+FP8QyqmpPEAw8xQfl6k49e1Y7yklvn+fAIB5GRU9bGXmzUWfzDjJyRjbjIyB3pqyOYkJY8jHXGD6VnLIWXDkDjOR0B9qY0pZ2OUbPzAdCMevakKxqq5YKRjB4xn+dQC4CyLk7VIw24Zyw7D2qvBKWLBcYb5gVORkc4GaN8nK5+YjcA2MCgC2kwMhL+WSw+VRk7T9elKXG0gHYXO44HOR157g1VRlCkqSG6hQfvfnSsSNzKTkD/dIFA7FjzMMFVlBzlcDGOORUTMkalkDsPvDbx17VCeE43Y7diaVt3mHDZYfMqnpz70DLCTDaMMGx94Nkce30pS3mHbGSQpxyOoNUTndj74Xuf4h3pGdRkZHyds4yDQKxbRsAiRo8jh/THrmlEqynaWztOOex9aqhyAxyJABgBfSlR/3u5ivA2scYp6hYs/eXzI8Hkg/XuKMYVTkDJzj39KiWUFhkDA64GMVLHMnILjcxOfai9gK7oP4Sc9QG6mkkQox+U7sd+4/+tUjyiRjsCgk8ljnaR1qvK5WIbCFYnI+bOTTDcYMEJyeh+hH+NUtVjMltkAlkP5ircVxGWOCGdxlc8kDuKsuNjQiJA0s7bEGeFX+Jqa3GnZnKr83Wp0B256U/ULM2d7LCc4VjtPqO1LGDt+YHHamzdaiwnLDPNWpGZwqIcsOvsKhjATlR83Y1ct7ZwQf+WhPPtUW1KlKyMeXT5yd/yn8eTUckdxGylo3GO+OMV0DK2AP4+xPQc8inlSpbBOB93PX6Vakc9jmxnkMeRzimqCucn3FbnlxspZkyerKB1FMNjA+CY2X2DYzVcwJdTKU7iRk9c9albaec4BHTNWn0wclZGGB0xnNRPpkoC7SjN3wad10CzIFChiQRwMfWoQWDZz7VaNvIigNHkA44qCRNobBIOe4oTJ2PW8iRXUEH5wDgenemv88rEcc4UnkcetMQiVVEacKx4B5/+tSyCWUO0ijBbBJPUen096yFYkZBvLYDLnAwfbmmTDcvz5YDg5wOtIcbGcMfLJwMA/lQWRlYYxjH3hxRfoAr4HmHJLBQcKDxTJ4Tlz8obaOCCW/EipGCszyLlOQOoJ/DFLgbnXIBUA4PFDAbMEXcszhU2gleuD+FJ0MgSNR8nzAHqe1BJLOJM7iuccc//XpYWDxszdNuMsO/vQIcI/MkjCNgGPGB8wB/z2pqA+YcsCAuCoH+c05IWA3BNvyE5A+VR/UUyBcLGEABIJxwMmgYrEEqzHKFCv3gSPp2pigoU2v94YJfO7Pp/wDXpyxFRDvXaD2wDtPtjFN3xlQGYhiSCSNvAH8qQhI/nkjXC8nbgnO40KWCqQrMxJU98KPr1p6GLlUZgFbnIwOnr3pdu1TEshySDjqR+FMLEO0N5RkIZlJChV559cdal2v+7BwecPtPAHt3/OtfwtoN5rV7Ilt+5iDDzJmHyqO49yfQV6Jp3gHRbNw0nn3jekrYQ/8AARVRg2JysePHylYfKqAEhQByR9O1WbDR9Qu2RbLT7iUk4BCkgf8AAjXvFrpWn2YH2Wytocd1jG4fjU5+VTtFX7NEuR534b8FPp17Df6rNE88JLpBFyAexZu5HtxXS3DAo0jNkdvWrOoER7mBJc1x2p38izkIDkdqd7aE7ljUkJRmZiAfSuWulG8henrVi61GaY4kBUegqsDu57daGWkcJ42xDfxygkNsGffHFc8Jn25KtwcgDvXT/EHaJbVekjkgDHJFczDEcBiQARtbJyR9KydrmiJAzMckA4ORu6LUgdsHOSA3HGc/WkSMgLlfvcHI6VJHbyBkADM2cEg4GKkbYhbYuVdflHU8HHpUyAAsQOMhhj/OaQJ5aqcn5SUYgZ4zUpUgockkAqxYjijQBofZgvgjPyrjoPpTjKu0gjDLg8jOR7ClVVbJHmADqpOc/T2qKTK/KwUEdQOgH+NJCsP3bQGcjOTjI5UU0PtyF3Z64I7d6U4CgElVHcnqP8Kjx843D7vbpx7mhAw3YOEx8vGfUGn/AHVw/wB1eDxzimsMjc5PyHjntUTpJ2RWB9/4aoB3mFCflwByQPTtTFfn5t209VamyboyRlnC8nPIxQpA5zhvp0BoHclEnI3LgjAJUYwOxFNaXD5UMMDBJGc+4qFmGf3hPB5J7ioZCwfDA55PPp60WuKxLLKIkOHAcn5i3P41m3Vw0md2OtLc9GyCqDrnkEdjVRyASD1ArSMRFvS7c3ck8hJEUChmI45JwBXY6OQ09zKcExkQL7AAE/rWBoIU+FtXY7t4kU5HXjkVXl1S40/UZ7uxQXNrNGs80QPKHGCw9Peh6sai2ro6vVNLXUVU/dlXo3t6Gq9h4Ru7uZVeSNVzg4OTWr4Ynl1W0juls5VRxlQjo7N9BnP6V0F54p0vw5plzLJb3a6kqlYYZ7dk3SHgAZ96iLi3y31GpSS0OM17T7fS7wWVugJgOGbqXbvz2ArNcNkgqWVectV7V47mO9dbws10dvnHP/LQgE/zqmys5Kk8qcg4/iqZSsxp33DaGXcpB3Dt1xQybTgnIXBOefxpy/KdoYkE8ZHQmlwVAIAGBj/6xpc1xjNuCQMgseWzUfl4yzAqM4GOoqQOJGymckY9fwpwHIwDgcDPpTu+o0iDlWJZTtzxk9PahG3cAe4PX8DUpCH75G7PAPpSugHzbjuPHXrQBD5YG7IGG44PWo5I05HXjJGOKslcHcwJHUj0+lMyhXMjfMeAB2ouwsdp5ZSOIIV5Y/xZyPSow4jEZEgKb8BnBYkE9Aak2oFjDBgFUnOOfpTQgMscoZACTkseceg96DMXzFZ3KEYVsMvel3q28s6hc8896jKNuRvmGWAC9CR7n0/GnzFFKv5Jb5sepB9j/wDXp2EOZBiRshskZZef/wBVPDebFNkglV+72Hp/nNRyRrJDMFjwCR/FgH/P1p2xkSQsc8AkMOB/n60wEjxLE7rhGVcbgOP8/jTWzGYiuckYCk4yf60qkNzIc7Rg4Gc/SrUZDImMmVVbLZHAz1Ge1K2oyuwKFBycqSM8qD79PwodHCQMXj2r8zsT19qUMWeF5Q0YOQM/dY9vSnq3+jqrJuO7JYjAB/rQxECcOFQsGYnBHofU0GLCneqkowYtg/lSsIWztcqm7LZHDD09qk2EFjv4xxGeNo9TmjQQzAcOWkO1SD05+o9q3PCXhu58Q6g4KmKzTCyzj+H2X1J/SsP95NcrBHt81wNrAnvxivoLRbBNN0q0tUAVYYwCAMZbHJ/OtIQvuKTCwsbbTbOO1tIwkMQ2qPX3Pv71KykdKfIyY+Uj3qtLdR+WQXCj3NaszGy3Gw7cVQvLsIuS3PcVUv8AVYIUJaRMDvnFeb+LviNZWgeK0k+1zjgRxdAfc1LYJXO11DU1KlV6+p7Vy19MJJCVyX9R3ry651/xRqXnSJKLeIDIVE6fiaiew1ydGS41ecYG7lzkD8KhspKx393dImfNlQP2BIFUbjxFa2EJLzwl/RcMfyrkU8NQlG86V2mZQWJ3HnvV620aztzvWIHeu1SRyx7jmk3croZV+91rOotdXJkiiIyiMMsVqVoAEdNhGcEZAGfatpItqxkFSXHlkgdcdvpTXhLKmzaHQ4YuOB7DpUPyHcy4o9omG3A6gKOhpfLMgxyAV3AdOP8AGr4QLhjuyG5UHr7UFFUsImG5TuUBclc9vSpC5n+UDkk4B4PPQ04xZAO1MOMnjHP0rQljAiymMDkHAzj3qCRCFIRkct8wAGMAH71MaKvlMcnI9CF9aPs5CpuXKMMO3rirnkAhyxKAjJwec+goZHKjrhkJVDyVx60AUdq/eYcHupz+H0pXi8sv5oYjGwjHPPTFWvIEqo+CCQAzEdD/AEp+12fbjg9SD/OiwXsZyQZAbhl+7t6kcdaZtKI7E/Ihw5IxxWk0Y6qrbyNueeKhSN2Ult2MbTjnPvQFyiY/n3gcLx6hh+FNERPBHK9citBUIVSiA5GMpxxStEEjwyZ2jDdMmgZlSJhfukkdlGRio2g3KcNu2+g4IP8AOtcQ4Xc+0f3QTjP50j20YYt1VcnrgYPpTWgdTAvoSsWTj2PXNY7pnlecDJ+ldbPbllDIOOQM9f1rnLuHZK6A89cjpWkWJ7l3wtcqHu7CTkXKfIM9WFaekaZDDcwTTKXkL7IIEPz3JPWMj+76msDQlP8AbdiYgSwlB/DvXrA0SYNb3GnuBqN9IEjO35vKBG9AezEZI9gaVSy1ZUHbS43wzp3hyz1G4lfQIzrNsMmG1LG2iZvuhnfIV6fYa1D4ou7rT9US9ura0udqibZmBwDkjHDBR61Q1my1yytJp7l7+10o6gUtA0o8qVQcr+76/ieDXS67bPuhvG8uGW4/10McYVioIwSe/PH4c1hXmnFNrU0dD2cY1L73/A43xZpFxp159qaT7Ra3ZL29zFyki+nPQjoR1FYHlE5BycfeB6FexFdjqpaDS9Q0ySVXNtdebFG3cY/h9M5x+FcojFVXggj1P6VdlYnchO8ZZlJTAyVzhR71KCCCwwAB1Pf3FOD4YZRH67cgrUbgArtAVQc+/wBKVgQpi2BiM5PDY/SkG7ALZO0AMev0p2NwA+ZiTlc9AO+adGAgG3aw6jPU0WsMjkUSOcrjjn/Z9KQ4RQwzzwM1KEIwygMTn24z0pyBWBUnJye3Bo1C/YgAKng4x/epQxb5ggBOcAjGKcsRzjv2z0NRvvG4jJUjseD7UncGu52a7SCISybF+6OcfjQFwUAPUbm+Xn8PT8qXaN8gOOgA2jjH4/40ZVggIUAKSpYfgKszbCCLaoMTHLchRyPeoRLMWJcrgv8AL5fb6jrUjPsaCPgEg4XJ/E55/pSmEeQrSEhdxKmPnn0PUUbDGsyxiVl65APy8/gKmlmdmkWI5G3lRxu/AYpqYETSMw2K20ox+X6+h+tMIDRyBXATaANpJ4z3x0Oe1FxbAq4dApwACXZRnJ9sYpwPmKjIjIhJDfLlvoMUbWRwpVtoXD+i+pPWmoSDEuGYZKDB4z265zxT1ELIGLRfeXJ2qFPI9z/9enjcPkRmMgbPBzt/A9PyqImWFDtQgFwGJUc/Qen5USeUbeUeWMsRliOf04pX1CxJNt3Mp3t3DY4Hr/nFSk/M2xj5ZUM2T8zY/Kho2/ePGNybc9yp+nvTIhsQZ8sh8ncTjHf3yfagRY0m6tbPWNOnukxaROHkAGAOenbNe3w67aX0Cy20qOh5ypyK8DklkjSJkkL73IOV3BV9DjOKjS0ghJeJXjIbLNG5AbPrj37Yq4TsJxuew+I/FWmaOvmXc6oScBc8sfQDvXnup/EAXhddMsbuVgeS67APzrC+yoI5ZQAXByHkbd8vuamkiVAxQDysA5UnDH6dKcqnYSjZmZfpqetySDVLswRqctBB1x7n+lMstKtLRpxBbhAQCu8ZP58VrLl1MaksxXJBy348Ujbi0ZQZcDYTvDcfQVm3coroio8ZLAF0yV2EYalUs+zcy7Tlcg8EjrinyhRGAR8wOCwJOf8APpTmYspjYqFRsgY9e4/ChMCHYQg3A5ztA3Y49feh49qsyKvmCQFhk5OPWp2QBnAU7iuVJA4HtUUiBiVjZG+XP3sHJ/KmCEdGPmKYhlcMpHyketRSpvdguXXblWYcZ+h61YDzS+U0wVZF+U84yffp09aArCNPPYFUOC5yMfXFICssQ8wohwWUjKclvfJ6c0piWQgsvyZ2k4AH51JJ8jurBwiHKlRzJk8/WnPEQ7xgD5/nB6AUCKiwYQszLxkcHtn3prLg/PhthwVJq4Yy78AMr/MSSMZ9Pr7Zp8m51EbrGVkGCOCWPYgjNHkMz9h3Ham1VwU56j09qkYIVfuqcgr0x6D1IqZFjkdQkUjAAxkKc4I6ZpYixUFfM2occjG72H0NCQFXyQ+ViQsxBk+Xn86akQkD7gqbhhR2JFXBFhmCqAQchehHv15H0FLtwJl8zod6704x74pgZ0KEwyrEc8YdVBwDn86dbI25c7wW+U7uACB3qzIwIBQlm67V+UGmrHG7bXOHm5cFshcevoaVmFiLYY1GW2gZzt6Hj/PFRGA70OPmX3xx61bJieYBSojGUkLjGPpSyK3lxySeYoU4Kkg/mc4/WgZVCGMuvJYE7uPlx6gU1Y1XDZV1QfJs7j1PpVnYAGVHHHBA4BH19KGj+XeIwCpwqgAZH4daIiRROJSTJkuMsCDjI9K5rVYVQ4VevQr6eldbJEVdPveaoJAIB+X8Ky9bhL2wKxFnBGwD+KmtHoO6IvhzaiTxFKzwGbbbuEB4GSMfnXr2kaabuzljuS2WChAp5jI+6R6EHv8AWsrwzoSaQdOtUXMiwmeZj1Z27fhXZ3MMsemyizKJcyRlElkO1IyeMse3WtnG+5F9bo4zWdA0G/sp08ReKoY9VaZhBLDcNKiIcbUYMBjB7iujisPsFp9p1hhLHYwpDHcMNzSjHLnHv6da0otBsbWLS9M1HRLnWbW1XamqzQJIsZ7bghyVz9cVk6Tb6g2na9p1+iQTwag6QtCCIxGcFTHnoB29DU1IpxbRvUqtwSv+XXseY+LmdtcnlcNGJQHWJvvKCONw7HHbtWNIu+M4CnkDHvXT+PNMi03W4EtVcBofmZm3M7d2bPUnvXOgdmVNmMsR0/KudXitSYPTUYN5XpyG4z/DTSA6jp6nHUU6FSxczliD19wf60+NQrEjDIByMdRTVrlIhaNhGQUI6BueAaUAsqKcA8Bh0CnsSacNz5KIS2OBnPHvQVPl7fmZuuMcEf8A1qV9QEKkxggn8Dn8aWNABIoBHODjufWlCwbkY5GD8u09R3yKVkU4ZCSOgyMZH4U3qK4m7J3YUPwDg9KaI8hgwAJ+8Bx83qKeijd90njgj+VNdwu3naScjI6ihFM6eRwIZPKbPQA9gO/H/wBapASR5mPvLjPbH1FM3MwO+EE7zg8ZYfUc4pAPMEqthkIwF7Edx6j8Oaq/czJVVkMW2ItgH5sfdz247GoYyWCII2A3ZEbDGfennymjHyOVjXAMh4A9gcH8adGjCGEFyytk4H8zntRcL3GSb5i6rGCVYDAGFH4jBpxxHvGdrbckDlv8abNkl/N8wbsDaD8p9gP/AK9KuTI0m8BgnO4EL9B6/WkIfJIN6R7SRt5JzkH1PQ4pI0f5AyuJBk4XkY7GlBmR0WRAVkXDKwwoH0Ocn6UkO3y1BCkbsKDkKfZs5H5VQC4cl1Z495PK5C4H+13zUkhxujU7QvJxxv8AbJ5qB4nKzklXk3BQANuR6+hqRmClkSNMMByx4B7nuMUugCmGRNu8/LjIVj97/PrTVMkpjMaoGXOFYA49+386aZVDIysjcbS6L0HfuRilj2mL5hEqBxyvU5+mf5UJCBCqnYqh8NkuDtGe+OKlukZZJShRVGCjMM7vp/8ArpTvKyfLGmeVUHlvr2wPpTLZCZHZRuAQkben4kf4UD2CWNmmK/8ALLy+/IJHXr/SmHDfZXUcSDarZI6+xqSNQzLt3ZPzE5AyfXjkURTFX3Iow5ztb5QO31oshEaFhggyyKhIJbGT9OxFJIdtu4wqqXBGc4H16inOoCFGKyENuCKQDn0xwce/enSgLIXUOpkGTg/oCef60IBu0q7KSFQ/OisCVBHUYFSF0llYERyO+MsOq4HbHA/SmyDLwquSGBXLccepz3psW2OMmf5Qrkbduee3+c0DsDTRsiOSu1iVUFdu76AZoVmaIABWdc7gOw9Se35U1iVjLyfMyNlUCjGe+P8A9dODKZGRwU3DJHQH+f6GmIZsgfzFKb0OH6/yp6nKvuQl2GAWPJ98cU13WVRKykg5wHGCxH54pyRyRqsSgtJu5Dchec9s/nRogFA+eJEkVTghgB82fc8YpqKoWNg6SfNtJPzHPv0pxZlWQLJkowLbkxye34euKZ8gZxsRlk4w2Rn06YGfwoAlUeTEhRVHlnjHRgff/wCvTCG+dsARLyCF2qPbNAZWugVBcY2sCc7SPTpikby/L/eMpiU7WGcH6EcUkAu3dGypjacFUzgA/r/OmpnKGQnDqyqQMkke3p/KkKjA3L5YRgY0zndx39vfNOBMe5ful/3m3bnJ/HtQBCMRxo7hDIx8vKksR6Ee1PYRRQlXDl4m2lGxnn0HP8qlkG8uZgu2Tvz1HpjNG1SSYoywK7FEh5B9SeeM+tFrD6DDAFRypwq4Kjtjvx3OarlhGxjVxucbsFdpx+n5YqZA424XB5WQx9FFAVU3KnmFo+W3YII/oKYhgCu7FWVoyM5yM7v/AK3pUYjSNCFDYf5SSPuntUzH5CI4x03Ig4YnHYVGuJNhiXO/B3Fj8vsOlTqAkaxqcmVAiofMzng5/l+NCkAHo7AcepHY+1PONgIAG9cShxtzzwfekj5D+bEzMo2vsOMn8f51SGkQs7eUyADzOvPNUb2IvLbKBlRcRkMpyMbh/nFaLqWRUVyVjIJGO1Vb2zea3lSORtyfPGY+eeo/GhbgewCyb+3S7AYeJQoHtXQmySW2kgdVaN1KOjjIcHqDWNoFy+paVpuoW8iiV7cFlcZVz3Unscg8iuljdDarNjG4AhT1B9K7JK2pkzz3/hXL2t3u0bxJqmmWv/PAHzNo9FbI4+vSuvaBbSxiiae4uWRdnnXD75G+prTwCct1rM1Ihc84AGT/AI1k9i5TlO3M9jyD4nuW1y3RFyVi547ZrlADn7u0YzkD+Guw+IzQyeJAiSZEMCqWU/eLc/1rkz5iLgOc/ez1yK5p7lx2GRr8pVBlUGRznNIiOhOzaV27l9B7GpNrNlgmCSCD6/4U9UfeEyBu+6M45qSr2IQAWDRLsbBIz69/qKQsyeWGfaGOFwOh9Pxpkior/NG5OfmGT8v4elScH7xITrhaNQuM25HCheenoaVto35KAtwS3IB9TQxUKyrHu7H2pGXapYKGIO3n0P1qug7AisnyhioHUe/qKjkkfewfG7pzxn3zUmXCAHM2RtOzg4pJCzOgyQAvVu9S2ri1OhhlE0cRfaRn7rN/jinlw6spTOT1OMHt0pI1jEkW8sxIK7cnr7A03BRHclQA5VXOQB9QeD9atsnYlIjilTzMs2PlDdB+B6/nTgY3lUyIoPPKkpkn8xTRKY1lExKLGvQttB9zxilYhHjJPl4HAB27/wARnIxQFxj4IUq53N13Nwfx6U9wWe4YKFVAAcnG706cUuPlLgYJcbXAAGPqKPlDzjeGIUbuNw/HFC1AXfhonXazOpZMr94+oIqBnlAUhYlmaTJbOQB3+7VhWcmGRmJUp8rFQ24exGCPoRSW/wA0YKAMrSZA6nHv3ouIGwpuGDhUJHzKO+OhP/1qc8rl02qWAjLsVHX8sfypZVYtLGVDFz8mCG2/TPNRxsV8sqwJcY+c7unYZ5/Kmh2HW7giEhQ0jsQEVQG/HFNUESOI02lcFiCCevU96Jd/lYeTIyACflwfbPp9adLn5xO7qrOGIxjIx/L8aSYkMjVVmkYMS6r0XnPvk/yp3l+eyeaSUIGQZPvY784H5VIjRRyESHfEF+RcbQWP14NRs0qJEz25UlsABRwMfiOaLAMMbEKxjUqrkIOWGfofTvzU8hYQyJJKW+bIyBz7AHI+nNIxBidkby5BgmR+V69Aen4U5HUyt5iqFdcMFO4g+xHHNACJl5JN1s2GQHecAfTjp9OKYFdFil3ssXQ9fmz0zjI596egzskOY5M7Bnt9QtRCNwhaQ+ZKHztZRwfQdMcUgQbZCJUdOEPG0ZDL6Eg/rgU6QsFkARgxwUUc7eOxH9RSSO3mGJxhiNw2859Bzg5pzqGC+btQkbAxXdjP+8cn8DQhbix73ZUEe4lTnnknqen+FM3LE6LtZGDbFDkbvoOlR+Uzwv5kbKFcnbnB446nIwfakEQiYCPcFPzsCTtwO5znPH0psY+TdG0qZIdTuG5sYAHXPBx+NMd13sAkke9MiTHAOOmT/jUqxqzq6kFHGQAMbvr1zSEokaEltobjZnHP0/wo8wE3ECASYeM8MXGBn05zk02M/uhnG5CQ2QdpGegzkYpJ4nnDq25nU5UqdoA9M8U5yAWbbgOAdzY9PfB/AUb7CHyKxjMYcS+Wu4Y+UKD9P8KCTKkgGJQyggqOS2f7v/1qSN9+GVGZXG1gxxtGOvP9OaVFaOCKURsxUkKX4z+f+NHoDGbPLm8xUZpD1bIyCO3GMfrUishYMWbIJV1LbmPvnApVkUtME3YHzDcMAepHXilQecrKMiLHDdMn1wO31FPYBsjKkEhCyr5ZBwTgf5/GkhkXcsa8CRS671zkdMEnt+NMhf5AWZginaSpwD+HU/lTnXywxj3mTPCg4JHt0xikxjwUSSMyEhHJBYLx9fpTI5MtvDIFRjGxB3c/XmmhP37opXbuEoJO4fQdOKfEoEru5cLIuBhRgH6nHFADEAUYRQZV+6AeRn+lDRBSEwhBIZBngH29fypGV0w8g3zH5cA8Y9ST7elOH3WJcO8OPmbkfnz2poBm5Wi2suxSMAg9D+n4UxwoJEjqHYbd6gdexOe9OLGRBtO5c70K9/qPT8M0qI7Bnb5TJxjGeR3AHelYCMR+VgmXJQlXA7j1qN+BvZ9wQ8beSf8APpU5CoQ23a2NjHuR3z6Uh+XEnlqojzjGCPqKANHwB4jj0W7/ALG1CYLYXUnmWcrcLG56ofQE/rXs1iTcTYjjcIOBF3Vu5HqD6V89apZfa4Ck2Wz8ykjke34VlS33jOzsvsWkaxeGwYEKofBUegY810wqK1mTKPY+pbgGJissckbdg6EVkateW9jYy3l5hYYgWbPJPt+JrwTwL8QfGOh3vl6pPdapphUxtbTyZKt2ZW6g/oa2vEniLUteZRcwpbWaPlbdWyP95z3IolOK1Qowb3MW/mlv9RuL2cSI0jl1DDjB7YqBVKxEeYjs3zjnqKsrlUjC4Hlk454Yev1qJIufMRQHJLKRxiua7erNV5EQGMiUbYyAcDnBpoCvGeoWTjHoalTDgE7irLg5GCDTkVeCUGRjLOMjPrU6MbK0sRWL5ss38WG6inFMN5gDZ9vT1p5XcjMIy+3nee3+FCK0artCbs9W5z68UCb0I5FI4A3EjIAOR+dMZRhQpJQjdlhls+mKf95l2D7x9eAfT2pkmVfKkgeh7fSnbUYS5AXahwOjDtUbAbW3bVb0JPFSYMqMCSAPvKpxj3qJXy6BWyV4BfuPek0CfY6ZWJdT/dU44z/OpIo1ZElHykfwj7uPTB4xRRVokhtJDOtyzAKxlIO3IBAHHHT9KliixdAo7xsybiyHBJIoopEsjKhY4ox1LgF+jcmmXjfZtbECqrIAMFuDk9TkYoopdSkTXxNvPbHPmEuRl+o4zkEYqOUl7OR3JJc457fSiigRGyiOMGLKA4BUcg8e/T8KvTqIreF1AyIt/wAwyM/jRRSKZWkuJBpwnB+chevIwW6Y6VNFgyz8YVCcKCdvT06UUVaEysXMd5EqYG9NxOOc5qaPi++zjhN45HB6+tFFJiJbhUa+midAycHHTkcjpTraMFklPJ2FguBgHHbvRRSewnuRSyvHZeZnfsckK43DgZ780K7XVr50jEEpvKrwCT1oooQ0LAfPuI42AVCMYH/16V1RoCwRV2nAC5wACO1FFUCEyI765iVFwoLA/wBPpUDs4kt2LsWddxPTt7UUUhIluM7lZiW3PyM4yOBt47USfMHDcqWztPIH0oooAiidpcMxxyQR1B4HrUbuzLudi7LOVBbnHOP5UUUhllEDz3kGSqRkBCp5FQxOVkXPzGRTuJ/+txRRTW4i3FGBNFy2FJH3iM8Y59aLmJRuY5IVQwB7c+vX9aKKTGVo28zKuAVMe8AjODntmppEVo5mxjopHXIPrmiigER27GVUySpiHyleDyD1qC1maW+lgYAIMHjiiihAyxPiK8FrGoEUibm9SfrURkMMMBQAmQjJIz+NFFUxdR0H75NhJUK2BtPOKjRyLeQnk5KjPbHpRRQUPjIkVlZVAIbOOM4qJ5HWWBA2EZSSAAOhwOlFFSDJS2YZHKjcj7V6jHvx3qGaNUhjCj77gk9x9KKKpgDRp5jjaMbc4og/flfM5B4x2ooo6DK0zk2sT4Abdsz7U6Nt8oVlUjBbp3oopARI5echwCCM46c1WupGj2c7g3UGiikhsdKdluoXIA+Xr1BFOkG21iccse55xRRSkSxqRq6huQWYg4NV3YiUEHjpt7flRRS6oY8MS6KT0PFQFQrSKOzDBooqkJH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karl Fields, MD; Spencer Copland, MD; and John Tipton, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8930=[""].join("\n");
var outline_f8_46_8930=null;
var title_f8_46_8931="Patient information: Bradycardia (The Basics)";
var content_f8_46_8931=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"19\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16936\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/63/7154\">",
"         Person having an ECG",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/7/39039\">",
"          Holter monitor",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/51/25395\">",
"         Patient information: ECG and stress test (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/49/6931\">",
"         Patient information: Pacemakers (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/40/19075\">",
"         Patient information: Sick sinus syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/5/36946\">",
"         Patient information: Syncope (fainting) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?20/16/20741\">",
"         Patient information: Pacemakers (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/9/4245\">",
"         Patient information: Syncope (fainting) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bradycardia (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/bradycardia-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H10116183\">",
"      <span class=\"h1\">",
"       What is bradycardia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bradycardia is the term doctors use for when a person&rsquo;s heartbeat is slower than normal.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116198\">",
"      <span class=\"h1\">",
"       How do normal heartbeats happen?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A normal heartbeat happens when an electrical signal starts in one spot near the top of the heart. This electrical signal follows a path to spread across the heart. As it spreads, the signal causes the heart muscle to squeeze. Each time the heart squeezes (&ldquo;beats&rdquo;), it pumps blood all over the body. Normally, the heart beats in a regular way 60 to 100 times a minute.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116213\">",
"      <span class=\"h1\">",
"       What causes the heart to beat too slowly?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The heart can beat too slowly if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Electrical signals don&rsquo;t start often enough.",
"       </li>",
"       <li>",
"        The electrical signal gets slowed down or blocked as it spreads across the heart.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Having a slow heartbeat doesn&rsquo;t always cause problems. Both children and adults can have bradycardia and still be healthy. For example, it is common for athletes to have a slow heartbeat. It is also common for people to have a slower heartbeat when they are sleeping.",
"     </p>",
"     <p>",
"      Certain medicines, especially medicines used to treat heart problems or high blood pressure, can also cause bradycardia.",
"     </p>",
"     <p>",
"      Other times, bradycardia is caused by a problem or condition, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A problem with the heart&rsquo;s electrical system",
"       </li>",
"       <li>",
"        Other heart problems, including recent heart surgery or a heart attack",
"       </li>",
"       <li>",
"        Certain infections",
"       </li>",
"       <li>",
"        Sleep apnea &ndash; This is when people stop breathing for short amounts of time when they are asleep.",
"       </li>",
"       <li>",
"        Anorexia &ndash; This is an eating disorder that makes people lose more weight than is healthy.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116228\">",
"      <span class=\"h1\">",
"       What are the symptoms of bradycardia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people have no symptoms.",
"     </p>",
"     <p>",
"      Other people have symptoms with their bradycardia. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling light-headed or dizzy",
"       </li>",
"       <li>",
"        Fainting or feeling like you are going to faint",
"       </li>",
"       <li>",
"        Feeling tired, either all the time or only when you exercise",
"       </li>",
"       <li>",
"        Chest pain",
"       </li>",
"       <li>",
"        Trouble breathing",
"       </li>",
"       <li>",
"        Eating less than usual or acting tired (in babies)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116243\">",
"      <span class=\"h1\">",
"       Should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you or your child has symptoms of bradycardia, call your doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116258\">",
"      <span class=\"h1\">",
"       Is there a test for bradycardia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will ask about your symptoms and do an exam. During the exam, he or she will check your pulse and listen to your heart.",
"     </p>",
"     <p>",
"      To see if your heartbeat is slower than normal, he or she will do an ECG (also called an &ldquo;electrocardiogram&rdquo; or &ldquo;EKG&rdquo;). An ECG is a test that measures the electrical activity in the heart (",
"      <a class=\"graphic graphic_figure graphicRef53145 \" href=\"UTD.htm?6/63/7154\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Your doctor might want to record your heartbeat over the course of hours or days. If so, he or she will have you wear or carry a heart monitor device around at home (",
"      <a class=\"graphic graphic_figure graphicRef76605 \" href=\"UTD.htm?38/7/39039\">",
"       figure 2",
"      </a>",
"      ). This device will measure and record your heart&rsquo;s electrical activity. You should keep doing your normal activities while you wear or carry the monitor. While you wear the monitor, you should also write down any symptoms you have. That way, your doctor can see if bradycardia is causing your symptoms.",
"     </p>",
"     <p>",
"      After your doctor knows for sure that you have bradycardia, he or she will do tests to look for the cause. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Tests to see how your heartbeat changes when you get certain medicines",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116273\">",
"      <span class=\"h1\">",
"       How is bradycardia treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on your symptoms and what&rsquo;s causing your bradycardia.",
"     </p>",
"     <p>",
"      People who have no symptoms usually do not need treatment.",
"     </p>",
"     <p>",
"      People who have symptoms will likely need treatment. Your doctor might change or stop any medicines that could be slowing your heartbeat.",
"     </p>",
"     <p>",
"      Some people with bradycardia are treated with a device called a &ldquo;pacemaker.&rdquo; A pacemaker sits under the skin near a person&rsquo;s heart and sends electrical signals to the heart. These signals help the heart beat at a normal rate.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10116288\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/49/6931?source=see_link\">",
"       Patient information: Pacemakers (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/5/36946?source=see_link\">",
"       Patient information: Syncope (fainting) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/51/25395?source=see_link\">",
"       Patient information: ECG and stress test (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/40/19075?source=see_link\">",
"       Patient information: Sick sinus syndrome (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?4/9/4245?source=see_link\">",
"       Patient information: Syncope (fainting) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?20/16/20741?source=see_link\">",
"       Patient information: Pacemakers (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?8/46/8931?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16936 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-2345798AF2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8931=[""].join("\n");
var outline_f8_46_8931=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116183\">",
"      What is bradycardia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116198\">",
"      How do normal heartbeats happen?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116213\">",
"      What causes the heart to beat too slowly?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116228\">",
"      What are the symptoms of bradycardia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116243\">",
"      Should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116258\">",
"      Is there a test for bradycardia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116273\">",
"      How is bradycardia treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10116288\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16936\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/63/7154\">",
"      Person having an ECG",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/7/39039\">",
"       Holter monitor",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/51/25395?source=related_link\">",
"      Patient information: ECG and stress test (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/16/20741?source=related_link\">",
"      Patient information: Pacemakers (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/49/6931?source=related_link\">",
"      Patient information: Pacemakers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/40/19075?source=related_link\">",
"      Patient information: Sick sinus syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/9/4245?source=related_link\">",
"      Patient information: Syncope (fainting) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/5/36946?source=related_link\">",
"      Patient information: Syncope (fainting) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_46_8932="Isoproterenol: Patient drug information";
var content_f8_46_8932=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Isoproterenol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     see \"Isoproterenol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/25/38291?source=see_link\">",
"     see \"Isoproterenol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F184870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Isuprel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10112083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691685",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heartbeats that are not normal.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702332",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to isoproterenol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfite allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11975 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-F1EFE81ED1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8932=[""].join("\n");
var outline_f8_46_8932=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F184870\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10112083\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025643\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025642\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025647\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025648\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025650\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025645\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025646\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025651\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025652\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=related_link\">",
"      Isoproterenol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/25/38291?source=related_link\">",
"      Isoproterenol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_46_8933="Tinea incognito";
var content_f8_46_8933=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea incognito",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 334px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The classic appearance of tinea corporis has been altered by the use of topical corticosteroids in these two patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Panel A) Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"     <br>",
"      Panel B) Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8933=[""].join("\n");
var outline_f8_46_8933=null;
var title_f8_46_8934="EPT manifestations of weak peristalsis";
var content_f8_46_8934=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F86115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F86115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 666px\">",
"   <div class=\"ttl\">",
"    Esophageal pressure topography manifestations of weak peristalsis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 646px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In each panel, the black line depicts the 20 mmHg isobaric contour. Breaks in the 20 mmHg isobaric contour are characterized by length; &lt;2 cm is normal; 2 to 5 cm (panel A) constitute small breaks; &gt;5 cm (panel B) constitute large breaks. Panel C illustrates failed peristalsis where there is negligible contractile activity distal to the proximal pressure trough.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8934=[""].join("\n");
var outline_f8_46_8934=null;
var title_f8_46_8935="MRI of boy with ADEM";
var content_f8_46_8935=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Brain and spine MRI of a 7 year old boy with acute disseminated encephalomyelitis (ADEM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial T2-weighted MRI brain images show relatively symmetric high signal intensity in the deep gray matter, including bilateral thalami (panel A). There is also high T2 signal within the left aspect of the pons (panel B). Sagittal T2-weighted MRI of the cervical spine demonstrates expansion/swelling and high signal intensity within the spinal cord (panel C), and corresponding axial T2-weighted MRI reveal that the high signal is mostly posterior (panel D). One month later, T2-weighted axial images demonstrate resolution of the findings in the deep gray matter (panel E) and pons (panel F).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eric D Schwartz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8935=[""].join("\n");
var outline_f8_46_8935=null;
var title_f8_46_8936="Allergic contact dermatitis mechanism";
var content_f8_46_8936=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 621px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of contact allergic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 601px; height: 453px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the afferent phase of ACD, a na&iuml;ve host is exposed (over time) to a low molecular weight hapten, which chemically reacts with epidermal proteins. These epidermal proteins are taken up by cutaneous antigen presenting cells (Langerhans cells and other APC), and trafficked to the local lymph node where education of conventional T-cells occurs. This results in the development of T memory/effector lymphocytes. At the same time during the afferent phase of ACD, innate immunity is also activated. Epidermal glycolipids are released, and presented to invariant NKT-cells, which interact with CD1d bearing B-cells, which produce hapten specific IgM. During the efferent phase, upon re-exposure to the hapten, memory T-cells are mobilized to the site of hapten challenge by hapten specific IgM which fixes complement, and activates endothelial cells, promoting conventional T-lymphocyte trafficking into the challenge site. CD8+ T-lymphocytes, along with innate immune cells such as NK- and NKT-cells, are thought to be effector cells of ACD. This group of cells releases cytokines and mediates cytotoxicity to APC and epidermal KC, resulting in the clinical signs and symptoms of ACD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gober MD, Gaspari AA. Allergic contact dermatitis. Curr Dir Autoimmun 2008; 10:1. Copyright &copy; 2008 S. Karger AG, Basel. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8936=[""].join("\n");
var outline_f8_46_8936=null;
var title_f8_46_8937="Pelvic organ prolapse in women: Diagnostic evaluation";
var content_f8_46_8937=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pelvic organ prolapse in women: Diagnostic evaluation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Tola B Fashokun, MD, FACOG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Rebecca G Rogers, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8937/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/46/8937/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H4375792\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic organ prolapse (POP), the herniation of the pelvic organs to or beyond the vaginal walls, in women is diagnosed using pelvic examination. A medical history is also important to elicit prolapse-associated symptoms, since treatment is generally indicated only for symptomatic prolapse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=see_link&amp;anchor=H10284328#H10284328\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'Women with symptomatic prolapse'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Historically, the severity of prolapse was graded using a variety of imprecise classification systems that were not easily reproduced or communicated in a standard way among clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/1\">",
"     1",
"    </a>",
"    ]. The Pelvic Organ Prolapse Quantitation system (POPQ), introduced in 1996, has become the standard classification system [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic evaluation of women with POP is reviewed here. An overview of POP, general principles of the pelvic examination and additional aspects of evaluation of women with POP are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42681?source=see_link\">",
"     \"The gynecologic history and pelvic examination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1120849\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF PELVIC ORGAN PROLAPSE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1121013\">",
"    <span class=\"h2\">",
"     POPQ system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The POPQ system is an objective, site-specific system for describing and staging POP in women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/1\">",
"     1",
"    </a>",
"    ]. The POPQ system involves quantitative measurements of various points representing anterior, apical, and posterior vaginal prolapse to create a \"topographic\" map of the vagina. These anatomic points can then be used to determine the stage of the prolapse (",
"    <a class=\"graphic graphic_figure graphicRef74368 \" href=\"UTD.htm?14/54/15202\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef57450 \" href=\"UTD.htm?3/1/3100\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef72477 \" href=\"UTD.htm?26/26/27051\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The POPQ has proven interobserver and intraobserver reliability [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/4\">",
"     4",
"    </a>",
"    ]. Intraoperative POPQ measurements correlate well with preoperative findings, with slightly more prolapse under anesthesia when traction is placed on the POPQ points [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The POPQ system is the POP classification system of choice of the International Continence Society (ICS), the American Urogynecologic Society (AUGS), and the Society of Gynecologic Surgeons [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/2\">",
"     2",
"    </a>",
"    ]. It is the system used most commonly in the medical literature [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In a web-based survey of ICS and AUGS members, 40 percent routinely used the POPQ system in their clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this topic review, classification of POP will be described using the POPQ. (See",
"    <a class=\"local\" href=\"#H20651075\">",
"     'Using the POPQ system'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1121160\">",
"    <span class=\"h2\">",
"     Other classification systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Baden-Walker Halfway Scoring System is the next most commonly used POP staging system. The degree, or grade, of each prolapsed structure is described individually (eg, grade 1 anterior vaginal wall prolapse or grade 3 uterine prolapse). The",
"    <span class=\"nowrap\">",
"     grade/degree",
"    </span>",
"    is defined as the extent of prolapse for each structure noted on examination while the patient is straining.",
"   </p>",
"   <p>",
"    The system has five",
"    <span class=\"nowrap\">",
"     degrees/grades",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/9\">",
"     9",
"    </a>",
"    ]. For the urethra, posterior descent is graded, for other anatomic sites, the lowest part is graded:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      0 &ndash; Normal position for each respective site",
"     </li>",
"     <li>",
"      1 &ndash; Descent halfway to the hymen",
"     </li>",
"     <li>",
"      2 &ndash; Descent to the hymen",
"     </li>",
"     <li>",
"      3 &ndash; Descent halfway past the hymen",
"     </li>",
"     <li>",
"      4 &ndash; Maximum possible descent for each site",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Modifications of this system also exist.",
"   </p>",
"   <p>",
"    The Baden-Walker system lacks the precision and reproducibility of the POPQ system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7156552\">",
"    <span class=\"h1\">",
"     MEDICAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical history includes symptoms specific to prolapse, as well as urinary, defecatory, and sexual problems, which are often associated with POP. Treatment of urinary or defecatory conditions is often coordinated with POP treatment.",
"   </p>",
"   <p>",
"    A detailed discussion of symptoms associated with POP can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H21524755#H21524755\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Clinical manifestations'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Symptom assessment is important, since treatment is generally not indicated for asymptomatic POP. In addition, assessment of POP symptoms and their impact on a patient&rsquo;s quality of life helps patients and clinicians set treatment goals [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=see_link&amp;anchor=H10284328#H10284328\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'Women with symptomatic prolapse'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Current symptoms or history of conditions that may mimic (eg, pelvic mass, genital tract bleeding) or exacerbate (eg, etiologies of urinary or fecal incontinence other than pelvic relaxation) symptoms of POP should also be elicited. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H21524755#H21524755\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, the medical history should include a review of medical comorbidities that could impact whether the patient is a candidate for surgical treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41735?source=see_link\">",
"     \"Overview of the principles of medical consultation and perioperative medicine\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1120407\">",
"    <span class=\"h1\">",
"     APPROACH TO THE EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;POP is diagnosed with a pelvic examination. A medical history is also important to elicit prolapse-associated symptoms, since treatment is generally indicated only for symptomatic prolapse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=see_link&amp;anchor=H10284328#H10284328\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'Women with symptomatic prolapse'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1120534\">",
"    <span class=\"h2\">",
"     Examination components",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination of women with POP includes the following components:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Visual inspection",
"     </li>",
"     <li>",
"      Speculum examination",
"     </li>",
"     <li>",
"      Bimanual pelvic examination",
"     </li>",
"     <li>",
"      Rectovaginal examination",
"     </li>",
"     <li>",
"      Neuromuscular examination",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each component of the examination is discussed in the sections below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2794653\">",
"    <span class=\"h2\">",
"     Equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Instruments that are useful in assessment of pelvic prolapse include a Sims retractor (single blade speculum) or a bivalve speculum that can be easily taken apart so that the anterior and posterior blades can be used separately to observe individual compartments of the vagina (anterior, posterior, apical).",
"   </p>",
"   <p>",
"    To make the measurements for the POPQ system, a ruler or a large cotton swab or sponge forceps marked in 1 cm increments is used [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/1,6\">",
"     1,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1120391\">",
"    <span class=\"h2\">",
"     Patient positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The examination is performed in each position with the woman relaxed and then straining (to demonstrate the maximum degree of prolapse) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/13\">",
"     13",
"    </a>",
"    ]. The extent of prolapse visualized on examination should confirm the patient&rsquo;s description of bulging symptoms. If the severity of prolapse visualized does not correlate with the patient&rsquo;s description, a hand-held mirror may be beneficial to confirm that what the provider is seeing is the full extent of the prolapse.",
"   </p>",
"   <p>",
"    The patient is examined initially in the dorsal lithotomy position. A prospective series of 218 women reported that performing the pelvic examination in the left lateral position (a common position used to assess pelvic support in the United Kingdom) yielded results that correlated highly with findings in the lithotomy position [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The examination is then repeated with the patient standing [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/13,15\">",
"     13,15",
"    </a>",
"    ]. This is the position that will best approximate the extent of prolapse that the patient experiences daily. In the standing position, the patient places one foot on a well-supported footstool. The examining gown is lifted slightly to expose the genital area during the examination [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20651678\">",
"    <span class=\"h2\">",
"     Documentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A full description of the examination is recorded, including [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Type of examination table, speculum, and retractors",
"     </li>",
"     <li>",
"      Patient position",
"     </li>",
"     <li>",
"      Bladder and rectal fullness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to note and document any episodes of urinary, fecal, or flatal incontinence that occur during the examination.",
"   </p>",
"   <p>",
"    The findings of the examination should be recorded using a quantitative and reproducible method for recording POP. We use the POP-Q system, as noted above. (See",
"    <a class=\"local\" href=\"#H1121013\">",
"     'POPQ system'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1120399\">",
"    <span class=\"h1\">",
"     VISUAL INSPECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first part of the examination is a visual inspection of the vulvar, perineal, and perianal areas with the patient in the dorsal lithotomy position. As during other components of the examination, the inspection should be performed initially with the patient relaxed and then while straining. Findings that should be noted during this component of the examination include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transverse diameter of the genital hiatus (eg, the space between the labia majora)",
"     </li>",
"     <li>",
"      Protrusion of the vaginal walls or cervix to or beyond the introitus (uterine procidentia)",
"     </li>",
"     <li>",
"      Length and condition of the perineum",
"     </li>",
"     <li>",
"      Rectal prolapse",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with prolapse to or beyond the hymen, the vaginal tissue is examined for ulceration.",
"   </p>",
"   <p>",
"    Any other findings (eg, skin or mucosal lesions) should be noted and evaluated appropriately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42681?source=see_link&amp;anchor=H22#H22\">",
"     \"The gynecologic history and pelvic examination\", section on 'External genitalia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPECULUM AND BIMANUAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The speculum and bimanual examinations are the principal components used to evaluate POP. The patient is examined in the dorsal lithotomy and then standing positions, while relaxed and then straining, as noted above (See",
"    <a class=\"local\" href=\"#H1120391\">",
"     'Patient positioning'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Prolapse of each anatomic compartment is evaluated as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apical prolapse (prolapse of the cervix or vaginal vault) &ndash; A bivalve speculum is inserted into the vagina and then slowly withdrawn; any descent of the apex is noted.",
"     </li>",
"     <li>",
"      Anterior vaginal wall &ndash; A Sims retractor or the posterior blade of a bivalve speculum is inserted into the vagina with gentle pressure on the posterior vaginal wall to isolate visualization of the anterior vaginal wall.",
"     </li>",
"     <li>",
"      Posterior vaginal wall &ndash; A Sims retractor or the posterior blade of a bivalve speculum into the vagina with gentle pressure on the anterior vaginal wall to isolate visualization of the posterior vaginal wall.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The terms anterior vaginal wall prolapse, posterior vaginal wall prolapse and apical prolapse are preferred to the terms &ldquo;cystocele,&rdquo; &ldquo;rectocele,&rdquo; and &ldquo;enterocele&rdquo; because vaginal topography does not reliably predict the location of the associated viscera in women with POP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H7156411#H7156411\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Terminology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To complete the exam, a bimanual examination is performed in order to evaluate for any coexisting pelvic abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42681?source=see_link&amp;anchor=H25#H25\">",
"     \"The gynecologic history and pelvic examination\", section on 'Bimanual examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20651075\">",
"    <span class=\"h2\">",
"     Using the POPQ system",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the POPQ system, the topography of the vagina is described using six points (two on the anterior vaginal wall, two on the superior vagina, and two on the posterior vaginal wall) and several other measurements (",
"    <a class=\"graphic graphic_figure graphicRef74368 \" href=\"UTD.htm?14/54/15202\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/1\">",
"     1",
"    </a>",
"    ]. Taken together, these measurements can be used to produce a sagittal diagram of the prolapse.",
"   </p>",
"   <p>",
"    During the examination, the maximum extent of prolapse is determined for each of the six points. Maximal prolapse is defined by the following findings: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vaginal wall becomes tight during straining",
"     </li>",
"     <li>",
"      Traction on the prolapse causes no further descent",
"     </li>",
"     <li>",
"      Patient confirms that protrusion is maximal",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The maximal point of prolapse of each of the six points is then recorded in relation to a fixed point of reference, the anterior-posterior plane of the hymen.",
"   </p>",
"   <p>",
"    All measurements are expressed in centimeters; increments of 0.5 cm can also be used, if clinically useful. A minus sign is used to designate a point that is proximal, or superior, to the hymenal plane (eg, -3 cm), while points distal or inferior to the hymenal plane are preceded by a positive sign (eg, +2 cm).",
"   </p>",
"   <p>",
"    The measurements can be marked on line diagrams (",
"    <a class=\"graphic graphic_figure graphicRef62226 \" href=\"UTD.htm?27/61/28639\">",
"     figure 3",
"    </a>",
"    ), noted on a grid (",
"    <a class=\"graphic graphic_figure graphicRef57450 \" href=\"UTD.htm?3/1/3100\">",
"     figure 2",
"    </a>",
"    ), or recorded in text form.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20651194\">",
"    <span class=\"h3\">",
"     POPQ measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each point is located by measuring along the vaginal wall or identifying the most dependent point of a prolapsed structure. The measurement is then taken of the distance from the point to the hymenal plane. The anatomic location of each point is (",
"    <a class=\"graphic graphic_figure graphicRef74368 \" href=\"UTD.htm?14/54/15202\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anterior vaginal wall points:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Point",
"      <strong>",
"       Aa",
"      </strong>",
"      is located in the midline of the anterior vaginal wall, 3 cm proximal to the external urethral meatus, corresponding approximately to the urethrovesical junction. The quantitative value of point Aa is anywhere from &ndash;3 to +3 cm from the hymenal plane, depending upon the extent of anterior wall prolapse.",
"     </li>",
"     <li>",
"      Point",
"      <strong>",
"       Ba",
"      </strong>",
"      is the most distal (ie, most dependent) position of any part of the anterior vaginal wall between point Aa and the vaginal cuff or anterior vaginal fornix. If there is no prolapse, point Ba is &ndash;3 cm by definition. In a woman with total posthysterectomy vault prolapse, Ba has a positive value equal to the distance between the vaginal apex and hymenal plane (so the quantitative value of point Ba can range from the most supported measurement [-3], to the most prolapse portion beyond the hymenal ring [this may exceed +3 cm]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Superior vagina points:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Point",
"      <strong>",
"       C",
"      </strong>",
"      is the most distal (ie, most dependent) edge of the cervix or the leading edge of the vaginal cuff (posthysterectomy).",
"     </li>",
"     <li>",
"      Point",
"      <strong>",
"       D",
"      </strong>",
"      is measured only in women with a cervix. It is the deepest point of the posterior fornix, corresponding approximately to where the uterosacral ligaments attach to the posterior cervix. Measuring this point distinguishes between suspensory failure of the uterosacral-cardinal ligament complex and cervical elongation: if point C is significantly more positive than point D (&gt;4 cm), the cervix is elongated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Posterior vaginal wall points (these are analogous to the two points on the anterior wall):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Point",
"      <strong>",
"       Ap",
"      </strong>",
"      is located in the midline of the posterior vaginal wall, 3 cm proximal to the posterior hymen. The quantitative value of point Ap is anywhere from &ndash;3 to +3 cm from the hymenal plane, depending upon the extent of posterior wall prolapse.",
"     </li>",
"     <li>",
"      Point",
"      <strong>",
"       Bp",
"      </strong>",
"      is the most distal (ie, most dependent) position of any part of the upper posterior vaginal wall between point Ap and the vaginal cuff or posterior vaginal fornix. If there is no prolapse, point Bp is &ndash;3 cm by definition. In a woman with total posthysterectomy vaginal prolapse, Bp has a positive value equal to the distance between the vaginal apex and hymenal plane (so the quantitative value of point Bp can range from the most supported measurement [-3], to the most prolapse portion beyond the hymenal ring [this may exceed +3 cm]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, the total vaginal length (",
"    <strong>",
"     TVL",
"    </strong>",
"    ) is measured by reducing point C or D to its most superior position (eg, with a swab or ring forceps).",
"   </p>",
"   <p>",
"    Finally, two additional measurements give a frontal (coronal) view of the prolapse from the perspective of an examination in the lithotomy position. These measurements complement the points determined in the sagittal view:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The genital hiatus (",
"      <strong>",
"       gh",
"      </strong>",
"      ) is measured anterior-posteriorly from the middle of the external urethral meatus to the posterior midline hymen. If the location of the hymen is obscured by a band of skin (usually from surgery or episiotomy repair), the firm tissue of the perineal body is the posterior margin of this measurement.",
"     </li>",
"     <li>",
"      The perineal body (",
"      <strong>",
"       pb",
"      </strong>",
"      ) is measured from the posterior margin of the genital hiatus to the midanal opening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20651483\">",
"    <span class=\"h3\">",
"     POPQ staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The POPQ system provides a detailed description of vaginal anatomy. For the purposes of simple clinical communication or grouping patients for research purposes, an ordinal staging system using the POPQ measurements was developed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage 0 &ndash; No prolapse. Points Aa, Ap, Ba, and Bp are all &ndash;3 cm and point D (if uterus is present) or C (posthysterectomy) equals or nearly equals TVL (&ndash;TVL cm to &ndash;[TVL&ndash;2] cm).",
"     </li>",
"     <li>",
"      Stage I &ndash; The requirements for stage 0 are not met, but the most distal portion of the prolapse is &gt;1 cm distal to the level of the hymenal plane (ie, quantitation value &lt;-1 cm).",
"     </li>",
"     <li>",
"      Stage II &ndash; The most distal portion of the prolapse is between &le;1 cm proximal to the hymenal plane and &ge;1 cm distal to the hymenal plane (ie, quantitation value &ge; &ndash;1 cm to &le; +1 cm).",
"     </li>",
"     <li>",
"      Stage III &ndash; The most distal portion of the prolapse is between &gt;1 cm distal to the hymenal plane, but no further than 2 cm less than the total vaginal length in centimeters (quantitative value &gt;+1 cm but &lt;+[TVL-2] cm). In other words, the maximum prolapse is more than 1 cm outside the hymenal plane, but it is 2 cm less than the maximum possible protrusion.",
"     </li>",
"     <li>",
"      Stage IV &ndash; Eversion of the total length of the vagina. The protrusion extends to or beyond (TVL-2) cm (quantitative value &ge; +[TVL-2] cm).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The stage can be further defined in terms of a specific compartment (eg, stage II anterior vaginal wall prolapse).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9800359\">",
"    <span class=\"h3\">",
"     Modifications of the POPQ system and reporting POPQ results",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9800329\">",
"    <span class=\"h4\">",
"     Simplified POPQ",
"    </span>",
"    &nbsp;&mdash;&nbsp;A simplified version of the POPQ system, which was developed by an international group of investigators, has been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Like the standard POPQ examination, the Simple POPQ (S-POPQ) measures the anterior, posterior and up to two measurements of the apex, including both the cervix, in women who still have one, and posterior cul-de-sac. The S-POPQ records the ordinal stage of the four measurements by estimating the distances involved. For measurement of the anterior wall, a point approximately 3 cm or halfway up the anterior vaginal wall is visualized, the woman is asked to strain, and the amount of descent is recorded. A similar process is carried out to estimate the descent of the posterior wall. Finally, a Sims speculum is utilized to record the descent of the apex of the vagina. The following definitions are used to Stage the prolapse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage 1: Prolapse where the given point remains at least 1 cm above the hymenal remnants.",
"     </li>",
"     <li>",
"      Stage 2: Prolapse where the given point descends to the introitus, defined as an area extending from 1 cm above to 1 cm below the hymenal remnants.",
"     </li>",
"     <li>",
"      Stage 3: Prolapse where the given point descends greater than 1 cm past the hymenal remnants, but does not represent complete vaginal vault eversion or complete uterine procidentia. This implies that at least some portion of the vaginal mucosa is not everted.",
"     </li>",
"     <li>",
"      Stage 4: Complete vaginal vault eversion or complete uterine procidentia. This implies that the vagina",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      uterus are maximally prolapsed with essentially the entire extent of the vaginal mucosa everted.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The S-POPQ has been validated against the original staging system of the POPQ and has been found to be highly correlated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9800345\">",
"    <span class=\"h4\">",
"     SLmax",
"    </span>",
"    &nbsp;&mdash;&nbsp;SLmax, also known as maximum vaginal descent, was introduced as a continuous value of vaginal support that describes prolapse as a single summary score. This measure is calculated as a single score for comparison of prolapse between populations and is not meant to replace the more detailed POPQ. SLmax simply represents the most distal presenting part of the vagina, in centimeters. The minimum value is -3 by definition, and the measure was shown to correlate well with POPQ measurements and results of the Pelvic Organ Prolapse Distress Inventory [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Additional examination techniques",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Simulated apical support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeating the speculum examination with simulated apical support (ie, supporting the vaginal apex with a large cotton swab or ring forceps) approximates the results following apical prolapse repair. Reduction of apical prolapse temporarily corrects anterior and posterior vaginal wall prolapse in many women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/22\">",
"     22",
"    </a>",
"    ]. This examination technique may help a clinician decide whether a vaginal pessary may be helpful or, in preoperative patients, whether to perform apical prolapse relapse repair. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/7/17530?source=see_link\">",
"     \"Vaginal pessary treatment of prolapse and incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=see_link&amp;anchor=H2327483#H2327483\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'Concomitant repair of apical and anterior or posterior prolapse'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Inspection for paravaginal defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation for paravaginal defects is not part of the POPQ system, but it is used by some surgeons to plan the surgical approach to repairing anterior wall prolapse. Paravaginal defects occur when the anterior vaginal wall detaches from its lateral support, the arcus tendineus. The arcus tendineus is a line of connective tissue that runs from posterior (ischial spine) to anterior (symphysis pubis) anteriorly (",
"    <a class=\"graphic graphic_figure graphicRef51329 \" href=\"UTD.htm?6/27/6586\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Paravaginal defects can be detected by visual inspection during the speculum examination. With the patient performing a Valsalva maneuver, the posterior blade of a speculum is used to deflect the posterior vaginal wall. If a defect is present, the lateral attachment on either side will descend toward the hymen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=see_link&amp;anchor=H26#H26\">",
"     \"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse\", section on 'Paravaginal defect repair'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unfortunately, the inter- and intra-examiner reliability of the clinical examination for central, superior, and right and left paravaginal defects is poor. As an example, one study of 63 patients found poor interexaminer (42 percent, kappa 0.16) and intraexaminer (46 percent, kappa 0.16) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/23\">",
"     23",
"    </a>",
"    ]. Since it is difficult for examiners to agree on whether a paravaginal defect is present, the practice at our institution is not to routinely perform paravaginal defect repairs for anterior wall support.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1121338\">",
"    <span class=\"h1\">",
"     RECTOVAGINAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rectovaginal examination is performed to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnose an enterocele",
"     </li>",
"     <li>",
"      Differentiate between a high rectocele and an enterocele",
"     </li>",
"     <li>",
"      Assess the integrity of the perineal body",
"     </li>",
"     <li>",
"      Detect rectal prolapse",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The best method for detecting an enterocele is to perform the rectovaginal exam with the patient standing; the small bowel can be palpated in the cul-de-sac between thumb and forefinger (",
"    <a class=\"graphic graphic_figure graphicRef76450 \" href=\"UTD.htm?39/6/40034\">",
"     figure 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/47/4857?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and nonsurgical management of posterior vaginal defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1121527\">",
"    <span class=\"h1\">",
"     NEUROMUSCULAR EXAMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155323\">",
"    <span class=\"h2\">",
"     Neurologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gross neurologic assessment of the vulva and perineum is performed to screen for neurologic disease, although there is a low detection rate in the absence of gross neurologic symptoms or a prior diagnosis of a neurologic disorder.",
"   </p>",
"   <p>",
"    Sensory of the lumbosacral dermatomes for light touch and sharp touch is performed using a small cotton swab and a sharp point [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/24\">",
"     24",
"    </a>",
"    ]. If sensory function is abnormal, more detailed neurologic testing may be warranted.",
"   </p>",
"   <p>",
"    Sacral reflexes should also be assessed. To evaluate for sacral nerve integrity, the bulbocavernosus reflex is elicited by gently tapping or squeezing the clitoris. The anocutaneous reflex (anal wink sign) is triggered by stroking the skin immediately surrounding the anus and observing a reflexive contraction of the external anal sphincter; this reflex should be elicited bilaterally. Absence of these reflexes is not always abnormal and hyperreflexia or asymmetry may in fact be more suggestive of a neurologic etiology. As with sensory function, abnormal findings of reflex testing warrant a more detailed neurologic examination and possible referral to a specialist.",
"   </p>",
"   <p>",
"    Detailed neurologic evaluation begins with a thorough medical history, including a personal or family history of neurologic disease or related conditions. Any abnormalities of speech or gross motor function should be noted while taking the medical history.",
"   </p>",
"   <p>",
"    Sacral nerve route motor function is further evaluated by having the patient move the lower extremity; this includes active extension and flexion of the knee, ankle, and toes. Strength is assessed by having the patient move each joint against resistance. The patellar and plantar reflexes are also assessed.",
"   </p>",
"   <p>",
"    If abnormal findings are encountered, the patient should be referred to a neurologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20651633\">",
"    <span class=\"h2\">",
"     Pelvic floor muscle testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pelvic floor musculature is inspected to evaluate integrity and symmetry. The examiner should also note the presence of scarring and whether pelvic floor contraction pulls the perineum inward. Palpation through the vagina or rectum helps in assessing pelvic floor squeeze strength and levator muscle thickness. The tone and strength of the pelvic floor muscles can be assessed by asking the patient to contract the pelvic floor muscles around the examining fingers. Women with poor pelvic floor muscle function may benefit from pelvic physical therapy.",
"   </p>",
"   <p>",
"    Guidelines have been published by the International Continence Society to assess pelvic floor musculature tone [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/25\">",
"     25",
"    </a>",
"    ]. Four conditions have been defined: normal pelvic floor muscles are those which can voluntarily contract and relax, overactive pelvic floor muscles are muscles which do not relax, underactive pelvic floor muscles are those which cannot voluntarily contract, and non-functioning pelvic floor muscles is when there is no pelvic floor muscle action palpable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H8624747#H8624747\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Pelvic floor muscle exercises'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Instrumental muscle testing is available, but none of these techniques has proven clinical applicability in the assessment of POP. Electromyography with needle electrodes permits visualization of individual motor unit action potentials; surface electrodes detect activity of groups of motor units. Pressure recording from the urethra, vagina, and anus can be used to assess pelvic floor muscle strength. Pudendal nerve terminal motor latency testing has been used to test for pudendal neuropathy, but its value remains controversial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155687\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ancillary diagnostic procedures are performed mainly for evaluation of bladder or bowel function, although additional testing is occasionally used to further evaluate prolapse itself [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/26\">",
"     26",
"    </a>",
"    ]. Whether to proceed with ancillary testing depends upon the presenting symptoms and whether there are symptoms that do not correlate with physical examination findings (eg, bladder or bowel symptoms are present in the absence of prolapse).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7156175\">",
"    <span class=\"h2\">",
"     Evaluation of prolapse",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7156232\">",
"    <span class=\"h3\">",
"     Photography",
"    </span>",
"    &nbsp;&mdash;&nbsp;If prolapse is stage II or greater, photographs that include a centimeter tape as a frame of reference can help objectively document presurgical findings or serial changes in an individual patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155694\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few clinical uses of imaging to evaluate the anatomic findings of prolapse. Imaging techniques are used for some aspects of evaluation of urinary or bowel function.",
"   </p>",
"   <p>",
"    Dynamic magnetic resonance imaging is under investigation for use in identifying site-specific pelvic support defects, as well as differentiating between a rectocele and an enterocele. However, there are no standardized criteria for use of this modality for the diagnosis of POP and it is largely used for research purposes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155701\">",
"    <span class=\"h2\">",
"     Urinary tract evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract evaluation for women with prolapse is guided by an individual patient&rsquo;s complaints (eg, incontinence, urinary retention). Studies may include testing for urinary tract infection, urinary incontinence, or urinary retention.",
"   </p>",
"   <p>",
"    This section will briefly discuss major components of urinary tract evaluation in women with POP. A detailed discussion of the evaluation of women with urinary incontinence, overactive bladder syndrome, or obstructive urinary symptoms can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17319?source=see_link\">",
"     \"Stress urinary incontinence in women: Preoperative evaluation for a primary procedure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32120?source=see_link\">",
"     \"Urodynamic evaluation of women with incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155809\">",
"    <span class=\"h3\">",
"     Urinary incontinence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary incontinence, particularly stress urinary incontinence (SUI), often coexists with POP. While women with POP often have SUI symptoms, many women with stage II or higher apical prolapse remain continent despite loss of anterior vaginal and",
"    <span class=\"nowrap\">",
"     bladder/urethral",
"    </span>",
"    support. However, 13 to 65 percent of continent women develop symptoms of SUI after surgical correction of the prolapse [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. This likely occurs because the prolapse kinks and obstructs the urethra; this obstruction is alleviated when the prolapse is repaired. This is referred to as \"occult\" or \"potential\" stress incontinence.",
"   </p>",
"   <p>",
"    All continent women with apical prolapse should have a preoperative evaluation for occult SUI with clinical or urodynamic urinary stress testing with and without reduction of prolapse. However, preoperative prolapse reduction testing does not accurately predict postoperative stress incontinence (approximately 40 percent of women with negative testing will develop postoperative stress incontinence) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1546?source=see_link&amp;anchor=H9#H9\">",
"     \"Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment\", section on 'Detecting occult incontinence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The routine use of urodynamics in women with prolapse, with or without symptomatic SUI, is controversial. Urodynamic testing is time-consuming and incurs expense, and it is unclear whether it improves surgical decision-making in women with uncomplicated SUI. We suggest urodynamics be performed only in women with complicated SUI (eg, previous anti-incontinence surgery, neurogenic lower urinary tract dysfunction, or suspicion of a non-stress etiology of urinary incontinence) or when symptoms are not consistent with physical examination findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17319?source=see_link&amp;anchor=H13#H13\">",
"     \"Stress urinary incontinence in women: Preoperative evaluation for a primary procedure\", section on 'Urodynamic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155816\">",
"    <span class=\"h3\">",
"     Urinary retention",
"    </span>",
"    &nbsp;&mdash;&nbsp;A postvoid residual urine volume (PVR) is one method used to evaluate for urinary retention. Testing PVR entails measuring the amount of urine that remains in the bladder within 10 minutes after the patient voids. In general, a PVR of greater than 200 cc may be suggestive of voiding dysfunction or detrusor weakness; the range of normal values for PVR and treatment options remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8937/abstract/33-35\">",
"     33-35",
"    </a>",
"    ] (these values may vary in elderly women or those with advanced POP).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7155823\">",
"    <span class=\"h2\">",
"     Bowel function evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who are undergoing evaluation for POP may also require further evaluation of anal incontinence or obstructive symptoms (eg, constipation, incomplete emptying). A detailed discussion of the evaluation of these conditions can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link&amp;anchor=H17#H17\">",
"     \"Fecal incontinence in adults\", section on 'Evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7156303\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with symptoms of a vaginal bulge or pelvic pressure, a pelvic mass should be excluded with pelvic examination, and if appropriate, imaging studies. Common conditions that may present with these symptoms include adnexal (eg, benign ovarian cysts or ovarian cancer) and uterine masses (eg, fibroids). Women with genital tract bleeding should also undergo appropriate evaluation to identify the source of bleeding and exclude malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link&amp;anchor=H11#H11\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24601?source=see_link&amp;anchor=H3883656#H3883656\">",
"     \"Approach to the patient with an adnexal mass\", section on 'Clinical approach'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Urinary (incontinence, retention, overactive bladder syndrome) or bowel (incontinence, obstructive symptoms) conditions are often associated with POP, as noted above (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H21524755#H21524755\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Clinical manifestations'",
"    </a>",
"    .) While these symptoms are suggestive of POP, pelvic examination may reveal the presence of one or more of these conditions without significant prolapse. Regardless of the presence or absence of POP, women with these symptoms should undergo thorough evaluation to determine whether they are caused or exacerbated by medical conditions other than pelvic relaxation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\", section on 'Diagnostic evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link&amp;anchor=H17#H17\">",
"     \"Fecal incontinence in adults\", section on 'Evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pelvic organ prolapse (POP) in women, the herniation of the pelvic organs to or beyond the vaginal walls, is diagnosed using pelvic examination. A medical history is also important to elicit prolapse-associated symptoms, since treatment is generally indicated only for symptomatic prolapse. (See",
"      <a class=\"local\" href=\"#H4375792\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The medical history includes symptoms specific to prolapse, as well as urinary, defecatory, and sexual complaints, which are often associated with POP. Conditions that can mimic prolapse (eg, pelvic mass) or comorbidities that may impact surgical treatment are assessed during the medical history. (See",
"      <a class=\"local\" href=\"#H7156552\">",
"       'Medical history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Pelvic Organ Prolapse Quantitation (POPQ) system is an objective, site-specific system for describing and staging POP. The POPQ system is the classification system of choice of the International Continence Society, the American Urogynecologic Society, and the Society of Gynecologic Surgeons. We suggest the use of the POPQ system rather than the Baden-Walker Halfway scoring system or other systems for classification of POP in women. (See",
"      <a class=\"local\" href=\"#H1120849\">",
"       'Classification of pelvic organ prolapse'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A rectovaginal examination is performed to diagnose an enterocele and differentiate between a high rectocele and an enterocele. (See",
"      <a class=\"local\" href=\"#H1121338\">",
"       'Rectovaginal examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A neuromuscular examination is performed. (See",
"      <a class=\"local\" href=\"#H1121527\">",
"       'Neuromuscular examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ancillary diagnostic procedures are performed mainly for evaluation of bladder or bowel function, although additional testing is occasionally used to further evaluate prolapse itself. (See",
"      <a class=\"local\" href=\"#H7155687\">",
"       'Ancillary studies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/1\">",
"      Bump RC, Mattiasson A, B&oslash; K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/2\">",
"      Brubaker, L, Norton, P. Current Clinical Nomenclature for Description of Pelvic Organ Prolapse. Journal of Pelvic Surgery 1996; 2:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/3\">",
"      Brubaker, L, Norton, P. Current clinical nomenclature for description of pelvic organ prolapse. J Pelvic Surg 1996; 2:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/4\">",
"      Hall AF, Theofrastous JP, Cundiff GW, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol 1996; 175:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/5\">",
"      Vierhout ME, Stoutjesdijk J, Spruijt J. A comparison of preoperative and intraoperative evaluation of patients undergoing pelvic reconstructive surgery for pelvic organ prolapse using the Pelvic Organ Prolapse Quantification System. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/6\">",
"      Muir TW, Stepp KJ, Barber MD. Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature. Am J Obstet Gynecol 2003; 189:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/7\">",
"      Treszezamsky AD, Rascoff L, Shahryarinejad A, Vardy MD. Use of pelvic organ prolapse staging systems in published articles of selected specialized journals. Int Urogynecol J 2010; 21:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/8\">",
"      Auwad W, Freeman RM, Swift S. Is the pelvic organ prolapse quantification system (POPQ) being used? A survey of members of the International Continence Society (ICS) and the American Urogynecologic Society (AUGS). Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/9\">",
"      ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin No. 85: Pelvic organ prolapse. Obstet Gynecol 2007; 110:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/10\">",
"      Elkadry EA, Kenton KS, FitzGerald MP, et al. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 2003; 189:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/11\">",
"      Hullfish KL, Bovbjerg VE, Steers WD. Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. Am J Obstet Gynecol 2004; 191:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/12\">",
"      Mahajan ST, Elkadry EA, Kenton KS, et al. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 2006; 194:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/13\">",
"      Barber MD, Lambers A, Visco AG, Bump RC. Effect of patient position on clinical evaluation of pelvic organ prolapse. Obstet Gynecol 2000; 96:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/14\">",
"      Digesu GA, Athanasiou S, Cardozo L, et al. Validation of the pelvic organ prolapse quantification (POP-Q) system in left lateral position. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/15\">",
"      Visco AG, Wei JT, McClure LA, et al. Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/16\">",
"      Shull BL. Clinical evaluation of women with pelvic support defects. Clin Obstet Gynecol 1993; 36:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/17\">",
"      Kenton K, Shott S, Brubaker L. Vaginal topography does not correlate well with visceral position in women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8:336.",
"     </a>",
"    </li>",
"    <li>",
"     Walters, MD. Description and classification of lower urinary tract dysfunction and pelvic organ prolapse. In: Urogynecology and Reconstructive Pelvic Surgery, 3rd ed, Walters, MD, Karram MM (Eds), Mosby Elsevier, Philadelphia 2007. p.58.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/19\">",
"      Parekh M, Swift S, Lemos N, et al. Multicenter inter-examiner agreement trial for the validation of simplified POPQ system. Int Urogynecol J 2011; 22:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/20\">",
"      Manonai J, Mouritsen L, Palma P, et al. The inter-system association between the simplified pelvic organ prolapse quantification system (S-POP) and the standard pelvic organ prolapse quantification system (POPQ) in describing pelvic organ prolapse. Int Urogynecol J 2011; 22:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/21\">",
"      Brubaker L, Barber MD, Nygaard I, et al. Quantification of vaginal support: are continuous summary scores better than POPQ stage? Am J Obstet Gynecol 2010; 203:512.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/22\">",
"      Lowder JL, Park AJ, Ellison R, et al. The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse. Obstet Gynecol 2008; 111:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/23\">",
"      Whiteside JL, Barber MD, Paraiso MF, et al. Clinical evaluation of anterior vaginal wall support defects: interexaminer and intraexaminer reliability. Am J Obstet Gynecol 2004; 191:100.",
"     </a>",
"    </li>",
"    <li>",
"     Walters, MD. Evaluation of urinary Incontinence and Pelvic Organ Prolapse. In: Urogynecology and Reconstructive Surgery, 3rd, Walters, MD, Karram, MM (Eds), Mosby Elsevier, Phildelphia 2007. p.69.",
"    </li>",
"    <li>",
"     www.icsoffice.org/ASPNET_membership/membership/documents/documents.aspx. (Accessed on January 16, 2012).",
"    </li>",
"    <li>",
"     Flynn, MK, Amundsen, CL. Diagnosis of pelvic organ prolapse. In: Multidisiplinary management of female pelvic floor disorders, Chapple, CR, Zimmerman, PE (Eds), Churchill Livingstone, Philadelphia 2006. p. 120.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/27\">",
"      Broekhuis SR, F&uuml;tterer JJ, Barentsz JO, et al. A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/28\">",
"      Ellerkmann RM, Cundiff GW, Melick CF, et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001; 185:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/29\">",
"      Gutman RE, Ford DE, Quiroz LH, et al. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol 2008; 199:683.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/30\">",
"      Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005; 192:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/31\">",
"      Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/32\">",
"      Visco AG, Brubaker L, Nygaard I, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/33\">",
"      American College of Obstetricians and Gynecologists. Urinary incontinence in women. Obstet Gynecol 2005; 105:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/34\">",
"      Kleeman S, Goldwasser S, Vassallo B, Karram M. Predicting postoperative voiding efficiency after operation for incontinence and prolapse. Am J Obstet Gynecol 2002; 187:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8937/abstract/35\">",
"      Foster RT Sr, Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007; 197:627.e1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8080 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.96.59.103-ECAAE0F0B7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8937=[""].join("\n");
var outline_f8_46_8937=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4375792\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1120849\">",
"      CLASSIFICATION OF PELVIC ORGAN PROLAPSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1121013\">",
"      POPQ system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1121160\">",
"      Other classification systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7156552\">",
"      MEDICAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1120407\">",
"      APPROACH TO THE EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1120534\">",
"      Examination components",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2794653\">",
"      Equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1120391\">",
"      Patient positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20651678\">",
"      Documentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1120399\">",
"      VISUAL INSPECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPECULUM AND BIMANUAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20651075\">",
"      Using the POPQ system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20651194\">",
"      - POPQ measurements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20651483\">",
"      - POPQ staging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9800359\">",
"      - Modifications of the POPQ system and reporting POPQ results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9800329\">",
"      Simplified POPQ",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9800345\">",
"      SLmax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Additional examination techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Simulated apical support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Inspection for paravaginal defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1121338\">",
"      RECTOVAGINAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1121527\">",
"      NEUROMUSCULAR EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7155323\">",
"      Neurologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20651633\">",
"      Pelvic floor muscle testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7155687\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7156175\">",
"      Evaluation of prolapse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7156232\">",
"      - Photography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7155694\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7155701\">",
"      Urinary tract evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7155809\">",
"      - Urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7155816\">",
"      - Urinary retention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7155823\">",
"      Bowel function evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7156303\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/8080\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8080|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/54/15202\" title=\"figure 1\">",
"      Sites pelvic organ support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/1/3100\" title=\"figure 2\">",
"      Three by three grid POP-Q",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/61/28639\" title=\"figure 3\">",
"      Form for documentation POP-Q",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/27/6586\" title=\"figure 4\">",
"      Pelvic floor muscles 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/6/40034\" title=\"figure 5\">",
"      Enterocele examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8080|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/26/27051\" title=\"table 1\">",
"      Stage of pelvic organ prolapse",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=related_link\">",
"      An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24601?source=related_link\">",
"      Approach to the patient with an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/47/4857?source=related_link\">",
"      Clinical manifestations, diagnosis, and nonsurgical management of posterior vaginal defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=related_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=related_link\">",
"      Fecal incontinence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=related_link\">",
"      Overview of causes of genital tract bleeding in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41735?source=related_link\">",
"      Overview of the principles of medical consultation and perioperative medicine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1546?source=related_link\">",
"      Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=related_link\">",
"      Pelvic organ prolapse in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17319?source=related_link\">",
"      Stress urinary incontinence in women: Preoperative evaluation for a primary procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42681?source=related_link\">",
"      The gynecologic history and pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32120?source=related_link\">",
"      Urodynamic evaluation of women with incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/7/17530?source=related_link\">",
"      Vaginal pessary treatment of prolapse and incontinence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_46_8938="Diabetic autonomic neuropathy";
var content_f8_46_8938=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"17\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diabetic autonomic neuropathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/46/8938/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8938/contributors\">",
"     Martin J Stevens, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/46/8938/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8938/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8938/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/46/8938/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/46/8938/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/46/8938/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic autonomic neuropathy (DAN) is classified as subclinical or clinical depending upon the presence or absence of symptoms. A wide spectrum of symptoms affecting many different organ systems can occur, including the cardiovascular, gastrointestinal, genitourinary, pupillary, sudomotor and neuroendocrine systems (",
"    <a class=\"graphic graphic_table graphicRef79376 \" href=\"UTD.htm?23/11/23739\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GLYCEMIC CONTROL AND MULTIFACTORIAL RISK FACTOR REDUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The therapy of diabetic autonomic neuropathy (DAN) can be difficult. It is therefore desirable to prevent this complication or, once established, to slow disease progression.",
"   </p>",
"   <p>",
"    Poor glucose control and vascular risk factors appear to be associated with the development of diabetic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/1\">",
"     1",
"    </a>",
"    ]. This observation is supported by the results of the EURODIAB study, which found that the incidence of neuropathy was associated with poor glucose control, elevated triglyceride levels, elevated body mass index, smoking, and hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41928?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis and prevention of diabetic polyneuropathy\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, results from a large prospective observational study suggest that the incidence of DAN is declining in type 1 diabetes, potentially reflecting improvements in the management of risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the Diabetes Control and Complications Trial (DCCT), intensive therapy with insulin in subjects with type 1 diabetes was found to reduce cardiovascular autonomic neuropathy incidence by 53 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/4\">",
"     4",
"    </a>",
"    ], and the benefit of prior intensive therapy was found to persist for up to 14 years in these subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential efficacy of intensive combined therapy in patients with type 2 diabetes and microalbuminuria was examined in the Steno type 2 trial [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/6\">",
"     6",
"    </a>",
"    ]. In this prospective open-label trial, 160 patients were randomly assigned to standard or multifactorial intensive therapy. The intensive regimen consisted of behavioral therapy (including advice concerning diet, exercise, and smoking cessation) and pharmacologic intervention (consisting of the administration of multiple agents to attain several aggressive therapeutic goals) (",
"    <a class=\"graphic graphic_table graphicRef69810 \" href=\"UTD.htm?5/1/5148\">",
"     table 2",
"    </a>",
"    ). DAN was present at baseline in 28 percent. At the end of the trial (mean follow-up of 7.8 years), intensive therapy reduced both microvascular and macrovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, intensive therapy reduced the rate of progression to DAN (30 versus 54 percent, relative risk [RR] 0.37, 95% CI 0.18-0.79). This benefit was sustained at a mean of 13.3 years (the trial intervention period plus an additional 5.5 years of observational follow-up) with a RR of 0.53 (95% CI 0.34-0.81) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/7\">",
"     7",
"    </a>",
"    ]. In contrast, there was no slowing of progression of peripheral neuropathy.",
"   </p>",
"   <p>",
"    The details of the protocol and overall results of this study are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36458?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of medical care in adults with diabetes mellitus\", section on 'Multifactorial risk factor reduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR AUTONOMIC NEUROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular autonomic neuropathy is defined as the impairment of autonomic control of the cardiovascular system [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/8\">",
"     8",
"    </a>",
"    ]. It is associated with several abnormalities in autonomic cardiovascular function. The prevalence of cardiovascular autonomic neuropathy varies considerably, which reflects the tests used, diagnostic criteria, and the population studied.",
"    <strong>",
"    </strong>",
"    Subclinically, the disease is defined by cardiovascular reflex testing, which may have prognostic implications. Clinically, the impairment in autonomic function is associated with resting tachycardia, exercise intolerance, orthostatic hypotension, intraoperative cardiovascular instability, silent myocardial infarction and ischemia, and increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Tachycardia and exercise intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise intolerance is usually due to impaired augmentation of cardiac output resulting from inadequate sympathetic modulation. Persistent sinus tachycardia can occur and there may be no variation in heart rate during activities that normally increase parasympathetic vagal tone, such as deep breathing and the Valsalva maneuver. Sympathetic tone may be increased during the day and parasympathetic tone decreased at night, which may predispose to nocturnal arrhythmogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Considerable interest has centered upon the role of abnormal myocardial electrical activity in arrhythmogenesis including, for example, QT prolongation and altered ventricular repolarization. In the EURODIAB Type 1 Complications Study, the prevalence of QT prolongation was 16 percent overall (11 percent in men, 21 percent in women) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac denervation can occur in diabetic patients with advanced autonomic neuropathy. It is characterized by a fixed heart rate, in the range of 80 to 90 beats per minute, and is associated with painless myocardial infarction and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Postural hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postural hypotension (defined as an orthostatic fall in systolic blood pressure in excess of 20 mmHg) results from a combination of central and peripheral cardiovascular sympathetic denervation. It reflects failure of vasoconstriction in both the splanchnic and peripheral vascular beds. In its most severe disabling form, postural hypotension can be refractory to treatment and result in the victim becoming wheelchair bound and unable to stand [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/14\">",
"     14",
"    </a>",
"    ]. Fortunately, this severity of orthostasis is rare, with the majority of patients having milder symptoms which are amenable to therapeutic interventions.",
"   </p>",
"   <p>",
"    Orthostasis with DAN has the following hemodynamic characteristics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is a loss of the diurnal variation in blood pressure, with supine hypertension occurring at night [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/15\">",
"       15",
"      </a>",
"      ]. This may also occur to a lesser degree in diabetic patients without neuropathy. In addition, ambulatory 24 hour blood pressure monitoring has detected hypertension in over 50 percent of subjects with type 2 diabetes and cardiovascular autonomic neuropathy, despite normal office blood pressure measurements [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is day-to-day variability of symptoms that may be exacerbated by insulin therapy, which can provoke hypotension in both diabetic [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/17\">",
"       17",
"      </a>",
"      ] and nondiabetic [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/18\">",
"       18",
"      </a>",
"      ] patients with autonomic failure.",
"     </li>",
"     <li>",
"      In occasional patients, supine and standing systolic blood pressures may fall profoundly after meals [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/14\">",
"       14",
"      </a>",
"      ]. The mechanism of postprandial hypotension in DAN is unclear. Both inadequate sympathetic compensation to meal-induced pooling of blood in the splanchnic circulation and vasodilatory gut peptides may contribute [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. A hematocrit should also be checked, since anemia can result from erythropoietin deficiency secondary to renal denervation, which may exacerbate orthostatic symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=see_link\">",
"       \"Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Postural tachycardia syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A posture-induced tachycardia without a fall in blood pressure can result in similar symptoms as are experienced in postural hypotension. The etiology is poorly understood. This condition is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=see_link\">",
"     \"Postural tachycardia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Increased mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least two meta-analyses of diabetic patients have found that cardiovascular autonomic neuropathy is associated with an increased risk of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In one meta-analysis, the mortality of autonomic neuropathy-free subjects over 5.5 years was approximately 5 percent, but this increased to 27 percent with the onset of abnormal cardiovascular reflex tests [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/22\">",
"     22",
"    </a>",
"    ]. In a subsequent meta-analysis, the magnitude of the association was stronger for studies that required more than one abnormality of cardiovascular function to define cardiovascular autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/23\">",
"     23",
"    </a>",
"    ]. In the ACCORD trial, over a mean follow-up of 3.5 years, subjects with cardiovascular autonomic neuropathy at baseline had overall mortality and cardiovascular mortality rates that were approximately 1.6 to 2.1 and 1.9 to 3.0 times higher, respectively, compared with those who did not have cardiovascular autonomic neuropathy, even after adjusting for baseline cardiovascular risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Longitudinal studies of patients with DAN have typically found mortality rates over five years ranging between 16 and 53 percent (mean about 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Although the majority of deaths result from associated macrovascular and microvascular disease, cardiorespiratory arrest secondary to autonomic denervation has been implicated in some diabetic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In the EURODIAB Prospective Complications Study of over 2700 subjects with type 1 diabetes, an annual mortality rate of 5 per 1,000 person-years was reported, with peripheral neuropathy (standardized hazard ratio [SHR] 1.88, 95% CI 1.06-3.35) and autonomic neuropathy (SHR 2.40, 95% CI 1.32-4.36) being the most important risk markers for mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the evidence that DAN is associated with increased cardiac morbidity and mortality, sudden cardiac death in patients with DAN may have a stronger relationship with atherosclerotic heart disease and nephropathy than with DAN itself. In the Rochester Diabetic Neuropathy Study (RDNS), a prospective, longitudinal, population-based study, 21 cases of sudden cardiac death occurred in 462 patients with diabetes (151 with type 1) who were followed for over 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/32\">",
"     32",
"    </a>",
"    ]. All 21 with sudden cardiac death had evidence of preceding severe atherosclerosis and myocardial damage. After adjusting for ECG abnormalities (including evolving or previous Q wave changes indicative of myocardial infarction, left bundle branch block, or pacing) and stage of nephropathy, autonomic dysfunction was not significantly associated with sudden cardiac death.",
"   </p>",
"   <p>",
"    Conversely, in a prospective observational study that followed patients with type 1 diabetes who had nephropathy (n = 197) or no nephropathy (n = 191) for 10 years, the presence of cardiovascular autonomic neuropathy (as measured by decreased heart rate variability) in the patients with nephropathy was an independent risk factor for cardiovascular morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies reporting the highest mortality rates have typically enrolled symptomatic patients with abnormalities of both the sympathetic and parasympathetic divisions of the autonomic nervous system. Postural hypotension appears to predict a poorer prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Adverse cardiovascular events and silent ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of cardiovascular autonomic neuropathy (CAN) is associated with adverse cardiac outcomes and with silent ischemia, as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the DIAD study, 522 patients with type 2 diabetes and no known or suspected coronary artery disease at baseline had adenosine stress radionuclide myocardial perfusion imaging studies, and silent ischemia was detected in 113 (22 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 120 patients with type 1 or type 2 diabetes and no history of myocardial infarction or angina but at least two additional cardiovascular risk factors followed for an average of 4.5 years found that a major cardiac event was significantly more common in patients with CAN than in those without CAN (24 versus 7 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A meta-analysis of 12 cross-sectional studies found that patients with CAN had a significantly higher frequency of silent myocardial ischemia than patients without CAN (pooled prevalence rate ratio 1.96, 95% CI 1.53-2.51) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanisms of silent myocardial ischemia are complex and not completely understood. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/9/42135?source=see_link&amp;anchor=H6#H6\">",
"     \"Silent myocardial ischemia: Epidemiology and pathogenesis\", section on 'Pathophysiology and pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Adverse renal and cerebrovascular outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of cardiovascular autonomic neuropathy may be associated with adverse renal and cerebrovascular outcomes, as suggested by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of subjects with type 1 diabetes who were followed for over 14 years, cardiovascular autonomic neuropathy and abnormal orthostatic diastolic blood pressure were associated with the subsequent development of renal complications [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In patients with type 2 diabetes patients enrolled in the longitudinal Appropriate Blood pressure Control in Diabetes (ABCD) trial, cardiovascular autonomic neuropathy was an independent risk factor for the occurrence of stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In a study including 1523 subjects with diabetes followed for 16 years, higher resting HR and lower HR variability and a higher resting heart rate increased the risk of developing end-stage renal disease [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/39\">",
"       39",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is evidence that sleep apnea and respiratory arrest may contribute to the increased mortality complicating DAN [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstructive",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      central sleep apnea have been reported in 26 to 50 percent of subjects with type 1 diabetes and DAN [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/41,42\">",
"       41,42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The number of oxygen desaturation episodes during sleep correlate with DAN severity [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/43\">",
"       43",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In nonobese adults with DAN and postural hypotension, the frequency of obstructive sleep apnea-hypopnea is &gt;30 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/44\">",
"       44",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In obese subjects, DAN is associated with an increased risk of obstructive sleep apnea compared with other obese subjects with or without diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/45\">",
"       45",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subclinical autonomic neuropathy is usually found in association with distal symmetric polyneuropathy and may only be detected by using cardiovascular reflex tests or tests of peripheral sympathetic function. Conventional measures of autonomic function use indirect methods relying on cardiovascular reflexes which can detect early abnormalities in parasympathetic integrity, but are relatively insensitive to sympathetic deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The choice of tests (",
"    <a class=\"graphic graphic_table graphicRef66386 \" href=\"UTD.htm?39/2/39979\">",
"     table 3",
"    </a>",
"    ) remains debatable and dependent upon the indication. There is no evidence that any one test has diagnostic superiority [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/8,47,48\">",
"     8,47,48",
"    </a>",
"    ]. However, cardiovascular reflex tests (",
"    <a class=\"graphic graphic_table graphicRef57628 \" href=\"UTD.htm?35/32/36363\">",
"     table 4",
"    </a>",
"    ) have good sensitivity and specificity. In addition, they are noninvasive, safe, and easy to perform [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/49\">",
"     49",
"    </a>",
"    ]. The majority of tests primarily evaluate cardiac parasympathetic integrity, and the most widely used are those that measure heart rate variability in response to deep breathing, standing, and the Valsalva maneuver [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/47\">",
"     47",
"    </a>",
"    ]. Of these tests, heart rate variability to deep breathing has the greatest specificity (approximately 80 percent). Spectral analysis of the mid (0.05-0.15 Hz) and high (0.15-0.5 Hz) frequency heart rate fluctuations is thought to reflect predominantly parasympathetic function. Tests that include a sympathetic component include measurement of blood pressure change in response to postural change and sustained handgrip, the Valsalva maneuver, muscle sympathetic nerve activity, and heart rate fluctuations in the low (0.01-0.05 Hz) frequency range.",
"   </p>",
"   <p>",
"    Some experts believe that a confident diagnosis of cardiovascular autonomic neuropathy requires abnormalities in more than one test, which evaluate different limbs of the reflex arc [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/36\">",
"     36",
"    </a>",
"    ]. This notion underlies proposed criteria for the diagnosis and staging of cardiovascular autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/8\">",
"     8",
"    </a>",
"    ], which identify possible or early cardiovascular autonomic neuropathy on the basis of one abnormal cardiovagal test [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/50\">",
"     50",
"    </a>",
"    ], definite or confirmed cardiovascular autonomic neuropathy on the basis of two abnormal cardiovagal tests [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/51\">",
"     51",
"    </a>",
"    ], and severe or advanced cardiovascular autonomic neuropathy by the additional presence of orthostatic hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/52\">",
"     52",
"    </a>",
"    ], which usually occurs late in the course of diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/47\">",
"     47",
"    </a>",
"    ]. However, the dependence of these criteria on the number of abnormal tests rather than the degree of the abnormality and reliability of individual tests appears to be arbitrary and not clearly evidence based.",
"   </p>",
"   <p>",
"    Direct assessment of cardiac sympathetic integrity has become possible with the introduction of radiolabeled analogues of norepinephrine, which are actively taken up by the sympathetic nerve terminals of the heart. The use of either 123-I-metaiodobenzylguanidine (MIBG) or 11-C-hydroxyephedrine scintigraphy permits noninvasive assessment of the pattern of sympathetic innervation of the heart [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/53-56\">",
"     53-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These tests have limited clinical utility because they are expensive and not widely available. They have, however, provided useful information because of their greater sensitivity to detect more subtle degrees of DAN than is possible by cardiovascular reflex testing:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with no evidence of DAN on cardiovascular reflex testing, abnormalities in cardiac innervation have been found in 40 to 71 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/53,55\">",
"       53,55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diabetic patients with confirmed autonomic neuropathy have more pronounced abnormalities, but the MIBG scans do not differentiate between minimal or severe DAN on reflex testing [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/55,56\">",
"       55,56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      11-C-hydroxyephedrine undergoes highly specific uptake and retention in sympathetic nerve terminals [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/57,58\">",
"       57,58",
"      </a>",
"      ] and, in comparison to MIBG, the images are less affected by non-neuronal uptake [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/59\">",
"       59",
"      </a>",
"      ] and tissue attenuation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/60\">",
"       60",
"      </a>",
"      ]. This characteristic facilitates the quantitative regional characterization of sympathetic neuronal dysfunction and loss [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A statement of the American Diabetes Association in 2005 noted that a patient's history and physical examination are ineffective for the early detection of cardiovascular autonomic neuropathy and recommended tests that quantify the loss of heart rate variability be performed to assess autonomic function (",
"    <a class=\"graphic graphic_table graphicRef66386 \" href=\"UTD.htm?39/2/39979\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/62\">",
"     62",
"    </a>",
"    ]. These heart rate variability tests are more widely available than the more specialized tests discussed above. However, heart rate variability tests do require standardized and accurate procedures to ensure accuracy and reproducibility of results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/10/4264?source=see_link\">",
"     \"Heart rate variability: Technical aspects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/39/35449?source=see_link\">",
"     \"Heart rate variability: Uses other than after myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/45/3799?source=see_link\">",
"     \"Evaluation of parasympathetic nervous system function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment should aim initially to improve overall cardiovascular fitness, since there is evidence that an exercise program can improve both early and more advanced cardiovascular autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. However, a cardiac stress study is suggested before this program is initiated.",
"   </p>",
"   <p>",
"    Mild postural symptoms can be treated by discontinuation of aggravating drugs (eg, tranquilizers, antidepressants, and diuretics) and elevation of the head of the bed by up to 30 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/65\">",
"     65",
"    </a>",
"    ]. There are several other general recommendations that may be helpful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Making changes in posture slowly, ie, standing slowly in \"stages.\"",
"     </li>",
"     <li>",
"      Tensing the legs by crossing them while actively standing on both legs. In one report of patients with autonomic neuropathy, this procedure raised the cardiac output by 16 percent and the systemic blood pressure by 13 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/66\">",
"       66",
"      </a>",
"      ]. It can therefore minimize postural symptoms.",
"     </li>",
"     <li>",
"      Performing dorsiflexion of the feet or handgrip exercise before standing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The major form of medical therapy consists of increasing the plasma volume with the mineralocorticoid",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    (0.1 to 0.4",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    and a high salt diet. This regimen may be helpful in more severe cases but can cause hypertension or peripheral edema. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"     \"Treatment of orthostatic and postprandial hypotension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other treatments that have been tried with variable success are atrial tachypacing, the alpha adrenoreceptor agonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/67,68\">",
"     67,68",
"    </a>",
"    ], the beta-blocker",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10487?source=see_link\">",
"     pindolol",
"    </a>",
"    (which has intrinsic sympathomimetic activity),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/69\">",
"     69",
"    </a>",
"    ], or intranasal or oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"     desmopressin",
"    </a>",
"    (dDAVP) to reduce nocturnal vasopressin release. One study, for example, evaluated the effect of fluoxetine (20",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    in five patients with orthostatic symptoms that were resistant to other treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/69\">",
"     69",
"    </a>",
"    ]. Two had marked and two had moderate improvement in symptoms.",
"   </p>",
"   <p>",
"    Measures aimed at increasing peripheral vascular tone (such as body stockings and gravity suits) are often tried. They may, however, prove ineffective since blood pooling probably occurs in the large splanchnic vascular bed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The somatostatin analogue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    (50 mcg three times daily, subcutaneously) may be helpful in diabetic patients with refractory and symptomatic postural or postprandial hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/14,20\">",
"     14,20",
"    </a>",
"    ]. It acutely raises the blood pressure only in patients with autonomic failure but tends to be poorly tolerated because it may exacerbate bowel dysfunction and cause fluctuations in glycemic control. Treatment of anemia (including the judicious use of EPO), if present, may also be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Supine hypertension (usually at night) is characteristic of autonomic neuropathy and may reflect a",
"    <span class=\"nowrap\">",
"     sympathetic/parasympathetic",
"    </span>",
"    imbalance. Occasional patients have severe supine hypertension combined with orthostatic hypotension. Their management is challenging with no clear therapeutic solution. Because of safety issues, treatment of the hypotension with volume expansion (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    ) and sympathetic stimulation (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    ) usually takes precedence. However, this approach may worsen their hypertension. In order to minimize daytime hypotension, short acting antihypertensive agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    can be administered before bed, but this strategy may not be successful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PERIPHERAL AUTONOMIC DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral autonomic nerve dysfunction may be manifest as changes in the texture of the skin, itching, edema, venous prominence, callus formation, loss of nails, and sweating abnormalities of the feet [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/8\">",
"     8",
"    </a>",
"    ]. The association between peripheral autonomic denervation and the resultant effects on the peripheral vasculature was recognized as early as 1941, when it was noted that diabetic patients with neuropathy had similar peripheral vasomotor reflexes as nondiabetic patients after sympathectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/71\">",
"     71",
"    </a>",
"    ]. This loss of sympathetic vascular innervation results in high peripheral blood flow through arteriovenous shunts [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/72\">",
"     72",
"    </a>",
"    ] and abnormal local reflex vascular control [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peripheral autonomic neuropathy may be a contributing factor for the development of foot ulceration [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. Animal studies have suggested that autonomic neuropathy alone can precipitate plantar ulceration [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/77\">",
"     77",
"    </a>",
"    ]. Diabetic patients with neuropathic foot ulceration (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11464?source=see_link\">",
"     \"Evaluation of the diabetic foot\"",
"    </a>",
"    ) have greater impairment of heart rate variation than patients with neuropathy with no foot ulcers [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peripheral autonomic neuropathy is thought to contribute to several other abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms such as aching, pulsation, tightness, cramping, dry skin, and pruritus.",
"     </li>",
"     <li>",
"      Peripheral edema, which is often associated with both foot ulceration and poor wound healing.",
"     </li>",
"     <li>",
"      The development of Charcot arthropathy (neuroarthropathy). In this condition, fractures can occur either spontaneously or with minimal stress and are followed by progressive bone disorganization with an increased risk of secondary ulceration (",
"      <a class=\"graphic graphic_picture graphicRef67753 \" href=\"UTD.htm?26/18/26927\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39527?source=see_link\">",
"       \"Diabetic neuropathic arthropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      High peripheral blood flow can cause weakening of the bones in the foot, thereby predisposing to fractures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quantitative sudomotor axon reflex testing (QSART) is widely utilized for the detection of early peripheral sympathetic denervation. Galvanic skin responses offer a simple measure of the presence of sympathetic innervation in the hands and feet [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/79\">",
"     79",
"    </a>",
"    ]. This technique, however, does not reliably detect more subtle degrees of sympathetic denervation. Sudomotor dysfunction may also be assessed using the indicator plaster Neuropad test [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/8,80\">",
"     8,80",
"    </a>",
"    ]. This test consists of a patch that is applied to the skin in order to measure sweat production visually by a change in color from blue to pink that occurs with absorption of water [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite growing acceptance as a useful marker of small fiber neuropathy, the role of skin intraepidermal nerve fiber assessment for the quantitation of DAN remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Measurement of vascular responses in the foot is an alternative method to detect peripheral sympathetic denervation. Thermal-induced vasoconstriction (rather than the normal vasodilation) reflects vascular denervation and is present only in those patients with both autonomic and somatic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/73\">",
"     73",
"    </a>",
"    ]. Impairment of local axon reflex dilatation is thought to reflect depletion of local vasoactive neuropeptides. The role of alteration in the skin blood flow regulation in the development of foot ulceration is being evaluated. Although peripheral autonomic neuropathy correlates poorly with motor nerve dysfunction, motor nerve conduction velocity is decreased in patients with other evidence of small fiber damage, particularly loss of thermal sensation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy of peripheral autonomic neuropathy mainly centers on careful foot care to prevent foot infection and ulceration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11464?source=see_link\">",
"     \"Evaluation of the diabetic foot\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A stepwise approach is indicated once neuropathy occurs that includes the following measures:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stop aggravating drugs",
"     </li>",
"     <li>",
"      Foot elevation when sitting",
"     </li>",
"     <li>",
"      Support stockings",
"     </li>",
"     <li>",
"      Diuretics for edema",
"     </li>",
"     <li>",
"      Screen for cardiovascular disease",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"       Midodrine",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Peripheral vascular denervation in diabetic neuropathy results in excess peripheral circulation and arteriovenous shunting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/72,83\">",
"     72,83",
"    </a>",
"    ]. Neuropathic edema is distinguished from that due to heart or renal failure by the history and by the lack of elevated jugular venous pressure.",
"   </p>",
"   <p>",
"    Sympathomimetic drugs, by reducing the shunting, may have a beneficial effect on edema [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/84\">",
"     84",
"    </a>",
"    ] and also on the high bone blood flow, which has been implicated in the pathogenesis of Charcot arthropathy. Ephedrine (30 mg, three times a day) is an effective treatment for neuropathic edema, although side effects (irritability, insomnia, hypertension and tachycardia) may limit its use [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/84\">",
"     84",
"    </a>",
"    ]. Midodrine (10 mg three times daily) is better tolerated and is now the preferred choice. Ephedrine is no longer available in the United States but is still available in Europe; it should not be used in patients with a history of cardiovascular disease. Bisphosphonates may also be helpful in the acute management of the Charcot foot [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL AUTONOMIC NEUROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In diabetes, gastrointestinal autonomic neuropathy can result in disorders of esophageal motility, gastric emptying (gastroparesis), and intestinal function [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/86\">",
"     86",
"    </a>",
"    ]. This section will briefly review these problems, and they are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link\">",
"     \"Diabetic autonomic neuropathy of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of gastrointestinal autonomic neuropathy vary with the site of involvement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with esophageal motility disorders have dysphagia, retrosternal pain and \"heartburn.\" However, esophageal disease is rarely clinically important in diabetics, even among those with autonomic neuropathy.",
"     </li>",
"     <li>",
"      Patients with delayed gastric emptying have anorexia, nausea, vomiting, early satiety, and postprandial fullness. The diagnosis of delayed gastric emptying is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=see_link\">",
"       \"Etiology and diagnosis of delayed gastric emptying\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diabetic enteropathy reflects widespread gastrointestinal autonomic neuropathy. Affected patients present with constipation, diarrhea, or even incontinence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link&amp;anchor=H9#H9\">",
"       \"Diabetic autonomic neuropathy of the gastrointestinal tract\", section on 'Diabetic enteropathy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diabetic diarrhea is characterized by severe nocturnal exacerbations and may be secondary to a variety of factors including abnormal intestinal motility; bacterial overgrowth; pancreatic exocrine insufficiency; fecal incontinence due to anorectal dysfunction; concurrent celiac disease, which occurs with increased frequency in diabetics;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bile salt malabsorption. Both diarrhea and gastroparesis can adversely affect glycemic control. Hyperglycemia can further perturb gastrointestinal function and result in dehydration requiring parenteral fluid therapy. On the other hand, hypoglycemia may result from insulin administration to a patient with impaired enteral delivery or delayed absorption. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link\">",
"     \"Diabetic autonomic neuropathy of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Treatment of gastroparesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy varies with the type of symptoms that are present, and there are a number of therapeutic options:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dietary modifications (eg, hydration and nutrition)",
"     </li>",
"     <li>",
"      Optimizing glycemic control",
"     </li>",
"     <li>",
"      Medications",
"     </li>",
"     <li>",
"      Occasional surgical therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The treatment of gastroparesis is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=see_link\">",
"     \"Treatment of delayed gastric emptying\"",
"    </a>",
"    .) The American Gastroenterological Association (AGA) technical review for the diagnosis and treatment of gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/87\">",
"     87",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     file://www.gastro.org/practice/medical-position-statements",
"    </a>",
"    (accessed on September 20, 2010).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Treatment of enteropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of diabetic autonomic enteropathy varies with the causative factors responsible for the diarrhea. This may include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     loperamide",
"    </a>",
"    for aberrant motility, rotating antibiotics for bacterial overgrowth, and biofeedback for anorectal dysfunction. Stool softeners are effective when constipation is the predominant complaint, while increased dietary fiber may exacerbate the constipation. Finally, some patients with intractable diarrhea have been reported to respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The treatment of diabetic enteropathy is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link&amp;anchor=H9#H9\">",
"     \"Diabetic autonomic neuropathy of the gastrointestinal tract\", section on 'Diabetic enteropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     GENITOURINARY AUTONOMIC NEUROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic genitourinary autonomic neuropathy is responsible for several syndromes including bladder dysfunction, retrograde ejaculation, erectile dysfunction, and dyspareunia (due to decreased vaginal lubrication) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/86\">",
"     86",
"    </a>",
"    ]. Erectile dysfunction is associated with the development of cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/88\">",
"     88",
"    </a>",
"    ]. Diabetic bladder dysfunction initially presents as a decrease in the ability to sense a full bladder, secondary to loss of autonomic afferent innervation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/89\">",
"     89",
"    </a>",
"    ]. This abnormality leads to infrequent urination, while involvement of efferent nerves of the bladder results in incomplete emptying. These abnormalities can result in recurrent urinary tract infections and overflow incontinence with dribbling and poor urinary stream. Urinary incontinence is more common in type 1 diabetes. Lower urinary tract symptoms were presence in approximately 20 percent of men with type 1 diabetes at the 10 year follow up time point after DCCT close out [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/90\">",
"     90",
"    </a>",
"    ]. In the same cohort, 38 percent of women reported urinary incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sexual problems are common in women with diabetes. In a study of 120 women with diabetes, 27 percent reported sexual dysfunction compared with 15 percent of 180 age-matched control women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/92\">",
"     92",
"    </a>",
"    ]. Decreased libido and reduced vaginal lubrication were more common in the diabetic women (17 versus 9 percent for decreased libido; 14 versus 6 percent for reduced vaginal lubrication, respectively). Depression was a significant predictor of sexual dysfunction in both groups.",
"   </p>",
"   <p>",
"    In men, retrograde ejaculation reflects loss of coordinated internal sphincter closure with external vesicle sphincter relaxation during ejaculation. It may be manifest as cloudy urine postcoitally due to the presence of sperm. Impotence secondary to autonomic neuropathy usually occurs with other systemic manifestations of either somatic or autonomic neuropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic bladder dysfunction should be confirmed by complete urodynamic testing. Treatment initially consists of a strict voluntary urination schedule, frequently coupled with the Crede maneuver. Scheduled urinations should be coupled with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25476?source=see_link\">",
"     bethanechol",
"    </a>",
"    (10 to 30 mg three times daily). More advanced cases require intermittent catheterization, and in extreme cases, resection of the internal sphincter at the bladder neck.",
"   </p>",
"   <p>",
"    The multiple potential etiologies of erectile impotence make it difficult to treat each patient with a standard protocol. An attempt should initially be made to establish the diagnosis: psychogenic, endocrine, vascular, iatrogenic (secondary to drugs), or autonomic neuropathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=see_link\">",
"     \"Evaluation of male sexual dysfunction\"",
"    </a>",
"    .) Particularly in men with type 2 diabetes, atherosclerosis with resulting low penile blood flow may be the causative lesion, a lesion that can be diagnosed by measuring brachial-to-penile Doppler blood pressure ratios. Many of the men respond to treatment with type 5 phosphodiesterase inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/93\">",
"     93",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=see_link\">",
"     \"Treatment of male sexual dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Retrograde ejaculation, a cause of infertility, has been treated with an antihistamine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/94\">",
"     94",
"    </a>",
"    ]. Treatment for female sexual dysfunction involves vaginal lubricants and estrogen creams.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OTHER MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other symptoms may occur with DAN, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sweating abnormalities such as distal anhidrosis with central hyperhidrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/95\">",
"       95",
"      </a>",
"      ]; the latter can occur in response to foods including cheese.",
"     </li>",
"     <li>",
"      Pupillary abnormalities may result in failure in dark adaptation and difficulties in night driving.",
"     </li>",
"     <li>",
"      Alterations in neuroendocrine responses, which have been attributed to DAN include a reduction in glucagon and epinephrine secretion in response to hypoglycemia, thereby increasing the likelihood of hypoglycemic episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/96\">",
"       96",
"      </a>",
"      ]. In subjects with DAN, decreased counterregulatory catecholamine responses may increase the risk for severe hypoglycemia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/97\">",
"       97",
"      </a>",
"      ]. However, autonomic neuropathy does not appear to be responsible for hypoglycemia unawareness. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"       \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Diabetes Association recommends screening for DAN at the time of diagnosis of type 2 diabetes and five years after the diagnosis of type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/46/8938/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Screening should include a history and physical examination for signs of autonomic dysfunction",
"     </li>",
"     <li>",
"      Tests of heart rate variability may be indicated, including expiration to inspiration ratio, response to the Valsalva maneuver, and response to standing (",
"      <a class=\"graphic graphic_table graphicRef66386 \" href=\"UTD.htm?39/2/39979\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      If initial screening is negative, a history and physical examination for signs of autonomic dysfunction should be repeated annually",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20208?source=see_link\">",
"       \"Patient information: Nerve damage caused by diabetes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/5/21587?source=see_link\">",
"       \"Patient information: Diabetic neuropathy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H173511014\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetic autonomic neuropathy (DAN) is classified as subclinical or clinical depending upon the presence or absence of symptoms. A wide spectrum of symptoms can affect many different organs, including the cardiovascular, gastrointestinal, genitourinary, pupillary, sudomotor and neuroendocrine systems (",
"      <a class=\"graphic graphic_table graphicRef79376 \" href=\"UTD.htm?23/11/23739\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Cardiovascular autonomic neuropathy is defined as the impairment of autonomic control of the cardiovascular system. The prevalence of cardiovascular autonomic neuropathy varies considerably, which reflects the tests used, diagnostic criteria, and the population studied.",
"      <strong>",
"      </strong>",
"      Subclinically, the disease is defined by cardiovascular reflex testing. Clinically, the impairment in autonomic function is associated with resting tachycardia, exercise intolerance, orthostatic hypotension, intraoperative cardiovascular instability, silent myocardial infarction and ischemia, and increased mortality. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cardiovascular autonomic neuropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Peripheral autonomic nerve dysfunction may be manifest as changes in the texture of the skin, itching, edema, venous prominence, callus formation, loss of nails, and sweating abnormalities of the feet. The loss of sympathetic vascular innervation results in high peripheral blood flow through arteriovenous shunts and abnormal local reflex vascular control. Peripheral autonomic neuropathy may be a contributing factor for the development of foot ulceration, and may contribute to several other abnormalities such as aching, pulsation, tightness, cramping, dry skin and pruritus, peripheral edema, and the development of Charcot arthropathy (neuroarthropathy). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Peripheral autonomic dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal autonomic neuropathy can result in disorders of esophageal motility, gastric emptying (gastroparesis), and intestinal function. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Gastrointestinal autonomic neuropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diabetic genitourinary autonomic neuropathy is responsible for several syndromes including bladder dysfunction, retrograde ejaculation, erectile dysfunction, and dyspareunia. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Genitourinary autonomic neuropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The American Diabetes Association recommends screening for DAN at the time of diagnosis of type 2 diabetes and five years after the diagnosis of type 1 diabetes. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/1\">",
"      Ko SH, Park SA, Cho JH, et al. Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care 2008; 31:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/2\">",
"      Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/3\">",
"      Pambianco G, Costacou T, Ellis D, et al. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006; 55:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/4\">",
"      The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998; 41:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/5\">",
"      Pop-Busui R, Low PA, Waberski BH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009; 119:2886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/6\">",
"      Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/7\">",
"      Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/8\">",
"      Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33:2285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/9\">",
"      Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/10\">",
"      Bernardi L, Ricordi L, Lazzari P, et al. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 1992; 86:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/11\">",
"      Aronson D, Weinrauch LA, D'Elia JA, et al. Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy. Am J Cardiol 1999; 84:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/12\">",
"      Veglio M, Borra M, Stevens LK, et al. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia 1999; 42:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/13\">",
"      Zander E, Schulz B, Heinke P, et al. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care 1989; 12:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/14\">",
"      Stevens MJ, Edmonds ME, Mathias CJ, Watkins PJ. Disabling postural hypotension complicating diabetic autonomic neuropathy. Diabet Med 1991; 8:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/15\">",
"      Hornung RS, Mahler RF, Raftery EB. Ambulatory blood pressure and heart rate in diabetic patients: an assessment of autonomic function. Diabet Med 1989; 6:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/16\">",
"      Istenes I, Keresztes K, Herm&aacute;nyi Z, et al. Relationship between autonomic neuropathy and hypertension--are we underestimating the problem? Diabet Med 2008; 25:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/17\">",
"      Page MM, Watkins PJ. Provocation of postural hypotension by insulin in diabetic autonomic neuropathy. Diabetes 1976; 25:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/18\">",
"      Mathias CJ, da Costa DF, Fosbraey P, et al. Hypotensive and sedative effects of insulin in autonomic failure. Br Med J (Clin Res Ed) 1987; 295:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/19\">",
"      Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995; 122:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/20\">",
"      Mathias CJ. Effect of food intake on cardiovascular control in patients with impaired autonomic function. J Neurosci Methods 1990; 34:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/21\">",
"      Winkler AS, Landau S, Watkins PJ. Erythropoietin treatment of postural hypotension in anemic type 1 diabetic patients with autonomic neuropathy: a case study of four patients. Diabetes Care 2001; 24:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/22\">",
"      Ziegler, D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Reviews 1999; 7:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/23\">",
"      Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26:1895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/24\">",
"      Pop-Busui R, Evans GW, Gerstein HC, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/25\">",
"      O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 1991; 79:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/26\">",
"      Navarro X, Kennedy WR, Sutherland DE. Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation. Diabetologia 1991; 34 Suppl 1:S108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/27\">",
"      Rathmann W, Ziegler D, Jahnke M, et al. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/28\">",
"      Sampson MJ, Wilson S, Karagiannis P, et al. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990; 75:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/29\">",
"      Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/30\">",
"      Watkins PJ, Mackay JD. Cardiac denervation in diabetic neuropathy. Ann Intern Med 1980; 92:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/31\">",
"      Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/32\">",
"      Suarez GA, Clark VM, Norell JE, et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry 2005; 76:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/33\">",
"      Astrup AS, Tarnow L, Rossing P, et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/34\">",
"      Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27:1954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/35\">",
"      Valensi P, Sachs RN, Harfouche B, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 2001; 24:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/36\">",
"      Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/37\">",
"      Fors&eacute;n A, Kangro M, Sterner G, et al. A 14-year prospective study of autonomic nerve function in Type 1 diabetic patients: association with nephropathy. Diabet Med 2004; 21:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/38\">",
"      Cohen JA, Estacio RO, Lundgren RA, et al. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Auton Neurosci 2003; 108:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/39\">",
"      Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 2010; 21:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/40\">",
"      Page MM, Watkins PJ. Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet 1978; 1:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/41\">",
"      Rees PJ, Prior JG, Cochrane GM, Clark TJ. Sleep apnoea in diabetic patients with autonomic neuropathy. J R Soc Med 1981; 74:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/42\">",
"      Ficker JH, Dertinger SH, Siegfried W, et al. Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J 1998; 11:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/43\">",
"      Neumann C, Martinez D, Schmid H. Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy. Diabetes Res Clin Pract 1995; 28:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/44\">",
"      Bottini P, Dottorini ML, Cristina Cordoni M, et al. Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 2003; 22:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/45\">",
"      Bottini P, Redolfi S, Dottorini ML, Tantucci C. Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration 2008; 75:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/46\">",
"      Wieling W, Borst C, van Dongen Torman MA, et al. Relationship between impaired parasympathetic and sympathetic cardiovascular control in diabetes mellitus. Diabetologia 1983; 24:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/47\">",
"      Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/48\">",
"      Bernardi L, Spallone V, Stevens M, et al. Investigation methods for cardiac autonomic function in human research studies. Diabetes Metab Res Rev 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/49\">",
"      Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996; 46:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/50\">",
"      Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 2004; 27:2942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/51\">",
"      Valensi P, Pari&egrave;s J, Attali JR, French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study. Metabolism 2003; 52:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/52\">",
"      Witte DR, Tesfaye S, Chaturvedi N, et al. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005; 48:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/53\">",
"      Allman KC, Stevens MJ, Wieland DM, et al. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993; 22:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/54\">",
"      M&auml;ntysaari M, Kuikka J, Mustonen J, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes 1992; 41:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/55\">",
"      Kreiner G, Wolzt M, Fasching P, et al. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 1995; 44:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/56\">",
"      Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995; 25:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/57\">",
"      Wieland, DM, Hutchins, GD, Rosenspire, K, et al. C-11 hydroxyephedrine (HED): a high specific activity alternative to F-18 fluorometaraminol (FMR) for heart neuronal imaging. J Nucl Med 1989; 30:A767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/58\">",
"      Melon PG, Nguyen N, DeGrado TR, et al. Imaging of cardiac neuronal function after cocaine exposure using carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1994; 23:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/59\">",
"      Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986; 27:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/60\">",
"      Schwaiger M, Kalff V, Rosenspire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990; 82:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/61\">",
"      Pop-Busui R, Kirkwood I, Schmid H, et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004; 44:2368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/62\">",
"      Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/63\">",
"      Howorka K, Pumprla J, Haber P, et al. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res 1997; 34:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/64\">",
"      Pagkalos M, Koutlianos N, Kouidi E, et al. Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy. Br J Sports Med 2008; 42:47.",
"     </a>",
"    </li>",
"    <li>",
"     Bannister, R, Mathias, CJ. Management of postural hypotension. In: Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System, 2d ed, Bannister, R (Ed), Oxford University Press, Oxford 1988. p.569.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/66\">",
"      Ten Harkel AD, van Lieshout JJ, Wieling W. Effects of leg muscle pumping and tensing on orthostatic arterial pressure: a study in normal subjects and patients with autonomic failure. Clin Sci (Lond) 1994; 87:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/67\">",
"      Kaufmann H, Brannan T, Krakoff L, et al. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988; 38:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/68\">",
"      Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995; 99:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/69\">",
"      Grubb BP, Samoil D, Kosinski D, et al. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med 1994; 97:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/70\">",
"      Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/71\">",
"      Wilkins, RW, Kolb, LC. Vasomotor disturbance in peripheral neuritis. Am J Med Sci 1941; 202:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/72\">",
"      Edmonds ME, Roberts VC, Watkins PJ. Blood flow in the diabetic neuropathic foot. Diabetologia 1982; 22:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/73\">",
"      Stevens MJ, Edmonds ME, Douglas SL, Watkins PJ. Influence of neuropathy on the microvascular response to local heating in the human diabetic foot. Clin Sci (Lond) 1991; 80:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/74\">",
"      Edmonds, ME, Nicolaides, K, Watkins, PJ. The importance of autonomic neuropathy in the etiology of diabetic neuropathic foot ulceration. Diabetologia 1981; 21:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/75\">",
"      Ryder RE, Kennedy RL, Newrick PG, et al. Autonomic denervation may be a prerequisite of diabetic neuropathic foot ulceration. Diabet Med 1990; 7:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/76\">",
"      Tentolouris N, Marinou K, Kokotis P, et al. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009; 26:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/77\">",
"      Borkowski M. An experimental study on the role of arteriovenous anastomoses in the pathogenesis of trophic ulcer. Arch Immunol Ther Exp (Warsz) 1973; 21:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/78\">",
"      Aso Y, Fujiwara Y, Inukai T, Takemura Y. Power spectral analysis of heart rate variation in diabetic patients with neuropathic foot ulceration. Diabetes Care 1998; 21:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/79\">",
"      Shahani BT, Halperin JJ, Boulu P, Cohen J. Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry 1984; 47:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/80\">",
"      Ziegler D, Papanas N, Roden M, GDC Study Group. Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet Med 2011; 28:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/81\">",
"      Papanas N, Papatheodorou K, Christakidis D, et al. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 2005; 113:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/82\">",
"      Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007; 56:2148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/83\">",
"      Boulton AJ, Scarpello JH, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 1982; 22:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/84\">",
"      Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet 1983; 1:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/85\">",
"      Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001; 44:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/86\">",
"      Kempler P, Amarenco G, Freeman R, et al. Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/87\">",
"      Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/88\">",
"      Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/89\">",
"      Brown JS, Wessells H, Chancellor MB, et al. Urologic complications of diabetes. Diabetes Care 2005; 28:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/90\">",
"      Van Den Eeden SK, Sarma AV, Rutledge BN, et al. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care 2009; 32:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/91\">",
"      Sarma AV, Kanaya A, Nyberg LM, et al. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology 2009; 73:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/92\">",
"      Enzlin P, Mathieu C, Van den Bruel A, et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 2002; 25:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/93\">",
"      Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999; 281:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/94\">",
"      Andaloro VA Jr, Dube A. Treatment of retrograde ejaculation with brompheniramine. Urology 1975; 5:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/95\">",
"      Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 1989; 64:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/96\">",
"      Amiel S. Glucose counter-regulation in health and disease: current concepts in hypoglycaemia recognition and response. Q J Med 1991; 80:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/46/8938/abstract/97\">",
"      Meyer C, Grossmann R, Mitrakou A, et al. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care 1998; 21:1960.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5285 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-218.189.88.190-75239E8C8F-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8938=[""].join("\n");
var outline_f8_46_8938=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H173511014\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GLYCEMIC CONTROL AND MULTIFACTORIAL RISK FACTOR REDUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CARDIOVASCULAR AUTONOMIC NEUROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Tachycardia and exercise intolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Postural hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Postural tachycardia syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Increased mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Adverse cardiovascular events and silent ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Adverse renal and cerebrovascular outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PERIPHERAL AUTONOMIC DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      GASTROINTESTINAL AUTONOMIC NEUROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Treatment of gastroparesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Treatment of enteropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      GENITOURINARY AUTONOMIC NEUROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OTHER MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H173511014\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5285\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5285|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/18/26927\" title=\"picture 1\">",
"      Charcot foot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5285|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/11/23739\" title=\"table 1\">",
"      Sx diabetic autonomic neurop",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/1/5148\" title=\"table 2\">",
"      Treatment goals Steno type 2 study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/2/39979\" title=\"table 3\">",
"      Diagnosis autonomic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/32/36363\" title=\"table 4\">",
"      Cardiovascular autonomic tests",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=related_link\">",
"      Diabetic autonomic neuropathy of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39527?source=related_link\">",
"      Diabetic neuropathic arthropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=related_link\">",
"      Etiology and diagnosis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=related_link\">",
"      Evaluation of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/45/3799?source=related_link\">",
"      Evaluation of parasympathetic nervous system function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11464?source=related_link\">",
"      Evaluation of the diabetic foot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/10/4264?source=related_link\">",
"      Heart rate variability: Technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/39/35449?source=related_link\">",
"      Heart rate variability: Uses other than after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=related_link\">",
"      Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36458?source=related_link\">",
"      Overview of medical care in adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41928?source=related_link\">",
"      Pathogenesis and prevention of diabetic polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/5/21587?source=related_link\">",
"      Patient information: Diabetic neuropathy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20208?source=related_link\">",
"      Patient information: Nerve damage caused by diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=related_link\">",
"      Postural tachycardia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/9/42135?source=related_link\">",
"      Silent myocardial ischemia: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=related_link\">",
"      Treatment of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=related_link\">",
"      Treatment of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_46_8939="Phakomatosis pigmentovascularis classification";
var content_f8_46_8939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of phakomatosis pigmentovascularis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Type I",
"       </td>",
"       <td>",
"        Capillary malformation + epidermal nevus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Type II",
"       </td>",
"       <td>",
"        Capillary malformation + dermal melanocytosis +/- nevus anemicus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Type III",
"       </td>",
"       <td>",
"        Capillary malformation + nevus spilus +/- nevus anemicus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Type IV",
"       </td>",
"       <td>",
"        Capillary malformation + dermal melanocytosis + nevus spilus +/- nevus anemicus",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original table modified for this publication. Reproduced from: Paller AS, Mancini AJ. Vascular disorders of childhood. In: Hurwitz Clinical Pediatric Dermatology, 3rd ed, Elsevier, 2006. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8939=[""].join("\n");
var outline_f8_46_8939=null;
var title_f8_46_8940="Causes of false negative TST";
var content_f8_46_8940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potential causes of false negative tuberculin tests",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Technical (potentially correctable)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Tuberculin material:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Improper storage (exposure to light or heat)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Contamination, improper dilution, or chemical denaturation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Administration:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Injection of too little tuberculin, or too deeply (should be intradermal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Administration more than 20 minutes after drawing up into the syringe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Reading:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Inexperienced or biased reader",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Error in recording",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Biologic (not correctable)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infections:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Active TB (especially if advanced)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Other bacterial infection (typhoid fever, brucellosis, typhus, leprosy, pertussis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        HIV infection (especially if CD4 count &lt;200)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Other viral infection (measles, mumps, varicella)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fungal infection (South American blastomycosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent live virus vaccination: (measles, mumps, polio)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunosuppressive drugs: (corticosteroids, TNF inhibitors, and others)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic disease: chronic renal failure, severe malnutrition, stress (surgery, burns)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diseases of lymphoid organs: (lymphoma, chronic lymphocytic leukemia, sarcoidosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age: infants &lt;6 months, elderly",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8940=[""].join("\n");
var outline_f8_46_8940=null;
var title_f8_46_8941="Rhythms with DDD pacemaker";
var content_f8_46_8941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rhythms seen with a normal DDD pacemaker",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 267px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The rhythms that occur in a patient with a DDD pacemaker depend upon the underlying heart rate and atrioventricular nodal conduction. The pacemaker spike is represented in blue. First panel: The pacemaker may be completely inhibited when the sinus rate is greater than the lower rate limit of the pacemaker. Second panel: P-wave synchronous pacing occurs when there is intrinsic atrioventricular nodal delay which is greater than the AV delay in the pacemaker. Third panel: Atrial pacing occurs when the sinus rate falls below the lower limit of the pacemaker and AV nodal conduction is intact. Fourth panel: If there is sinus bradycardia and AV nodal conduction delay, the pacemaker paces both atrium and ventricle, known as AV sequential pacing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8941=[""].join("\n");
var outline_f8_46_8941=null;
var title_f8_46_8942="CHOP-21";
var content_f8_46_8942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP-21) for peripheral T-cell non-Hodgkin lymphoma",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: 21 days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cyclophosphamide",
"        </strong>",
"       </td>",
"       <td>",
"        750 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL normal saline (NS) or 5 percent dextrose in water (D5W) and administer over 30 minutes.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Doxorubicin",
"        </strong>",
"       </td>",
"       <td>",
"        50 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 50 mL NS or D5W and administer over three to five minutes.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Vincristine",
"        </strong>",
"       </td>",
"       <td>",
"        1.4 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV (max dose 2 mg)",
"       </td>",
"       <td>",
"        Dilute in 50 mL NS or D5W and administer over 15 to 20 minutes.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Prednisone",
"        </strong>",
"        *",
"       </td>",
"       <td>",
"        100 mg orally",
"       </td>",
"       <td>",
"        Administer 30 minutes prior to chemotherapy on day 1, then every 24 hours on days 2 to 5.",
"       </td>",
"       <td>",
"        Days 1 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent frequency of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        No premedication to prevent infusion reactions. Refer to UpToDate topic on \"Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Doxorubicin and vincristine are vesicants. Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        The risk of febrile neutropenia with this regimen is 10 to 20 percent",
"        <sup>",
"         [1]",
"        </sup>",
"        ; primary prophylaxis with hematopoietic growth factors should be considered on an individual basis, particularly for high-risk patients such as those with preexisting neutropenia, advanced disease, poor performance status, or patients over age 65 years. Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Adjustment of initial cyclophosphamide, doxorubicin, and vincristine doses may be needed for preexisting liver dysfunction",
"        <sup>",
"         [2-4]",
"        </sup>",
"        . In addition, dose adjustment of cyclophosphamide may be required for renal dysfunction. Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiac screening:",
"        </strong>",
"        LVEF should be evaluated prior to initiation of therapy. Dose alterations should be considered for LVEF &lt;50 percent, and doxorubicin therapy is contraindicated in patients with LVEF &lt;30 percent at initiation. Infusion times and schedule may be adjusted to decrease the risk of cardiotoxicity in individuals at high risk for its development. Refer to UpToDate topic on \"Cardiotoxicity of anthracycline-like chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess basic metabolic panel (creatinine and electrolytes) and liver function prior to each subsequent treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; LVEF should be evaluated periodically based on LVEF at initiation of therapy and cumulative dose of doxorubicin. Refer to UpToDate topic on \"Cardiotoxicity of anthracycline-like chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelosuppression:",
"        </strong>",
"        Treatment should be delayed until ANC is greater than 1000/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelet count is greater than 100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        . If a patient develops grade 4 (ANC &lt;500) neutropenia or febrile neutropenia with any cycle, HGF support is added to the regimen for subsequent cycles. If grade 4 neutropenia or febrile neutropenia occurs despite HGF support, or if the patient develops grade 3 (25,000 to 50,000 platelets) or 4 (&lt;25,000 platelets) thrombocytopenia with any cycle, the doses of cyclophosphamide and doxorubicin should be decreased by 50 percent for subsequent cycles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neuropathy:",
"        </strong>",
"        Dose adjustment of vincristine may be necessary if the severity of neuropathy persists or worsens. No specific guidelines are available for dose adjustments.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated for all drugs.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; LVEF: left ventricular ejection fraction; CBC: complete blood count; ANC: absolute neutrophil count; HGF: hematopoietic growth factor.",
"     <br/>",
"     * Many prospective studies have dosed prednisone by body surface area with doses ranging from 40 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day to 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day; however, many institutions use the 100 mg/day dosing listed for convenience without apparent loss in efficacy.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Simon A, et al. Br J Haematol 2010; 151:159.",
"      </li>",
"      <li>",
"       Cytoxan (cyclophosphamide) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 10, 2012).",
"      </li>",
"      <li>",
"       Adriamycin (doxorubicin hydrochloride) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 10, 2012).",
"      </li>",
"      <li>",
"       Vincristine (vincristine sulfate) injection. US FDA-approved product information. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 10, 2012).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8942=[""].join("\n");
var outline_f8_46_8942=null;
var title_f8_46_8943="Erythema nodosum";
var content_f8_46_8943=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema nodosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 238px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Painful erythematous nodules of erythema nodosum are often found in a symmetric distribution on the legs. The nodules can also appear to be pigmented.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore. 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_46_8943=[""].join("\n");
var outline_f8_46_8943=null;
